Page last updated: 2024-10-16

gamma-aminobutyric acid and Chronic Disease

gamma-aminobutyric acid has been researched along with Chronic Disease in 294 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
" Gabapentin (a GABA analogue) is efficacious and often well tolerated in other chronic pain conditions."9.27GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol. ( Baranowski, A; Bhattacharya, S; Birch, J; Cheong, Y; Cregg, R; Daniels, J; Hewitt, CA; Horne, AW; Macfarlane, GJ; Middleton, L; Szubert, W; Tracey, I; Vincent, K; Williams, ACC, 2018)
" Adults with refractory chronic cough (>8 weeks' duration) without active respiratory disease or infection were randomly assigned to receive gabapentin (maximum tolerable daily dose of 1800 mg) or matching placebo for 10 weeks."9.16Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. ( Birring, SS; Gibson, PG; Ryan, NM, 2012)
" Gabapentin significantly improved cough-specific quality of life compared with placebo (between-group difference in LCQ score during treatment period 1·80, 95% CI 0·56-3·04; p=0·004; number needed to treat of 3·58)."9.16Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. ( Birring, SS; Gibson, PG; Ryan, NM, 2012)
"The treatment of refractory chronic cough with gabapentin is both effective and well tolerated."9.16Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. ( Birring, SS; Gibson, PG; Ryan, NM, 2012)
"Pregabalin, a high-affinity ligand for α2δ subunits of voltage-gated calcium channels, is a novel pharmacotherapy for chronic pain, partial seizures, and other disorders."9.15Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures. ( Bockbrader, HN; Burger, P; Corrigan, BW; Knapp, L, 2011)
"Using nonlinear mixed-effect modeling, 5,583 plasma pregabalin concentration-time samples from 1,723 subjects were analyzed: 2,868 samples from healthy volunteers or subjects with renal impairment (n = 123), 1,513 from patients with partial seizures (n = 626), and 1,202 from patients with chronic pain (n = 974)."9.15Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures. ( Bockbrader, HN; Burger, P; Corrigan, BW; Knapp, L, 2011)
"Pregabalin CL/F is related to CLcr, and this relationship is similar among healthy volunteers and patients with either partial seizures or chronic pain disorders."9.15Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures. ( Bockbrader, HN; Burger, P; Corrigan, BW; Knapp, L, 2011)
"To evaluate the adequacy of a low-dose combination of oxycodone and paracetamol (acetaminophen) in patients with multimodal, chronic, non-malignant pain using the Pain Management Index (PMI)."9.14Adequacy assessment of oxycodone/paracetamol (acetaminophen) in multimodal chronic pain : a prospective observational study. ( Bertini, L; Carucci, A; Gatti, A; Mammucari, M; Occhioni, R; Sabato, AF, 2009)
"The purpose of this, open-label, non-comparative study, was to evaluate the efficacy on quality of life and the efficacy of gabapentin monotherapy in patients with chronic radiculopathy."9.14Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality. ( Deniz, O; Erdal, A; Gureser, G; Karatay, S; Senel, K; Ugur, M; Yildirim, K, 2009)
"Thirty-five patients with radicular pain and diagnosed as L4, L5 or S1 radiculopathy were treated with oral gabapentin from a total of 300 mg per day once up to a total of 1800 mg per day divided in 3 doses for eight-week trial period."9.14Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality. ( Deniz, O; Erdal, A; Gureser, G; Karatay, S; Senel, K; Ugur, M; Yildirim, K, 2009)
"Gabapentin may provide benefits in terms of alleviation of pain and overall quality of life in patients with chronic radiculopathy."9.14Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality. ( Deniz, O; Erdal, A; Gureser, G; Karatay, S; Senel, K; Ugur, M; Yildirim, K, 2009)
"Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception."9.12Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. ( Bergasa, NV; Engler, D; Ginsburg, IH; McGee, M, 2006)
"The aim of this study was to compare the efficacy and side effects of gabapentin, amitriptyline, and their combination in women with chronic pelvic pain."9.11Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. ( Ellend, A; Frickey, N; Gleiss, A; Kozek-Langenecker, SA; Kress, HG; Sator-Katzenschlager, SM; Scharbert, G, 2005)
"Gabapentin alone or in combination with amitriptyline is better than amitriptyline alone in the treatment of female chronic pelvic pain."9.11Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. ( Ellend, A; Frickey, N; Gleiss, A; Kozek-Langenecker, SA; Kress, HG; Sator-Katzenschlager, SM; Scharbert, G, 2005)
"To assess the effectiveness and safety of the lidocaine patch 5%, a targeted peripheral analgesic, in the treatment of postherpetic neuralgia, painful diabetic neuropathy, and low back pain patients with incomplete responses to their current analgesic treatment regimen containing gabapentin."9.10Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. ( Drass, M; Nalamachu, S; Patel, N; White, WT, 2003)
"Significant improvements in BPI measures of pain intensity and pain relief were reported for all groups of patients after 2 weeks of lidocaine patch 5% treatment."9.10Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. ( Drass, M; Nalamachu, S; Patel, N; White, WT, 2003)
"A retrospective audit of the perceived efficacy and tolerability of adjunctive gabapentin (GBT) therapy in patients with intractable epilepsy was carried out."9.09An audit of the perceived efficacy and tolerability of gabapentin therapy in an out-patient cohort with chronic epilepsy. ( Duncan, JS; Langan, Y; Sander, JW, 1999)
"To assess the efficacy and safety of low doses of gabapentin in cases of chronic daily headache."9.09Low doses of gabapentin may be helpful in the management of chronic daily headache. ( Carrazana, EJ; Fragoso, YD, 2000)
"Despite the inherent limitations of such a small open trial, the authors concluded that ratings of excellent and good by two thirds of this population of patients with chronic daily headache should encourage the setup of a large double-blind, multicentric, placebo-controlled trial of low doses of gabapentin for chronic daily headache."9.09Low doses of gabapentin may be helpful in the management of chronic daily headache. ( Carrazana, EJ; Fragoso, YD, 2000)
"The authors investigate: (1) whether there is a lateral effect of hydrogen (1H) magnetic resonance (MR) spectroscopy observable metabolite ratios between the right and the left prefrontal lobe in chronic schizophrenia; (2) whether there is a change of proton metabolite ratios in chronic schizophrenia after neuroleptic treatment; (3) whether there is a relation between changes in 1H MR spectra and the clinical assessment of Brief Psychiatric Rating Scale (BPRS); and (4) to investigate a hypofrontality hypothesis in schizophrenia in terms of neurochemical aspects."9.08Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy. ( Choe, BY; Lee, C; Lee, CW; Paik, IH; Shinn, KS; Suh, TS, 1996)
" Results of a clinical open trial with pivagabine (4-[(2,2-dimethyl-1-oxopropyl) amino]butanoic acid, CAS 69542-93-4, Tonerg) on 22 young patients affected by dysthymic disorders and on 38 older patients affected by adjustment disorders following different stressors (mourning, retirement and recovery in institutions of assistance) are reported."9.08Clinical evaluation of the efficacy of pivagabine in the treatment of mood and adjustment disorders. ( Gilotta, SM; Luca, S; Terranova, R, 1997)
"To substantiate a previously reported disturbance of gamma-aminobutyric acid (GABA) in chronic schizophrenia, plasma growth hormone (GH) response to a direct GABA agonist (baclofen, 10 mg) was assessed in 12 unmedicated chronic schizophrenic males and 10 sex- and age-matched healthy controls."9.06Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia. ( Forziati, D; Iovino, M; Maj, M; Monteleone, P; Steardo, L; Veltro, F, 1988)
"Recent developments in the treatment of cough include the use of speech pathology and pharmacotherapy with gabapentin."8.91Gabapentin in chronic cough. ( Gibson, PG; Vertigan, AE, 2015)
"The effectiveness of neuromodulating medications such as gabapentin and pregabalin in the treatment of cough has been supported primarily through case series, case reports, prospective reviews and a double blind randomised controlled trial."8.91Gabapentin in chronic cough. ( Gibson, PG; Vertigan, AE, 2015)
"To assess the analgesic efficacy and adverse effects of gabapentin in chronic neuropathic pain and fibromyalgia."8.90Gabapentin for chronic neuropathic pain and fibromyalgia in adults. ( Derry, S; Moore, RA; Rice, AS; Toelle, T; Wiffen, PJ, 2014)
"We identified randomised trials of gabapentin for chronic neuropathic pain or fibromyalgia by searching the databases MEDLINE (1966 to March 2014), EMBASE (1980 to 2014 week 10), and CENTRAL in The Cochrane Library (Issue 3 of 12, 2014)."8.90Gabapentin for chronic neuropathic pain and fibromyalgia in adults. ( Derry, S; Moore, RA; Rice, AS; Toelle, T; Wiffen, PJ, 2014)
"Randomised, double-blind studies reporting the analgesic and adverse effects of gabapentin in neuropathic pain or fibromyalgia with assessment of pain intensity, pain relief, or both, using validated scales."8.90Gabapentin for chronic neuropathic pain and fibromyalgia in adults. ( Derry, S; Moore, RA; Rice, AS; Toelle, T; Wiffen, PJ, 2014)
"gov, Google Scholar, and reference lists of articles and abstracts from conference proceedings, without language restriction for pregabalin treatment of Class III prostatitis and CP/CPPS."8.88Pregabalin for chronic prostatitis. ( Aboumarzouk, OM; Nelson, RL, 2012)
"Twenty-nine studies (3571 participants), studied gabapentin at daily doses of 1200 mg or more in 12 chronic pain conditions; 78% of participants were in studies of postherpetic neuralgia, painful diabetic neuropathy or mixed neuropathic pain."8.87Gabapentin for chronic neuropathic pain and fibromyalgia in adults. ( Derry, S; McQuay, HJ; Moore, RA; Wiffen, PJ, 2011)
"Gabapentin was initially developed as an antiepileptic drug but was later discovered to be an effective treatment of neuropathic pain."8.86Gabapentin for the treatment of cancer-related pain syndromes. ( Bar Ad, V, 2010)
"Recent studies showed effectiveness of gabapentin in improving the pain control in patients with neuropathic cancer pain, already treated with opiates."8.86Gabapentin for the treatment of cancer-related pain syndromes. ( Bar Ad, V, 2010)
"Given the significant benefits of gabapentin and the combination of gabapentin with opioids for the treatment of neuropathic pain, randomized clinical trials are needed to establish the role of these analgesic regimens for the treatment of neuropathic cancer pain."8.86Gabapentin for the treatment of cancer-related pain syndromes. ( Bar Ad, V, 2010)
"Pregabalin has proven efficacy in neuropathic pain conditions and fibromyalgia."8.85Pregabalin for acute and chronic pain in adults. ( Derry, S; McQuay, HJ; Moore, RA; Straube, S; Wiffen, PJ, 2009)
"To assess analgesic efficacy and associated adverse events of pregabalin in acute and chronic pain."8.85Pregabalin for acute and chronic pain in adults. ( Derry, S; McQuay, HJ; Moore, RA; Straube, S; Wiffen, PJ, 2009)
"Randomised, double blind trials reporting on the analgesic effect of pregabalin, with subjective pain assessment by the patient as either the primary or a secondary outcome."8.85Pregabalin for acute and chronic pain in adults. ( Derry, S; McQuay, HJ; Moore, RA; Straube, S; Wiffen, PJ, 2009)
"There was no clear evidence of beneficial effects of pregabalin in established acute postoperative pain."8.85Pregabalin for acute and chronic pain in adults. ( Derry, S; McQuay, HJ; Moore, RA; Straube, S; Wiffen, PJ, 2009)
"To evaluate the analgesic effectiveness and adverse effects of gabapentin for pain management in clinical practice."8.82Gabapentin for acute and chronic pain. ( Edwards, JE; McQuay, HJ; Moore, RA; Wiffen, PJ, 2005)
"Randomised trials of gabapentin in acute, chronic or cancer pain were identified by MEDLINE (1966-Nov 2004), EMBASE (1994-Nov 2004), SIGLE (1980-Jan 2004) and the Cochrane Central Register of Controlled Trials (CENTRAL) (Cochrane Library Issue 4, 2004)."8.82Gabapentin for acute and chronic pain. ( Edwards, JE; McQuay, HJ; Moore, RA; Wiffen, PJ, 2005)
"Randomised trials reporting the analgesic effects of gabapentin in patients, with subjective pain assessment as either the primary or a secondary outcome."8.82Gabapentin for acute and chronic pain. ( Edwards, JE; McQuay, HJ; Moore, RA; Wiffen, PJ, 2005)
"There is evidence to show that gabapentin is effective in neuropathic pain."8.82Gabapentin for acute and chronic pain. ( Edwards, JE; McQuay, HJ; Moore, RA; Wiffen, PJ, 2005)
"Response to gabapentin was defined by physician-documented subjective patient report of improvement in cough symptoms."7.85Unilateral Laryngoscopic Findings Associated With Response to Gabapentin in Patients With Chronic Cough. ( Dibildox, D; Giliberto, JP; Merati, A, 2017)
" Therapy was initiated in patients with chronic cough with gabapentin, 100 mg twice daily, which was titrated to response or adverse effects."7.85Unilateral Laryngoscopic Findings Associated With Response to Gabapentin in Patients With Chronic Cough. ( Dibildox, D; Giliberto, JP; Merati, A, 2017)
"In patients with chronic cough suspected to be related to vagal neuropathy, the odds of response to gabapentin are higher with the presence of VFMA noted on videostroboscopy."7.85Unilateral Laryngoscopic Findings Associated With Response to Gabapentin in Patients With Chronic Cough. ( Dibildox, D; Giliberto, JP; Merati, A, 2017)
"In the present work, we investigated the antinociceptive effect of gabapentin in a chronic myositis model and its interference in spinal glial cells."7.85Gabapentin decreases microglial cells and reverses bilateral hyperalgesia and allodynia in rats with chronic myositis. ( Chacur, M; Freitas, MF; Rocha, IR; Rosa, AS, 2017)
"Latrunculin A microperfusion of the hippocampus induces acute epileptic seizures and long-term biochemical changes leading to spontaneous seizures."7.80Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. ( Loureiro, AI; Sierra-Marcuño, G; Sierra-Paredes, G; Soares-da-Silva, P; Wright, LC, 2014)
"Oral administration of ESL (100 mg/kg), previous to latrunculin A microperfusion, completely prevented acute latrunculin A-induced seizures as well as chronic seizures and all EEG chronic signs of paroxysmal activity."7.80Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. ( Loureiro, AI; Sierra-Marcuño, G; Sierra-Paredes, G; Soares-da-Silva, P; Wright, LC, 2014)
"ESL treatment prevented acute latrunculin A-induced seizures as well as chronic seizures and all EEG chronic signs of paroxysmal activity, supporting a possible anti-epileptogenic effect of ESL in mice."7.80Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. ( Loureiro, AI; Sierra-Marcuño, G; Sierra-Paredes, G; Soares-da-Silva, P; Wright, LC, 2014)
"To analyze the survival and the changes of proportions of Calbindin, Calretinin and Parvalbumin positive neurons in mouse hippocampal CA area at chronic stage of Pilocarpine-induced epilepsy."7.79[Survival of calbindin, calretinin and parvalbumin positive neurons in mouse hippocampal CA area at chronic stage of pilocarpine-induced epilepsy]. ( Liu, J; Liu, Y; Tang, F, 2013)
"Calbindin, Calretinin and Parvalbumin immunofluoresence staining were done 2 months after Pilocarpine-induced epilepsy in mice or saline injection."7.79[Survival of calbindin, calretinin and parvalbumin positive neurons in mouse hippocampal CA area at chronic stage of pilocarpine-induced epilepsy]. ( Liu, J; Liu, Y; Tang, F, 2013)
"The changes of proportions of Calbindin, Calretinin and Parvalbumin positive neurons in the CA area of mouse hippocampus may be a factor in the ongoing epileptic activity at chronic stage of Pilocarpine-induced epilepsy."7.79[Survival of calbindin, calretinin and parvalbumin positive neurons in mouse hippocampal CA area at chronic stage of pilocarpine-induced epilepsy]. ( Liu, J; Liu, Y; Tang, F, 2013)
"The aim of this study was to assess the role of adding gabapentin (Neurontin) to the prescription of patients with opiate resistant pain as a result of critical limb ischaemia (CLI)."7.76Gabapentin (Neurontin) improves pain scores of patients with critical limb ischaemia: an observational study. ( Lewis, MH; Morris-Stiff, G, 2010)
"The study has demonstrated that gabapentin is a useful adjuvant in the management of CLI and leads to significant reductions in pain scores and improves night pain for most patients."7.76Gabapentin (Neurontin) improves pain scores of patients with critical limb ischaemia: an observational study. ( Lewis, MH; Morris-Stiff, G, 2010)
"The objective of this study was to develop a pharmacokinetic-pharmacodynamic (PK-PD) model of the static allodynia response to pregabalin with and without sildenafil in a chronic constriction injury model of neuropathic pain."7.76Pharmacokinetic-pharmacodynamic analysis of the static allodynia response to pregabalin and sildenafil in a rat model of neuropathic pain. ( Bender, G; Bies, RR; Bramwell, S; Danhof, M; DeJongh, J; Field, MJ; Florian, JA; Marshall, S; Tan, KK, 2010)
"Despite widely replicated abnormalities of gamma-aminobutyric acid (GABA) neurons in schizophrenia postmortem, few studies have measured tissue GABA levels in vivo."7.76Elevated gamma-aminobutyric acid levels in chronic schizophrenia. ( Cohen, BM; McCarthy, J; Ongür, D; Prescot, AP; Renshaw, PF, 2010)
"We found elevations in GABA/creatine in the schizophrenia group compared with control subjects [F(1,65) = 4."7.76Elevated gamma-aminobutyric acid levels in chronic schizophrenia. ( Cohen, BM; McCarthy, J; Ongür, D; Prescot, AP; Renshaw, PF, 2010)
"Pregabalin is used for treatment of neuropathic pain conditions."7.74Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats. ( Audette, KM; Maeda, Y; Sluka, KA; Yokoyama, T, 2007)
"This study shows that pregabalin reduces both cutaneous and muscle hyperalgesia in inflammatory and noninflammatory models of muscle pain."7.74Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats. ( Audette, KM; Maeda, Y; Sluka, KA; Yokoyama, T, 2007)
"Pregabalin is often used for the treatment of chronic pain syndromes."7.74Pregabalin-induced generalized myoclonic status epilepticus in patients with chronic pain. ( Hamer, HM; Hattemer, K; Klein, KM; Knake, S; Oertel, WH; Rosenow, F; Wellek, A, 2007)
"This prospective, open-label study aimed to evaluate the efficacy of pregabalin treatment in patients suffering from trigeminal neuralgia with and without concomitant facial pain."7.74Efficacy of pregabalin in the treatment of trigeminal neuralgia. ( Diener, HC; Katsarava, Z; Maschke, M; Obermann, M; Sensen, K; Yoon, MS, 2008)
"The anticonvulsant gabapentin (GBP) has been shown effective for the treatment of neuropathic pain, although its mechanism of action remains unclear."7.73Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: implications for mechanism of action. ( Aiyar, J; Anker, N; Belley, M; Bristow, L; Campbell, B; Cohen, C; Park, KT; Ren, K; Stearns, B; Urban, MO, 2005)
"This study was designed to characterize, in anterior, mediobasal, and posterior hypothalamic and median eminence, the 24h changes of gamma aminobutyric acid (GABA) and taurine (TAU) contents in adult male rats and to analyze whether chronic hyperprolactinemia may affect these patterns."7.72Daily changes of GABA and taurine concentrations in various hypothalamic areas are affected by chronic hyperprolactinemia. ( Alvarez, MP; Cano, P; Castrillón, PO; Duvilanski, BH; Esquifino, AI, 2003)
" Chronic seizures were induced by amygdalar injection of kainic acid 60 days before death."7.71Collapse of extracellular glutamate regulation during epileptogenesis: down-regulation and functional failure of glutamate transporter function in rats with chronic seizures induced by kainic acid. ( Doi, T; Kamada, H; Mitsuyama, Y; Nakajima, A; Ohya-Nishiguchi, H; Tokumaru, J; Ueda, Y; Willmore, LJ; Yokoyama, H, 2001)
"Postmortem samples from individuals with schizophrenia (n = 13) and control subjects (n = 10) were investigated for binding of [(3)H]tiagabine to GABA transporter-1 GAT-1."7.71Increased [(3)H]tiagabine binding to GAT-1 in the cingulate cortex in schizophrenia. ( Blennow, K; Dandenell, AK; Davidsson, P; Marcusson, J; Sundman-Eriksson, I, 2002)
"To present two years of experience in the use of gabapentin for the alleviation of neuropathic pain in spinal cord injury patients."7.71Gabapentin for neuropathic pain following spinal cord injury. ( Brown, DJ; Cooper, N; Frauman, AG; Hill, ST; Kirsa, SW; Lim, TC; To, TP, 2002)
"Data were retrieved from the medical records of all spinal cord injury patients prescribed gabapentin for neuropathic pain."7.71Gabapentin for neuropathic pain following spinal cord injury. ( Brown, DJ; Cooper, N; Frauman, AG; Hill, ST; Kirsa, SW; Lim, TC; To, TP, 2002)
"Seventy-six per cent of patients receiving gabapentin reported a reduction in neuropathic pain."7.71Gabapentin for neuropathic pain following spinal cord injury. ( Brown, DJ; Cooper, N; Frauman, AG; Hill, ST; Kirsa, SW; Lim, TC; To, TP, 2002)
"Our experience suggests that gabapentin offers an effective therapeutic alternative for the alleviation of neuropathic pain following spinal cord injury."7.71Gabapentin for neuropathic pain following spinal cord injury. ( Brown, DJ; Cooper, N; Frauman, AG; Hill, ST; Kirsa, SW; Lim, TC; To, TP, 2002)
"To compare the long-term retention of gabapentin (GBP), lamotrigine (LTG), and vigabatrin (VGB) by patients with chronic epilepsy and the reasons for treatment discontinuation."7.70The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy. ( Chadwick, DW; Fenwick, PB; Mawer, GE; Sander, JW; Wong, IC, 1999)
"We sought to determine the long-term retention rates of lamotrigine (LTG), gabapentin (GBP), and topiramate (TPM) therapy for patients at a tertiary referral clinic for chronic, refractory epilepsy."7.70Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy. ( Lhatoo, SD; Polizzi, G; Sander, JW; Wong, IC, 2000)
"High affinity [3H]gamma-aminobutyric acid (GABA) and [3H]L-glutamate uptake were determined in synaptosomes prepared from the cerebral cortex of dogs with congenital hepatic encephalopathy and control dogs."7.69L-glutamate and gamma-aminobutyric acid uptake in synaptosomes from the cerebral cortex of dogs with congenital chronic hepatic encephalopathy. ( Johnston, GA; Maddison, JE; Watson, WE, 1995)
"The average pretreatment pruritus score was 9."6.78Use of pregabalin in the management of chronic uremic pruritus. ( Grenader, T; Lifschitz, M; Shavit, L; Slotki, I, 2013)
"This pharmacostatistical model showed that: (1) pregabalin oral clearance (CL/F) was directly proportional to creatinine clearance (CLcr), but was independent of gender, race, age, female hormonal status, daily dose, and dosing regimen; (2) apparent volume of distribution was dependent on body weight and gender; (3) absorption rate was decreased when given with food; and (4) coadministration with marketed antiepileptic drugs (AEDs) had no significant effect on pregabalin CL/F."6.76Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures. ( Bockbrader, HN; Burger, P; Corrigan, BW; Knapp, L, 2011)
" Pregabalin dosage was increased from 150 to 600 mg/d during the first 4 weeks."6.75Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. ( Alexander, RB; Anderson, RU; Cen, L; Chuai, S; Krieger, JN; Kusek, JW; Landis, JR; Litwin, MS; McNaughton-Collins, M; Nickel, JC; Nyberg, LM; O'Leary, M; Pontari, MA; Propert, KJ; Schaeffer, AJ; Shoskes, DA; White, PC; Zeitlin, S, 2010)
" Patients in group B who were receiving gabapentin continued this treatment up to a maximum daily dosage of 2400 mg during the observation period."6.74Adequacy assessment of oxycodone/paracetamol (acetaminophen) in multimodal chronic pain : a prospective observational study. ( Bertini, L; Carucci, A; Gatti, A; Mammucari, M; Occhioni, R; Sabato, AF, 2009)
"Multimodal pain is comprised of nociceptive/inflammatory and neuropathic components."6.74Adequacy assessment of oxycodone/paracetamol (acetaminophen) in multimodal chronic pain : a prospective observational study. ( Bertini, L; Carucci, A; Gatti, A; Mammucari, M; Occhioni, R; Sabato, AF, 2009)
"Gabapentin was associated with an increase in mean HSA, in contrast to the placebo, which was associated with a decrease."6.72Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. ( Bergasa, NV; Engler, D; Ginsburg, IH; McGee, M, 2006)
"Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception."6.72Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. ( Bergasa, NV; Engler, D; Ginsburg, IH; McGee, M, 2006)
"The lidocaine patch 5% was found to be safe and well tolerated."6.71Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. ( Drass, M; Nalamachu, S; Patel, N; White, WT, 2003)
"Patients with postherpetic neuralgia, painful diabetic neuropathy, or low back pain with partial responses (average daily pain intensity >4/10) to their current analgesic treatment regimen were included."6.71Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. ( Drass, M; Nalamachu, S; Patel, N; White, WT, 2003)
"Gabapentin has been successfully used for a variety of chronic pain conditions and therefore may be of use in the treatment of chronic headache."6.69Low doses of gabapentin may be helpful in the management of chronic daily headache. ( Carrazana, EJ; Fragoso, YD, 2000)
"Baclofen and placebo were administered orally, in a double-blind design, and blood samples were collected before and 30, 60, 90, 120, 180, and 240 min after drug or placebo administration."6.66Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia. ( Forziati, D; Iovino, M; Maj, M; Monteleone, P; Steardo, L; Veltro, F, 1988)
"Chronic pruritus is a distressing symptom that is often refractory to treatment."6.53Gabapentin and pregabalin for the treatment of chronic pruritus. ( Kwatra, SG; Matsuda, KM; Schonfeld, AR; Sharma, D, 2016)
"Gabapentin has been shown to cause minimal to no toxicity in overdose."6.52A review on the efficacy and safety of gabapentin in the treatment of chronic cough. ( Ryan, NM, 2015)
"Recent developments in the treatment of cough include the use of speech pathology and pharmacotherapy with gabapentin."6.52Gabapentin in chronic cough. ( Gibson, PG; Vertigan, AE, 2015)
"Chronic cough is regarded as a challenging clinical problem due to its frequency and often limited therapeutic options."6.52Gabapentin in chronic cough. ( Gibson, PG; Vertigan, AE, 2015)
"Results might vary between different neuropathic pain conditions, and the amount of evidence for gabapentin in neuropathic pain conditions except postherpetic neuralgia and painful diabetic neuropathy, and in fibromyalgia, is very limited."6.50Gabapentin for chronic neuropathic pain and fibromyalgia in adults. ( Derry, S; Moore, RA; Rice, AS; Toelle, T; Wiffen, PJ, 2014)
"Gabapentin was initially developed as an antiepileptic drug but was later discovered to be an effective treatment of neuropathic pain."6.46Gabapentin for the treatment of cancer-related pain syndromes. ( Bar Ad, V, 2010)
"Gabapentin has been successfully used for the treatment of multiple neuropathic pain syndromes such as diabetic neuropathy and postherpetic neuralgia."6.46Gabapentin for the treatment of cancer-related pain syndromes. ( Bar Ad, V, 2010)
"Haloperidol (HAL) is a compound that shows a high affinity with these receptors, acting as an antagonist."5.46Haloperidol Decreases Hyperalgesia and Allodynia Induced by Chronic Constriction Injury. ( Espinosa-Juárez, JV; Jaramillo-Morales, OA; López-Muñoz, FJ, 2017)
"Neuropathic pain has proven to be a difficult condition to treat, so investigational therapy has been sought that may prove useful, such as the use of sigma-1 antagonists."5.46Haloperidol Decreases Hyperalgesia and Allodynia Induced by Chronic Constriction Injury. ( Espinosa-Juárez, JV; Jaramillo-Morales, OA; López-Muñoz, FJ, 2017)
"Chronic cough is a debilitating, often multifactorial problem."5.46Unilateral Laryngoscopic Findings Associated With Response to Gabapentin in Patients With Chronic Cough. ( Dibildox, D; Giliberto, JP; Merati, A, 2017)
"Chronic myositis was induced by injection of Complete Freund Adjuvant (CFA) into the right gastrocnemius (GS) muscle of rats and tests for evaluating mechanical hyperalgesia, thermal hyperalgesia and tactile allodynia were performed."5.46Gabapentin decreases microglial cells and reverses bilateral hyperalgesia and allodynia in rats with chronic myositis. ( Chacur, M; Freitas, MF; Rocha, IR; Rosa, AS, 2017)
"Gabapentin was commenced at 300 mg daily and titrated to 300 mg tds over 3 days."5.36Gabapentin (Neurontin) improves pain scores of patients with critical limb ischaemia: an observational study. ( Lewis, MH; Morris-Stiff, G, 2010)
"Pain was assessed by visual analogue scoring at baseline, 4, 7, 14 and 28 days."5.36Gabapentin (Neurontin) improves pain scores of patients with critical limb ischaemia: an observational study. ( Lewis, MH; Morris-Stiff, G, 2010)
"The static allodynia endpoint was modeled by using three population PD approaches: 1) the behavior of the injured paw using a three-category ordinal logistic regression model; 2) paw withdrawal threshold (PWT) (g) between the injured and uninjured paw using the Hill equation with a baseline function; and 3) the baseline normalized difference in PWT between the injured and uninjured paw."5.36Pharmacokinetic-pharmacodynamic analysis of the static allodynia response to pregabalin and sildenafil in a rat model of neuropathic pain. ( Bender, G; Bies, RR; Bramwell, S; Danhof, M; DeJongh, J; Field, MJ; Florian, JA; Marshall, S; Tan, KK, 2010)
"Epilepsy is a serious neurological disorder in human beings and the long-term pathological events remain largely obscure."5.35Time-course of neuronal death in the mouse pilocarpine model of chronic epilepsy using Fluoro-Jade C staining. ( Chen, LW; Huang, YG; Liu, YH; Wang, L, 2008)
"Patients without concomitant facial pain showed better response rates (32 of 39, 82%) compared with patients with concomitant chronic facial pain (7 of 14, 50%, P = 0."5.35Efficacy of pregabalin in the treatment of trigeminal neuralgia. ( Diener, HC; Katsarava, Z; Maschke, M; Obermann, M; Sensen, K; Yoon, MS, 2008)
"Muscle hyperalgesia (withdrawal threshold to compression of the muscle) and cutaneous hyperalgesia of the paw (withdrawal threshold to von Frey filaments) were measured before and after induction of hyperalgesia and after treatment with pregabalin (saline, 10 to 100 mg/kg i."5.34Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats. ( Audette, KM; Maeda, Y; Sluka, KA; Yokoyama, T, 2007)
"Chronic seizures were induced by amygdalar injection of kainic acid 60 days before death."5.31Collapse of extracellular glutamate regulation during epileptogenesis: down-regulation and functional failure of glutamate transporter function in rats with chronic seizures induced by kainic acid. ( Doi, T; Kamada, H; Mitsuyama, Y; Nakajima, A; Ohya-Nishiguchi, H; Tokumaru, J; Ueda, Y; Willmore, LJ; Yokoyama, H, 2001)
"Gabapentin treatment significantly and reversibly changed the responses, consistent with the attenuation of the abnormal sensory behavior, and the attenuated responses lasted for the duration of the drug effect (up to 6 h)."5.31Rodent model of chronic central pain after spinal cord contusion injury and effects of gabapentin. ( Hulsebosch, CE; McAdoo, DJ; Perez-Polo, JR; Taylor, CP; Westlund, KN; Xu, GY, 2000)
"Pain was assessed prior to and during treatment at 1, 3 and 6 months with a 10 cm visual analogue scale which ranged from 0 ('no pain') to 10 ('worst pain imaginable'), or by the documentation of a verbal description of pain."5.31Gabapentin for neuropathic pain following spinal cord injury. ( Brown, DJ; Cooper, N; Frauman, AG; Hill, ST; Kirsa, SW; Lim, TC; To, TP, 2002)
" Gabapentin (a GABA analogue) is efficacious and often well tolerated in other chronic pain conditions."5.27GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol. ( Baranowski, A; Bhattacharya, S; Birch, J; Cheong, Y; Cregg, R; Daniels, J; Hewitt, CA; Horne, AW; Macfarlane, GJ; Middleton, L; Szubert, W; Tracey, I; Vincent, K; Williams, ACC, 2018)
" Adults with refractory chronic cough (>8 weeks' duration) without active respiratory disease or infection were randomly assigned to receive gabapentin (maximum tolerable daily dose of 1800 mg) or matching placebo for 10 weeks."5.16Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. ( Birring, SS; Gibson, PG; Ryan, NM, 2012)
" Gabapentin significantly improved cough-specific quality of life compared with placebo (between-group difference in LCQ score during treatment period 1·80, 95% CI 0·56-3·04; p=0·004; number needed to treat of 3·58)."5.16Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. ( Birring, SS; Gibson, PG; Ryan, NM, 2012)
"The treatment of refractory chronic cough with gabapentin is both effective and well tolerated."5.16Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. ( Birring, SS; Gibson, PG; Ryan, NM, 2012)
"The purpose of this study was to evaluate the analgesic effects of perioperative gabapentin on postoperative acute and chronic pain after coronary artery bypass graft (CABG) surgery with median sternotomy and internal mammary artery harvesting."5.15The effects of gabapentin on acute and chronic postoperative pain after coronary artery bypass graft surgery. ( Onan, B; Selcuk, I; Sen, H; Turan, A; Ucak, A; Yilmaz, AT, 2011)
"Pregabalin, a high-affinity ligand for α2δ subunits of voltage-gated calcium channels, is a novel pharmacotherapy for chronic pain, partial seizures, and other disorders."5.15Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures. ( Bockbrader, HN; Burger, P; Corrigan, BW; Knapp, L, 2011)
"Using nonlinear mixed-effect modeling, 5,583 plasma pregabalin concentration-time samples from 1,723 subjects were analyzed: 2,868 samples from healthy volunteers or subjects with renal impairment (n = 123), 1,513 from patients with partial seizures (n = 626), and 1,202 from patients with chronic pain (n = 974)."5.15Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures. ( Bockbrader, HN; Burger, P; Corrigan, BW; Knapp, L, 2011)
"Pregabalin CL/F is related to CLcr, and this relationship is similar among healthy volunteers and patients with either partial seizures or chronic pain disorders."5.15Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures. ( Bockbrader, HN; Burger, P; Corrigan, BW; Knapp, L, 2011)
"To evaluate the adequacy of a low-dose combination of oxycodone and paracetamol (acetaminophen) in patients with multimodal, chronic, non-malignant pain using the Pain Management Index (PMI)."5.14Adequacy assessment of oxycodone/paracetamol (acetaminophen) in multimodal chronic pain : a prospective observational study. ( Bertini, L; Carucci, A; Gatti, A; Mammucari, M; Occhioni, R; Sabato, AF, 2009)
"The purpose of this, open-label, non-comparative study, was to evaluate the efficacy on quality of life and the efficacy of gabapentin monotherapy in patients with chronic radiculopathy."5.14Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality. ( Deniz, O; Erdal, A; Gureser, G; Karatay, S; Senel, K; Ugur, M; Yildirim, K, 2009)
"Thirty-five patients with radicular pain and diagnosed as L4, L5 or S1 radiculopathy were treated with oral gabapentin from a total of 300 mg per day once up to a total of 1800 mg per day divided in 3 doses for eight-week trial period."5.14Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality. ( Deniz, O; Erdal, A; Gureser, G; Karatay, S; Senel, K; Ugur, M; Yildirim, K, 2009)
"Gabapentin may provide benefits in terms of alleviation of pain and overall quality of life in patients with chronic radiculopathy."5.14Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality. ( Deniz, O; Erdal, A; Gureser, G; Karatay, S; Senel, K; Ugur, M; Yildirim, K, 2009)
"Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception."5.12Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. ( Bergasa, NV; Engler, D; Ginsburg, IH; McGee, M, 2006)
" Fifty patients scheduled for breast cancer surgery were blindly randomized to receive gabapentin, eutectic mixture of local anesthetics cream, and ropivacaine in the wound or three placebos."5.11Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer. ( Fassoulaki, A; Melemeni, A; Sarantopoulos, C; Triga, A, 2005)
"The aim of this study was to compare the efficacy and side effects of gabapentin, amitriptyline, and their combination in women with chronic pelvic pain."5.11Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. ( Ellend, A; Frickey, N; Gleiss, A; Kozek-Langenecker, SA; Kress, HG; Sator-Katzenschlager, SM; Scharbert, G, 2005)
"Gabapentin alone or in combination with amitriptyline is better than amitriptyline alone in the treatment of female chronic pelvic pain."5.11Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. ( Ellend, A; Frickey, N; Gleiss, A; Kozek-Langenecker, SA; Kress, HG; Sator-Katzenschlager, SM; Scharbert, G, 2005)
"To assess the effectiveness and safety of the lidocaine patch 5%, a targeted peripheral analgesic, in the treatment of postherpetic neuralgia, painful diabetic neuropathy, and low back pain patients with incomplete responses to their current analgesic treatment regimen containing gabapentin."5.10Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. ( Drass, M; Nalamachu, S; Patel, N; White, WT, 2003)
"Significant improvements in BPI measures of pain intensity and pain relief were reported for all groups of patients after 2 weeks of lidocaine patch 5% treatment."5.10Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. ( Drass, M; Nalamachu, S; Patel, N; White, WT, 2003)
"A retrospective audit of the perceived efficacy and tolerability of adjunctive gabapentin (GBT) therapy in patients with intractable epilepsy was carried out."5.09An audit of the perceived efficacy and tolerability of gabapentin therapy in an out-patient cohort with chronic epilepsy. ( Duncan, JS; Langan, Y; Sander, JW, 1999)
"To assess the efficacy and safety of low doses of gabapentin in cases of chronic daily headache."5.09Low doses of gabapentin may be helpful in the management of chronic daily headache. ( Carrazana, EJ; Fragoso, YD, 2000)
"Despite the inherent limitations of such a small open trial, the authors concluded that ratings of excellent and good by two thirds of this population of patients with chronic daily headache should encourage the setup of a large double-blind, multicentric, placebo-controlled trial of low doses of gabapentin for chronic daily headache."5.09Low doses of gabapentin may be helpful in the management of chronic daily headache. ( Carrazana, EJ; Fragoso, YD, 2000)
" Data on 2724 subjects from 10 recently completed placebo-controlled clinical trials of pregabalin in diabetic neuropathy, postherpetic neuralgia, chronic low back pain, fibromyalgia, and osteoarthritis were used."5.09Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. ( Farrar, JT; LaMoreaux, L; Poole, MR; Werth, JL; Young, JP, 2001)
"The authors investigate: (1) whether there is a lateral effect of hydrogen (1H) magnetic resonance (MR) spectroscopy observable metabolite ratios between the right and the left prefrontal lobe in chronic schizophrenia; (2) whether there is a change of proton metabolite ratios in chronic schizophrenia after neuroleptic treatment; (3) whether there is a relation between changes in 1H MR spectra and the clinical assessment of Brief Psychiatric Rating Scale (BPRS); and (4) to investigate a hypofrontality hypothesis in schizophrenia in terms of neurochemical aspects."5.08Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy. ( Choe, BY; Lee, C; Lee, CW; Paik, IH; Shinn, KS; Suh, TS, 1996)
" Results of a clinical open trial with pivagabine (4-[(2,2-dimethyl-1-oxopropyl) amino]butanoic acid, CAS 69542-93-4, Tonerg) on 22 young patients affected by dysthymic disorders and on 38 older patients affected by adjustment disorders following different stressors (mourning, retirement and recovery in institutions of assistance) are reported."5.08Clinical evaluation of the efficacy of pivagabine in the treatment of mood and adjustment disorders. ( Gilotta, SM; Luca, S; Terranova, R, 1997)
"To substantiate a previously reported disturbance of gamma-aminobutyric acid (GABA) in chronic schizophrenia, plasma growth hormone (GH) response to a direct GABA agonist (baclofen, 10 mg) was assessed in 12 unmedicated chronic schizophrenic males and 10 sex- and age-matched healthy controls."5.06Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia. ( Forziati, D; Iovino, M; Maj, M; Monteleone, P; Steardo, L; Veltro, F, 1988)
"The hypothesis of a gamma-aminobutyric acid (GABA) involvement in the pathophysiology of schizophrenia has been recently proposed but not confirmed."5.06Growth hormone response to sodium valproate in chronic schizophrenia. ( Iovino, M; Maj, M; Monteleone, P; Steardo, L, 1986)
" Most studies used oral gabapentin or gabapentin encarbil at doses of 1200 mg or more daily in different neuropathic pain conditions, predominantly postherpetic neuralgia and painful diabetic neuropathy."4.95Gabapentin for chronic neuropathic pain in adults. ( Bell, RF; Derry, S; Moore, RA; Phillips, T; Rice, AS; Tölle, TR; Wiffen, PJ, 2017)
"Gabapentin at doses of 1800 mg to 3600 mg daily (1200 mg to 3600 mg gabapentin encarbil) can provide good levels of pain relief to some people with postherpetic neuralgia and peripheral diabetic neuropathy."4.95Gabapentin for chronic neuropathic pain in adults. ( Bell, RF; Derry, S; Moore, RA; Phillips, T; Rice, AS; Tölle, TR; Wiffen, PJ, 2017)
"With anticonvulsant, anxiolytic, and analgesic properties, pregabalin has been evaluated for neuropathic pain and fibromyalgia (FM)."4.91A systematic review of pharmacoeconomic studies for pregabalin. ( Huelin, R; Khankhel, Z; Mould, J; Parker, L; Wasiak, R, 2015)
"Recent developments in the treatment of cough include the use of speech pathology and pharmacotherapy with gabapentin."4.91Gabapentin in chronic cough. ( Gibson, PG; Vertigan, AE, 2015)
"The effectiveness of neuromodulating medications such as gabapentin and pregabalin in the treatment of cough has been supported primarily through case series, case reports, prospective reviews and a double blind randomised controlled trial."4.91Gabapentin in chronic cough. ( Gibson, PG; Vertigan, AE, 2015)
"To assess the analgesic efficacy and adverse effects of gabapentin in chronic neuropathic pain and fibromyalgia."4.90Gabapentin for chronic neuropathic pain and fibromyalgia in adults. ( Derry, S; Moore, RA; Rice, AS; Toelle, T; Wiffen, PJ, 2014)
"We identified randomised trials of gabapentin for chronic neuropathic pain or fibromyalgia by searching the databases MEDLINE (1966 to March 2014), EMBASE (1980 to 2014 week 10), and CENTRAL in The Cochrane Library (Issue 3 of 12, 2014)."4.90Gabapentin for chronic neuropathic pain and fibromyalgia in adults. ( Derry, S; Moore, RA; Rice, AS; Toelle, T; Wiffen, PJ, 2014)
"Randomised, double-blind studies reporting the analgesic and adverse effects of gabapentin in neuropathic pain or fibromyalgia with assessment of pain intensity, pain relief, or both, using validated scales."4.90Gabapentin for chronic neuropathic pain and fibromyalgia in adults. ( Derry, S; Moore, RA; Rice, AS; Toelle, T; Wiffen, PJ, 2014)
"The goal of this systematic review was to examine the evidence for the use of the neuromodulating agents, amitriptyline, gabapentin, pregabalin, and baclofen, in the management of chronic, idiopathic cough patients."4.89Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review. ( Cohen, SM; Misono, S, 2013)
"Benefit from neuromodulator treatment with amitriptyline, gabapentin, pregabalin, and baclofen in chronic, idiopathic cough patients was demonstrated."4.89Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review. ( Cohen, SM; Misono, S, 2013)
"gov, Google Scholar, and reference lists of articles and abstracts from conference proceedings, without language restriction for pregabalin treatment of Class III prostatitis and CP/CPPS."4.88Pregabalin for chronic prostatitis. ( Aboumarzouk, OM; Nelson, RL, 2012)
"Twenty-nine studies (3571 participants), studied gabapentin at daily doses of 1200 mg or more in 12 chronic pain conditions; 78% of participants were in studies of postherpetic neuralgia, painful diabetic neuropathy or mixed neuropathic pain."4.87Gabapentin for chronic neuropathic pain and fibromyalgia in adults. ( Derry, S; McQuay, HJ; Moore, RA; Wiffen, PJ, 2011)
"Gabapentin was initially developed as an antiepileptic drug but was later discovered to be an effective treatment of neuropathic pain."4.86Gabapentin for the treatment of cancer-related pain syndromes. ( Bar Ad, V, 2010)
"Recent studies showed effectiveness of gabapentin in improving the pain control in patients with neuropathic cancer pain, already treated with opiates."4.86Gabapentin for the treatment of cancer-related pain syndromes. ( Bar Ad, V, 2010)
"Given the significant benefits of gabapentin and the combination of gabapentin with opioids for the treatment of neuropathic pain, randomized clinical trials are needed to establish the role of these analgesic regimens for the treatment of neuropathic cancer pain."4.86Gabapentin for the treatment of cancer-related pain syndromes. ( Bar Ad, V, 2010)
"Pregabalin has proven efficacy in neuropathic pain conditions and fibromyalgia."4.85Pregabalin for acute and chronic pain in adults. ( Derry, S; McQuay, HJ; Moore, RA; Straube, S; Wiffen, PJ, 2009)
"To assess analgesic efficacy and associated adverse events of pregabalin in acute and chronic pain."4.85Pregabalin for acute and chronic pain in adults. ( Derry, S; McQuay, HJ; Moore, RA; Straube, S; Wiffen, PJ, 2009)
"Randomised, double blind trials reporting on the analgesic effect of pregabalin, with subjective pain assessment by the patient as either the primary or a secondary outcome."4.85Pregabalin for acute and chronic pain in adults. ( Derry, S; McQuay, HJ; Moore, RA; Straube, S; Wiffen, PJ, 2009)
"There was no clear evidence of beneficial effects of pregabalin in established acute postoperative pain."4.85Pregabalin for acute and chronic pain in adults. ( Derry, S; McQuay, HJ; Moore, RA; Straube, S; Wiffen, PJ, 2009)
"In recent years, anticonvulsant drugs (AEDs) have been considered promising drugs in the prevention of migraine and other forms of headache, based on their action on the metabolism of gamma-aminobutyric acid (GABA) and glutamate."4.82Antiepileptic drugs in the treatment of chronic headaches. ( Agostoni, E; Frigerio, R; Santoro, P, 2003)
"To evaluate the analgesic effectiveness and adverse effects of gabapentin for pain management in clinical practice."4.82Gabapentin for acute and chronic pain. ( Edwards, JE; McQuay, HJ; Moore, RA; Wiffen, PJ, 2005)
"Randomised trials of gabapentin in acute, chronic or cancer pain were identified by MEDLINE (1966-Nov 2004), EMBASE (1994-Nov 2004), SIGLE (1980-Jan 2004) and the Cochrane Central Register of Controlled Trials (CENTRAL) (Cochrane Library Issue 4, 2004)."4.82Gabapentin for acute and chronic pain. ( Edwards, JE; McQuay, HJ; Moore, RA; Wiffen, PJ, 2005)
"Randomised trials reporting the analgesic effects of gabapentin in patients, with subjective pain assessment as either the primary or a secondary outcome."4.82Gabapentin for acute and chronic pain. ( Edwards, JE; McQuay, HJ; Moore, RA; Wiffen, PJ, 2005)
"There is evidence to show that gabapentin is effective in neuropathic pain."4.82Gabapentin for acute and chronic pain. ( Edwards, JE; McQuay, HJ; Moore, RA; Wiffen, PJ, 2005)
" However, the neuroprotective effects and the mechanism of action of PNU-282987, an α7-nAChR agonist, in a chronic in vivo rat glaucoma model are poorly understood."3.85Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model. ( Cheng, Y; Li, G; Wu, J; Yang, B; Zhang, R; Zhang, S; Zhou, X, 2017)
"Response to gabapentin was defined by physician-documented subjective patient report of improvement in cough symptoms."3.85Unilateral Laryngoscopic Findings Associated With Response to Gabapentin in Patients With Chronic Cough. ( Dibildox, D; Giliberto, JP; Merati, A, 2017)
" Therapy was initiated in patients with chronic cough with gabapentin, 100 mg twice daily, which was titrated to response or adverse effects."3.85Unilateral Laryngoscopic Findings Associated With Response to Gabapentin in Patients With Chronic Cough. ( Dibildox, D; Giliberto, JP; Merati, A, 2017)
"In patients with chronic cough suspected to be related to vagal neuropathy, the odds of response to gabapentin are higher with the presence of VFMA noted on videostroboscopy."3.85Unilateral Laryngoscopic Findings Associated With Response to Gabapentin in Patients With Chronic Cough. ( Dibildox, D; Giliberto, JP; Merati, A, 2017)
"In the present work, we investigated the antinociceptive effect of gabapentin in a chronic myositis model and its interference in spinal glial cells."3.85Gabapentin decreases microglial cells and reverses bilateral hyperalgesia and allodynia in rats with chronic myositis. ( Chacur, M; Freitas, MF; Rocha, IR; Rosa, AS, 2017)
" Based on this, the aim of the present study was to investigate the effect of magnesium on the level of glutamic acid decarboxylase-67kDa (GAD-67) in the different brain areas in the chronic mild stress (CMS) and olfactory bulbectomy (OB) models of depression in rats."3.83Brain glutamic acid decarboxylase-67kDa alterations induced by magnesium treatment in olfactory bulbectomy and chronic mild stress models in rats. ( Nowak, G; Pochwat, B; Szewczyk, B, 2016)
"Latrunculin A microperfusion of the hippocampus induces acute epileptic seizures and long-term biochemical changes leading to spontaneous seizures."3.80Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. ( Loureiro, AI; Sierra-Marcuño, G; Sierra-Paredes, G; Soares-da-Silva, P; Wright, LC, 2014)
"Oral administration of ESL (100 mg/kg), previous to latrunculin A microperfusion, completely prevented acute latrunculin A-induced seizures as well as chronic seizures and all EEG chronic signs of paroxysmal activity."3.80Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. ( Loureiro, AI; Sierra-Marcuño, G; Sierra-Paredes, G; Soares-da-Silva, P; Wright, LC, 2014)
"ESL treatment prevented acute latrunculin A-induced seizures as well as chronic seizures and all EEG chronic signs of paroxysmal activity, supporting a possible anti-epileptogenic effect of ESL in mice."3.80Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. ( Loureiro, AI; Sierra-Marcuño, G; Sierra-Paredes, G; Soares-da-Silva, P; Wright, LC, 2014)
"To analyze the survival and the changes of proportions of Calbindin, Calretinin and Parvalbumin positive neurons in mouse hippocampal CA area at chronic stage of Pilocarpine-induced epilepsy."3.79[Survival of calbindin, calretinin and parvalbumin positive neurons in mouse hippocampal CA area at chronic stage of pilocarpine-induced epilepsy]. ( Liu, J; Liu, Y; Tang, F, 2013)
"Calbindin, Calretinin and Parvalbumin immunofluoresence staining were done 2 months after Pilocarpine-induced epilepsy in mice or saline injection."3.79[Survival of calbindin, calretinin and parvalbumin positive neurons in mouse hippocampal CA area at chronic stage of pilocarpine-induced epilepsy]. ( Liu, J; Liu, Y; Tang, F, 2013)
"The changes of proportions of Calbindin, Calretinin and Parvalbumin positive neurons in the CA area of mouse hippocampus may be a factor in the ongoing epileptic activity at chronic stage of Pilocarpine-induced epilepsy."3.79[Survival of calbindin, calretinin and parvalbumin positive neurons in mouse hippocampal CA area at chronic stage of pilocarpine-induced epilepsy]. ( Liu, J; Liu, Y; Tang, F, 2013)
"The aim of this study was to assess the role of adding gabapentin (Neurontin) to the prescription of patients with opiate resistant pain as a result of critical limb ischaemia (CLI)."3.76Gabapentin (Neurontin) improves pain scores of patients with critical limb ischaemia: an observational study. ( Lewis, MH; Morris-Stiff, G, 2010)
"The study has demonstrated that gabapentin is a useful adjuvant in the management of CLI and leads to significant reductions in pain scores and improves night pain for most patients."3.76Gabapentin (Neurontin) improves pain scores of patients with critical limb ischaemia: an observational study. ( Lewis, MH; Morris-Stiff, G, 2010)
"The objective of this study was to develop a pharmacokinetic-pharmacodynamic (PK-PD) model of the static allodynia response to pregabalin with and without sildenafil in a chronic constriction injury model of neuropathic pain."3.76Pharmacokinetic-pharmacodynamic analysis of the static allodynia response to pregabalin and sildenafil in a rat model of neuropathic pain. ( Bender, G; Bies, RR; Bramwell, S; Danhof, M; DeJongh, J; Field, MJ; Florian, JA; Marshall, S; Tan, KK, 2010)
"Despite widely replicated abnormalities of gamma-aminobutyric acid (GABA) neurons in schizophrenia postmortem, few studies have measured tissue GABA levels in vivo."3.76Elevated gamma-aminobutyric acid levels in chronic schizophrenia. ( Cohen, BM; McCarthy, J; Ongür, D; Prescot, AP; Renshaw, PF, 2010)
"We found elevations in GABA/creatine in the schizophrenia group compared with control subjects [F(1,65) = 4."3.76Elevated gamma-aminobutyric acid levels in chronic schizophrenia. ( Cohen, BM; McCarthy, J; Ongür, D; Prescot, AP; Renshaw, PF, 2010)
"Pregabalin is used for treatment of neuropathic pain conditions."3.74Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats. ( Audette, KM; Maeda, Y; Sluka, KA; Yokoyama, T, 2007)
"This study shows that pregabalin reduces both cutaneous and muscle hyperalgesia in inflammatory and noninflammatory models of muscle pain."3.74Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats. ( Audette, KM; Maeda, Y; Sluka, KA; Yokoyama, T, 2007)
"Although this is a small study, it appears that gabapentin and nortriptyline are effective in the treatment of idiopathic chronic orchialgia but not post-vasectomy pain."3.74Chronic orchialgia: consider gabapentin or nortriptyline before considering surgery. ( Lee, LK; Miller, B; Sinclair, AM, 2007)
"6% of patients commenced on nortriptyline had a greater than 50% improvement in pain."3.74Chronic orchialgia: consider gabapentin or nortriptyline before considering surgery. ( Lee, LK; Miller, B; Sinclair, AM, 2007)
" The case presentation illustrates the role of pregabalin in successful medical management of this chronic pain disorder, as well as the management of common psychiatric morbidities associated with this condition."3.74Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia. ( Jerome, L, 2007)
"Pregabalin is often used for the treatment of chronic pain syndromes."3.74Pregabalin-induced generalized myoclonic status epilepticus in patients with chronic pain. ( Hamer, HM; Hattemer, K; Klein, KM; Knake, S; Oertel, WH; Rosenow, F; Wellek, A, 2007)
"This prospective, open-label study aimed to evaluate the efficacy of pregabalin treatment in patients suffering from trigeminal neuralgia with and without concomitant facial pain."3.74Efficacy of pregabalin in the treatment of trigeminal neuralgia. ( Diener, HC; Katsarava, Z; Maschke, M; Obermann, M; Sensen, K; Yoon, MS, 2008)
"To determine whether altered central and/or peripheral gamma-aminobutyric acid (GABA)ergic mechanisms acting in GABA(A) receptors contribute to the abnormal ventilatory response to acute and sustained hypoxia in obese Zucker rats."3.73GABAergic modulation of ventilatory response to acute and sustained hypoxia in obese Zucker rats. ( Huang, CY; Lee, SD; Lin, TB; Lo, MJ; Ting, H, 2005)
"The anticonvulsant gabapentin (GBP) has been shown effective for the treatment of neuropathic pain, although its mechanism of action remains unclear."3.73Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: implications for mechanism of action. ( Aiyar, J; Anker, N; Belley, M; Bristow, L; Campbell, B; Cohen, C; Park, KT; Ren, K; Stearns, B; Urban, MO, 2005)
"This study was designed to characterize, in anterior, mediobasal, and posterior hypothalamic and median eminence, the 24h changes of gamma aminobutyric acid (GABA) and taurine (TAU) contents in adult male rats and to analyze whether chronic hyperprolactinemia may affect these patterns."3.72Daily changes of GABA and taurine concentrations in various hypothalamic areas are affected by chronic hyperprolactinemia. ( Alvarez, MP; Cano, P; Castrillón, PO; Duvilanski, BH; Esquifino, AI, 2003)
"GABA and glycine are inhibitory neurotransmitters used by many neurons in the spinal dorsal horn, and intrathecal administration of GABA(A) and glycine receptor antagonists produces behavioural signs of allodynia, suggesting that these transmitters have an important role in spinal pain mechanisms."3.72Selective loss of spinal GABAergic or glycinergic neurons is not necessary for development of thermal hyperalgesia in the chronic constriction injury model of neuropathic pain. ( Hughes, DI; Maxwell, DJ; Polgár, E; Puskár, Z; Riddell, JS; Todd, AJ, 2003)
"A pharmacokinetic-pharmacodynamic (PK/PD) model relating pain relief to gabapentin plasma concentrations was derived from a phase 3 study."3.72The use of clinical trial simulation to support dose selection: application to development of a new treatment for chronic neuropathic pain. ( Cook, JA; Ewy, WE; Lockwood, PA; Mandema, JW, 2003)
"A series of mutual prodrugs derived from gabapentin, pregabalin, memantine, venlafaxine were synthesized and their pharmacological properties to treat neuropathic pain were investigated in a rat model of chronic sciatic nerve constriction injury (CCI)."3.72Effect of gabapentin derivates on mechanical allodynia-like behaviour in a rat model of chronic sciatic constriction injury. ( Bo-Hua, Z; He, L; Hong-Ju, Y; Jun-Wei, W; Nan, Z; Wei-Guo, S; Wei-Xiu, Y; Zhe-Hui, G; Zheng-Hua, G; Zhi-Pu, L; Zhong-Wei, J, 2004)
" Chronic seizures were induced by amygdalar injection of kainic acid 60 days before death."3.71Collapse of extracellular glutamate regulation during epileptogenesis: down-regulation and functional failure of glutamate transporter function in rats with chronic seizures induced by kainic acid. ( Doi, T; Kamada, H; Mitsuyama, Y; Nakajima, A; Ohya-Nishiguchi, H; Tokumaru, J; Ueda, Y; Willmore, LJ; Yokoyama, H, 2001)
"Postmortem samples from individuals with schizophrenia (n = 13) and control subjects (n = 10) were investigated for binding of [(3)H]tiagabine to GABA transporter-1 GAT-1."3.71Increased [(3)H]tiagabine binding to GAT-1 in the cingulate cortex in schizophrenia. ( Blennow, K; Dandenell, AK; Davidsson, P; Marcusson, J; Sundman-Eriksson, I, 2002)
"To present two years of experience in the use of gabapentin for the alleviation of neuropathic pain in spinal cord injury patients."3.71Gabapentin for neuropathic pain following spinal cord injury. ( Brown, DJ; Cooper, N; Frauman, AG; Hill, ST; Kirsa, SW; Lim, TC; To, TP, 2002)
"Data were retrieved from the medical records of all spinal cord injury patients prescribed gabapentin for neuropathic pain."3.71Gabapentin for neuropathic pain following spinal cord injury. ( Brown, DJ; Cooper, N; Frauman, AG; Hill, ST; Kirsa, SW; Lim, TC; To, TP, 2002)
"Seventy-six per cent of patients receiving gabapentin reported a reduction in neuropathic pain."3.71Gabapentin for neuropathic pain following spinal cord injury. ( Brown, DJ; Cooper, N; Frauman, AG; Hill, ST; Kirsa, SW; Lim, TC; To, TP, 2002)
"Our experience suggests that gabapentin offers an effective therapeutic alternative for the alleviation of neuropathic pain following spinal cord injury."3.71Gabapentin for neuropathic pain following spinal cord injury. ( Brown, DJ; Cooper, N; Frauman, AG; Hill, ST; Kirsa, SW; Lim, TC; To, TP, 2002)
"This report describes the long-term follow-up of 56 patients with refractory partial epilepsy who, within 3 months of vigabatrin add-on therapy (3 g/day), showed a reduction in monthly seizure frequency of more than 50%."3.70Long-term treatment with vigabatrin - 10 years of clinical experience. ( Mumford, JP; Riekkinen, PJ; Salmenperä, T; Ylinen, A, 1999)
"To compare the long-term retention of gabapentin (GBP), lamotrigine (LTG), and vigabatrin (VGB) by patients with chronic epilepsy and the reasons for treatment discontinuation."3.70The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy. ( Chadwick, DW; Fenwick, PB; Mawer, GE; Sander, JW; Wong, IC, 1999)
"We sought to determine the long-term retention rates of lamotrigine (LTG), gabapentin (GBP), and topiramate (TPM) therapy for patients at a tertiary referral clinic for chronic, refractory epilepsy."3.70Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy. ( Lhatoo, SD; Polizzi, G; Sander, JW; Wong, IC, 2000)
"High affinity [3H]gamma-aminobutyric acid (GABA) and [3H]L-glutamate uptake were determined in synaptosomes prepared from the cerebral cortex of dogs with congenital hepatic encephalopathy and control dogs."3.69L-glutamate and gamma-aminobutyric acid uptake in synaptosomes from the cerebral cortex of dogs with congenital chronic hepatic encephalopathy. ( Johnston, GA; Maddison, JE; Watson, WE, 1995)
"The novel anti-epileptic drugs lamotrigine, felbamate and gabapentin were compared in rat experimental models of acute (tail flick) and chronic pain: the chronic constriction injury and spinal nerve ligation models."3.69The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. ( Fontana, DJ; Gogas, KR; Hedley, LR; Hunter, JC; Jacobson, LO; Kassotakis, L; Thompson, J, 1997)
"The alteration in circulating levels of PRL, GH, TSH, and cortisol was studied after the oral administration of muscimol (3-hydroxy-5-aminomethylisoxazole) to human subjects with Huntington's disease (n = 4) and chronic schizophrenia (n = 5)."3.66Stimulation of prolactin and growth hormone secretion by muscimol, a gamma-aminobutyric acid agonist. ( Chase, TN; Frohman, LA; Neophytides, A; Tamminga, CA, 1978)
"The average pretreatment pruritus score was 9."2.78Use of pregabalin in the management of chronic uremic pruritus. ( Grenader, T; Lifschitz, M; Shavit, L; Slotki, I, 2013)
"The assessment of postoperative pain at the 1- and 3-month follow-ups was performed using a numeric rating scale."2.76The effects of gabapentin on acute and chronic postoperative pain after coronary artery bypass graft surgery. ( Onan, B; Selcuk, I; Sen, H; Turan, A; Ucak, A; Yilmaz, AT, 2011)
"This pharmacostatistical model showed that: (1) pregabalin oral clearance (CL/F) was directly proportional to creatinine clearance (CLcr), but was independent of gender, race, age, female hormonal status, daily dose, and dosing regimen; (2) apparent volume of distribution was dependent on body weight and gender; (3) absorption rate was decreased when given with food; and (4) coadministration with marketed antiepileptic drugs (AEDs) had no significant effect on pregabalin CL/F."2.76Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures. ( Bockbrader, HN; Burger, P; Corrigan, BW; Knapp, L, 2011)
" Pregabalin dosage was increased from 150 to 600 mg/d during the first 4 weeks."2.75Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. ( Alexander, RB; Anderson, RU; Cen, L; Chuai, S; Krieger, JN; Kusek, JW; Landis, JR; Litwin, MS; McNaughton-Collins, M; Nickel, JC; Nyberg, LM; O'Leary, M; Pontari, MA; Propert, KJ; Schaeffer, AJ; Shoskes, DA; White, PC; Zeitlin, S, 2010)
"Assessment of postoperative pain at 1, 3 and 6 months was carried out with an 11-point numerical rating scale; 0 indicating 'no pain' and 10 indicating 'worst pain imaginable'."2.74The effects of gabapentin on acute and chronic pain after inguinal herniorrhaphy. ( Dağli, G; Inangil, G; Ozkan, S; Sen, H; Senol, MG; Sizlan, A; Sücüllü, I; Yanarateş, O, 2009)
" Patients in group B who were receiving gabapentin continued this treatment up to a maximum daily dosage of 2400 mg during the observation period."2.74Adequacy assessment of oxycodone/paracetamol (acetaminophen) in multimodal chronic pain : a prospective observational study. ( Bertini, L; Carucci, A; Gatti, A; Mammucari, M; Occhioni, R; Sabato, AF, 2009)
"Multimodal pain is comprised of nociceptive/inflammatory and neuropathic components."2.74Adequacy assessment of oxycodone/paracetamol (acetaminophen) in multimodal chronic pain : a prospective observational study. ( Bertini, L; Carucci, A; Gatti, A; Mammucari, M; Occhioni, R; Sabato, AF, 2009)
"MDD and PTSD patients present abnormalities in the HPA axis regulation, such as altered cortisol levels or failure to suppress cortisol release in the dexamethasone suppression test."2.72The Role of HPA Axis and Allopregnanolone on the Neurobiology of Major Depressive Disorders and PTSD. ( Almeida, FB; Barros, HMT; Pinna, G, 2021)
"Gabapentin was associated with an increase in mean HSA, in contrast to the placebo, which was associated with a decrease."2.72Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. ( Bergasa, NV; Engler, D; Ginsburg, IH; McGee, M, 2006)
"Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception."2.72Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. ( Bergasa, NV; Engler, D; Ginsburg, IH; McGee, M, 2006)
"Chronic neuropathic pain was associated with motor cortex disinhibition, suggesting impaired GABAergic neurotransmission related to some aspects of pain or to underlying sensory or motor disturbances."2.72Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain. ( Drouot, X; Keravel, Y; Lefaucheur, JP; Ménard-Lefaucheur, I; Nguyen, JP, 2006)
"The lidocaine patch 5% was found to be safe and well tolerated."2.71Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. ( Drass, M; Nalamachu, S; Patel, N; White, WT, 2003)
"Patients with postherpetic neuralgia, painful diabetic neuropathy, or low back pain with partial responses (average daily pain intensity >4/10) to their current analgesic treatment regimen were included."2.71Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. ( Drass, M; Nalamachu, S; Patel, N; White, WT, 2003)
"Chronic neuropathic pain occurs in 10-15% of patients with neuroborreliosis and is difficult to treat."2.71Gabapentin for the symptomatic treatment of chronic neuropathic pain in patients with late-stage lyme borreliosis: a pilot study. ( Hofmann, H; Ring, J; Weissenbacher, S, 2005)
"Fifty patients scheduled for breast cancer surgery were blindly randomized to receive gabapentin, eutectic mixture of local anesthetics cream, and ropivacaine in the wound or three placebos."2.71Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer. ( Fassoulaki, A; Melemeni, A; Sarantopoulos, C; Triga, A, 2005)
"Gabapentin has been successfully used for a variety of chronic pain conditions and therefore may be of use in the treatment of chronic headache."2.69Low doses of gabapentin may be helpful in the management of chronic daily headache. ( Carrazana, EJ; Fragoso, YD, 2000)
"Tonic SCS concurrently initiates neuropathic pain modulation through a supraspinal-spinal feedback loop and serotonergic descending fibers."2.66Mechanisms and mode of action of spinal cord stimulation in chronic neuropathic pain. ( Heijmans, L; Joosten, EA, 2020)
"Baclofen and placebo were administered orally, in a double-blind design, and blood samples were collected before and 30, 60, 90, 120, 180, and 240 min after drug or placebo administration."2.66Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia. ( Forziati, D; Iovino, M; Maj, M; Monteleone, P; Steardo, L; Veltro, F, 1988)
"Gabapentin is commonly used to treat neuropathic pain (pain due to nerve damage)."2.55Gabapentin for chronic neuropathic pain in adults. ( Bell, RF; Derry, S; Moore, RA; Phillips, T; Rice, AS; Tölle, TR; Wiffen, PJ, 2017)
"Evidence for other types of neuropathic pain is very limited."2.55Gabapentin for chronic neuropathic pain in adults. ( Bell, RF; Derry, S; Moore, RA; Phillips, T; Rice, AS; Tölle, TR; Wiffen, PJ, 2017)
"Chronic pruritus is a distressing symptom that is often refractory to treatment."2.53Gabapentin and pregabalin for the treatment of chronic pruritus. ( Kwatra, SG; Matsuda, KM; Schonfeld, AR; Sharma, D, 2016)
"In contrast, medical costs for neuropathic pain did not significantly differ after initiation of pregabalin vs."2.52A systematic review of pharmacoeconomic studies for pregabalin. ( Huelin, R; Khankhel, Z; Mould, J; Parker, L; Wasiak, R, 2015)
"Economic studies of pregabalin in neuropathic pain and FM indicate some results favorable to other forms of care, but heterogeneity among study designs and populations hinder comparisons."2.52A systematic review of pharmacoeconomic studies for pregabalin. ( Huelin, R; Khankhel, Z; Mould, J; Parker, L; Wasiak, R, 2015)
"Gabapentin has been shown to cause minimal to no toxicity in overdose."2.52A review on the efficacy and safety of gabapentin in the treatment of chronic cough. ( Ryan, NM, 2015)
"Recent developments in the treatment of cough include the use of speech pathology and pharmacotherapy with gabapentin."2.52Gabapentin in chronic cough. ( Gibson, PG; Vertigan, AE, 2015)
"Chronic cough is regarded as a challenging clinical problem due to its frequency and often limited therapeutic options."2.52Gabapentin in chronic cough. ( Gibson, PG; Vertigan, AE, 2015)
"Chronic refractory cough has factors in common with laryngeal hypersensitivity syndromes and chronic pain syndromes, and these similarities help to shed light on the pathophysiology of the condition."2.52Management of chronic refractory cough. ( Gibson, PG; Vertigan, AE, 2015)
"Results might vary between different neuropathic pain conditions, and the amount of evidence for gabapentin in neuropathic pain conditions except postherpetic neuralgia and painful diabetic neuropathy, and in fibromyalgia, is very limited."2.50Gabapentin for chronic neuropathic pain and fibromyalgia in adults. ( Derry, S; Moore, RA; Rice, AS; Toelle, T; Wiffen, PJ, 2014)
"Tinnitus is the perception of sound or noise in the absence of an external or internal acoustic stimulation."2.47Anticonvulsants for tinnitus. ( Hoekstra, CE; Rovers, MM; Rynja, SP; van Zanten, GA, 2011)
"Migraine and headache studies are excluded in this revision."2.46WITHDRAWN. Anticonvulsant drugs for acute and chronic pain. ( Carroll, D; Collins, S; Jadad, A; McQuay, HJ; Moore, RA; Wiffen, PJ, 2010)
"Gabapentin was initially developed as an antiepileptic drug but was later discovered to be an effective treatment of neuropathic pain."2.46Gabapentin for the treatment of cancer-related pain syndromes. ( Bar Ad, V, 2010)
"Gabapentin has been successfully used for the treatment of multiple neuropathic pain syndromes such as diabetic neuropathy and postherpetic neuralgia."2.46Gabapentin for the treatment of cancer-related pain syndromes. ( Bar Ad, V, 2010)
"Multimodal postoperative pain management targeted at diminishing harmful outcomes should include pregabalin in cases that need opioid reduction and when the risk of developing chronic neuropathic postsurgical pain is present."2.46Pregabalin for the treatment of postsurgical pain. ( Durkin, B; Glass, P; Page, C, 2010)
"Chronic pain is now viewed as a biopsychosocial phenomenon, in which biological, psychological, and social factors are at work."2.44Practical management strategies for the chronic pain patient. ( Forde, G; Stanos, S, 2007)
"Some mechanisms of the development of neuropathic pain have been proposed; 1) sprouting of A beta fibers to the superficial layer of the dorsal horn, 2) ectopic discharge in the dorsal root ganglion and/or in neuroma at the nerve stump, 3) spinal sensitization."2.44[Mechanisms of the development of neuropathic pain and its treatment]. ( Yamamoto, T, 2008)
"Neuropathic pain has been known to be refractory to traditional analgesics, such as opioids and non-steroidal anti-inflammatoy drugs."2.44[Mechanisms of the development of neuropathic pain and its treatment]. ( Yamamoto, T, 2008)
"neuropathic pain) is not very satisfactorily managed."2.44[Central and peripheral mechanisms in antinociception: current and future perspectives]. ( Fürst, Z, 2008)
"Gabapentin is a second generation anticonvulsant that is effective in the treatment of chronic neuropathic pain."2.44Gabapentin: a multimodal perioperative drug? ( Irwin, MG; Kong, VK, 2007)
"Persistent hiccups have been reported to occur occasionally during rehabilitation hospitalizations."2.44Persistent hiccups during rehabilitation hospitalization: three case reports and review of the literature. ( Browne, BA; Schuchmann, JA, 2007)
"Migraine and headache studies are excluded in this revision."2.43Anticonvulsant drugs for acute and chronic pain. ( Carroll, D; Collins, S; Jadad, A; McQuay, H; Moore, A; Wiffen, P, 2005)
" Thus, monitoring and dosage adjustment are required, without discontinuation of the drug."2.43Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment. ( Argyra, E; Moka, E; Siafaka, I; Vadalouca, A; Vrachnou, E, 2006)
"Treatment decisions for patients with neuropathic pain can be difficult."2.43Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment. ( Argyra, E; Moka, E; Siafaka, I; Vadalouca, A; Vrachnou, E, 2006)
"Neuropathic pain is defined as pain caused by a lesion in the nervous system and is common in clinical practice."2.43Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment. ( Argyra, E; Moka, E; Siafaka, I; Vadalouca, A; Vrachnou, E, 2006)
"Managing patients with chronic neuropathic pain is a common clinical challenge due to variability in individual symptoms, mechanisms, and treatment responses."2.42Diagnosis and management of neuropathic pain: a balanced approach to treatment. ( Nicholson, BD, 2003)
"Diagnosis and management of neuropathic pain syndromes is challenging."2.42Diagnosis and management of neuropathic pain: a balanced approach to treatment. ( Nicholson, BD, 2003)
"Lamotrigine has demonstrated efficacy in delaying time to depressive relapse."2.42Rethinking the treatment paradigm for bipolar depression: the importance of long-term management. ( Baldassano, CF; Ballas, CA; O'Reardon, JP, 2004)
"Stroke is a leading cause of adult disability owing largely to motor impairment and loss of function."1.51The Influence of Primary Motor Cortex Inhibition on Upper Limb Impairment and Function in Chronic Stroke: A Multimodal Study. ( Ackerley, SJ; Barber, PA; Byblow, WD; Cirillo, J; Mooney, RA; Rajeswaran, DK; Stinear, CM, 2019)
"Haloperidol (HAL) is a compound that shows a high affinity with these receptors, acting as an antagonist."1.46Haloperidol Decreases Hyperalgesia and Allodynia Induced by Chronic Constriction Injury. ( Espinosa-Juárez, JV; Jaramillo-Morales, OA; López-Muñoz, FJ, 2017)
"Neuropathic pain has proven to be a difficult condition to treat, so investigational therapy has been sought that may prove useful, such as the use of sigma-1 antagonists."1.46Haloperidol Decreases Hyperalgesia and Allodynia Induced by Chronic Constriction Injury. ( Espinosa-Juárez, JV; Jaramillo-Morales, OA; López-Muñoz, FJ, 2017)
"Chronic cough is a debilitating, often multifactorial problem."1.46Unilateral Laryngoscopic Findings Associated With Response to Gabapentin in Patients With Chronic Cough. ( Dibildox, D; Giliberto, JP; Merati, A, 2017)
"Gabapentin was used by 45% as first-, second-, or third-line treatment."1.46International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis. ( Bieber, BA; Ecder, T; Graham-Brown, M; Hasegawa, T; Kleophas, W; Larkina, M; Pisoni, RL; Rayner, HC; Robinson, BM; Tentori, F; van der Veer, SN; Wang, M, 2017)
"Chronic myositis was induced by injection of Complete Freund Adjuvant (CFA) into the right gastrocnemius (GS) muscle of rats and tests for evaluating mechanical hyperalgesia, thermal hyperalgesia and tactile allodynia were performed."1.46Gabapentin decreases microglial cells and reverses bilateral hyperalgesia and allodynia in rats with chronic myositis. ( Chacur, M; Freitas, MF; Rocha, IR; Rosa, AS, 2017)
"Fetal intrauterine growth restriction generates chronic hypoxia due to placental insufficiency."1.42Altered levels of brain neurotransmitter from new born rabbits with intrauterine restriction. ( Cortés-Camberos, AJ; Díaz, NF; Flores-Herrera, H; García-López, G; González-Jiménez, M; Hernández-Andrade, E; Molina-Hernández, A; Santamaría, A, 2015)
"Cyclothiazide (CTZ) has been reported to simultaneously enhance glutamate receptor excitation and inhibit GABAA receptor inhibition, and in turn it evokes epileptiform activities in hippocampal neurons."1.40Downregulated GABA and BDNF-TrkB pathway in chronic cyclothiazide seizure model. ( Cheng, Z; Kong, S; Liu, J; Wang, Y, 2014)
"However, whether CTZ induced seizure rats could develop to have recurrent seizure still remains unknown."1.40Downregulated GABA and BDNF-TrkB pathway in chronic cyclothiazide seizure model. ( Cheng, Z; Kong, S; Liu, J; Wang, Y, 2014)
"The effect of disc degeneration on behavioral measures of chronic pain has not been evaluated in this model."1.37Behavioral signs of chronic back pain in the SPARC-null mouse. ( Millecamps, M; Sage, EH; Stone, LS; Tajerian, M, 2011)
"Gabapentin failed to suppress the scratching behavior induced by the intradermal injection of compound 48/80 in normal mice."1.37Gabapentin and pregabalin inhibit the itch-associated response induced by the repeated application of oxazolone in mice. ( Manabe, H; Matsumoto, Y; Miura, H; Tsukumo, Y; Yano, H, 2011)
"Causes of symptomatic glossopharyngeal neuralgia can be tumors, infarction or trauma."1.37[Glossopharyngeal neuralgia after resection of a glossopharyngeal schwannoma]. ( Graf, BM; Kleinjung, T; Lassen, CL; Strutz, J; Wiese, CH, 2011)
"Glossopharyngeal neuralgia is a rare condition and the origin is mostly idiopathic."1.37[Glossopharyngeal neuralgia after resection of a glossopharyngeal schwannoma]. ( Graf, BM; Kleinjung, T; Lassen, CL; Strutz, J; Wiese, CH, 2011)
"In rats with four ligatures, prominent mechanical allodynia and thermal hyperalgesia developed; these behavioral signs were not prominent in rats with two ligatures."1.37Pharmacological and behavioral characterization of the saphenous chronic constriction injury model of neuropathic pain in rats. ( Buldum, D; Gunduz, O; Guven, R; Oltulu, C; Ulugol, A, 2011)
"Then, behavioral signs of neuropathic pain were observed for 8 weeks."1.37Pharmacological and behavioral characterization of the saphenous chronic constriction injury model of neuropathic pain in rats. ( Buldum, D; Gunduz, O; Guven, R; Oltulu, C; Ulugol, A, 2011)
"Chronic pain is a common neurological disease involving lasting, multifaceted maladaptations ranging from gene modulation to synaptic dysfunction and emotional disorders."1.37Epigenetic suppression of GAD65 expression mediates persistent pain. ( Bie, B; Cai, YQ; Pan, ZZ; Zhang, Z; Zou, F, 2011)
"Tobacco smoking and depression are strongly associated, but the possible effects of SHS have not been evaluated."1.36Secondhand smoke exposure and depressive symptoms. ( Arheart, KL; Bandiera, FC; Caban-Martinez, AJ; Davila, EP; Dietz, NA; Fleming, LE; Leblanc, WG; Lee, DJ; Lewis, JE; McCollister, K; Serdar, B, 2010)
"Gabapentin was commenced at 300 mg daily and titrated to 300 mg tds over 3 days."1.36Gabapentin (Neurontin) improves pain scores of patients with critical limb ischaemia: an observational study. ( Lewis, MH; Morris-Stiff, G, 2010)
"Pain was assessed by visual analogue scoring at baseline, 4, 7, 14 and 28 days."1.36Gabapentin (Neurontin) improves pain scores of patients with critical limb ischaemia: an observational study. ( Lewis, MH; Morris-Stiff, G, 2010)
"The static allodynia endpoint was modeled by using three population PD approaches: 1) the behavior of the injured paw using a three-category ordinal logistic regression model; 2) paw withdrawal threshold (PWT) (g) between the injured and uninjured paw using the Hill equation with a baseline function; and 3) the baseline normalized difference in PWT between the injured and uninjured paw."1.36Pharmacokinetic-pharmacodynamic analysis of the static allodynia response to pregabalin and sildenafil in a rat model of neuropathic pain. ( Bender, G; Bies, RR; Bramwell, S; Danhof, M; DeJongh, J; Field, MJ; Florian, JA; Marshall, S; Tan, KK, 2010)
"Chronic migraine is an important public health problem."1.36Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials. ( D'Amico, D, 2010)
"Neuropathic pain is a common problem following spinal cord injury (SCI)."1.36Role of NKCC1 and KCC2 in the development of chronic neuropathic pain following spinal cord injury. ( Ahmed, MM; Hasbargen, T; Kahle, KT; Li, L; Miranpuri, G; Resnick, D; Sun, D, 2010)
"CCI also evoked mechanical allodynia that was fully developed on a week post-operation, but showed no recovery for at least 8 weeks."1.35Pharmacological characteristics of the hind paw weight bearing difference induced by chronic constriction injury of the sciatic nerve in rats. ( Kurebayashi, Y; Nakazato-Imasato, E, 2009)
"Epilepsy is a serious neurological disorder in human beings and the long-term pathological events remain largely obscure."1.35Time-course of neuronal death in the mouse pilocarpine model of chronic epilepsy using Fluoro-Jade C staining. ( Chen, LW; Huang, YG; Liu, YH; Wang, L, 2008)
"Anxiety and depression are often also present."1.35Fibromyalgia: poorly understood; treatments are disappointing. ( , 2009)
"(1) Fibromyalgia is characterised by a range of symptoms that include muscle pain, fatigue and sleep disorders."1.35Fibromyalgia: poorly understood; treatments are disappointing. ( , 2009)
"Patients without concomitant facial pain showed better response rates (32 of 39, 82%) compared with patients with concomitant chronic facial pain (7 of 14, 50%, P = 0."1.35Efficacy of pregabalin in the treatment of trigeminal neuralgia. ( Diener, HC; Katsarava, Z; Maschke, M; Obermann, M; Sensen, K; Yoon, MS, 2008)
"Pelvic pain was detected 5 days after antigen instillation and was sustained beyond 30 days, indicating the development of chronic pain."1.35Experimental autoimmune prostatitis induces chronic pelvic pain. ( Rudick, CN; Schaeffer, AJ; Thumbikat, P, 2008)
"Muscle hyperalgesia (withdrawal threshold to compression of the muscle) and cutaneous hyperalgesia of the paw (withdrawal threshold to von Frey filaments) were measured before and after induction of hyperalgesia and after treatment with pregabalin (saline, 10 to 100 mg/kg i."1.34Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats. ( Audette, KM; Maeda, Y; Sluka, KA; Yokoyama, T, 2007)
"Chronic transauricular kindled seizure was induced by repeated application of initially subconvulsive electrical stimulation (40 mA, 0."1.34[Effects of acute maximal electroshock and chronic transauricular kindled seizures on learning abilities in Sprague-Dawley rats]. ( Chen, Z; Li, Q; Wu, DC; Zhang, Q, 2007)
"Chronic transauricular kindled seizures induced CA1 neuron damage and a decrease in histamine levels in the hippocampus."1.34[Effects of acute maximal electroshock and chronic transauricular kindled seizures on learning abilities in Sprague-Dawley rats]. ( Chen, Z; Li, Q; Wu, DC; Zhang, Q, 2007)
"Different types of kindling seizure produce different effects on cognitive behavior: (1) an acute MES impairs learning ability, which may be associated with an abnormal plasticity and an increase of GABA in the hippocampus; (2) the chronic transauricular kindled seizure impairs retrieval memory mainly, which may be related to CA1 neuron damage and a decrease in histaminergic activity in the hippocampus."1.34[Effects of acute maximal electroshock and chronic transauricular kindled seizures on learning abilities in Sprague-Dawley rats]. ( Chen, Z; Li, Q; Wu, DC; Zhang, Q, 2007)
"Six children with cerebral palsy are presented who developed neuropathic pain following multilevel orthopedic surgery."1.33Neuropathic pain following multilevel surgery in children with cerebral palsy: a case series and review. ( Lauder, GR; White, MC, 2005)
"Gabapentin is an anticonvulsant that successfully treats many neuropathic pain syndromes, although the mechanism of its antihyperalgesic action remains elusive."1.33Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate. ( Coderre, TJ; Kumar, N; Lefebvre, CD; Yu, JS, 2005)
"The severe burning pain, deep pressure-like pain, and deep mechanical allodynia, which presented over the contralateral side to the TBI, were successfully relieved with motor cortex stimulation (MCS)."1.33Motor cortex stimulation for central pain following a traumatic brain injury. ( Choi, ES; Hong, JT; Lee, SW; Son, BC; Sung, JH, 2006)
"We studied 14 chronic migraine patients, with or without depression, compared to age-and sex-matched controls."1.33Cerebrospinal fluid GABA levels in chronic migraine with and without depression. ( Alonso, EO; Cavalheiro, EA; Faulhaber, MH; Naffah-Mazacoratti, MG; Peres, MF; Senne Soares, CA; Vieira, DS; Zukerman, E, 2006)
"Patients with hepatic encephalopathy show altered motor function, psychomotor slowing and hypokinesia."1.33Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra. ( Cauli, O; Erceg, S; Felipo, V; Llansola, M, 2006)
"Gabapentin has been shown to be useful in treatment of different conditions which may be caused by increased neuronal excitability."1.32Treatment of chronic neuropathic pain after traumatic central cervical cord lesion with gabapentin. ( Haller, H; Leblhuber, F; Schmidhammer, R; Trenkler, J, 2003)
"Very low birth weight (VLBW) and fetal growth restriction are associated with increased risks of long-term visual impairments, including alterations to contrast sensitivity, a parameter mediated in part by dopaminergic amacrine cells."1.32Chronic placental insufficiency affects retinal development in the guinea pig. ( Briscoe, T; Caddy, J; Dieni, S; Lambert, G; Loeliger, M; Rees, S; Rehn, A, 2004)
" The norepinephrine dose-response curve was shifted to the left with dehydration, revealing an increase in norepinephrine sensitivity."1.32Dehydration-induced synaptic plasticity in magnocellular neurons of the hypothalamic supraoptic nucleus. ( Di, S; Tasker, JG, 2004)
"Thus, dehydration leads to an increase in glutamate and GABA release onto supraoptic magnocellular neurons as well as a marked enhancement of the facilitatory effect of norepinephrine on glutamate release and inhibitory effect on GABA release."1.32Dehydration-induced synaptic plasticity in magnocellular neurons of the hypothalamic supraoptic nucleus. ( Di, S; Tasker, JG, 2004)
"Chronic seizures were induced by amygdalar injection of kainic acid 60 days before death."1.31Collapse of extracellular glutamate regulation during epileptogenesis: down-regulation and functional failure of glutamate transporter function in rats with chronic seizures induced by kainic acid. ( Doi, T; Kamada, H; Mitsuyama, Y; Nakajima, A; Ohya-Nishiguchi, H; Tokumaru, J; Ueda, Y; Willmore, LJ; Yokoyama, H, 2001)
"Gabapentin treatment significantly and reversibly changed the responses, consistent with the attenuation of the abnormal sensory behavior, and the attenuated responses lasted for the duration of the drug effect (up to 6 h)."1.31Rodent model of chronic central pain after spinal cord contusion injury and effects of gabapentin. ( Hulsebosch, CE; McAdoo, DJ; Perez-Polo, JR; Taylor, CP; Westlund, KN; Xu, GY, 2000)
"Lactic acidosis has been implicated; however, increases in the excitotoxic amino acid glutamate, which correlate with increased neuronal damage, may be the cause for the increased damage seen in hyperglycemic stroke."1.31The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex. ( Diaz, FG; Guyot, LL; O'Regan, MH; Phillis, JW; Song, D, 2001)
"SCI gabapentin-treated rats did not display differences in total rearing time until PSD 28 and a significant difference in total activity of all measured parameters was not seen until PSD 60."1.31Changes in exploratory behavior as a measure of chronic central pain following spinal cord injury. ( Grady, JJ; Hulsebosch, CE; Mills, CD, 2001)
"Gabapentin was effective in approximately 50% of pretreated patients with intractable pain."1.31[Gabapentin in the treatment of chronic intractable pain]. ( Gustorff, B; Kress, HG; Nahlik, G; Spacek, A, 2002)
"Gabapentin has been shown to reduce pain associated with diabetic neuropathia and postherpetic neuralgia."1.31[Gabapentin in the treatment of chronic intractable pain]. ( Gustorff, B; Kress, HG; Nahlik, G; Spacek, A, 2002)
"Pain was assessed prior to and during treatment at 1, 3 and 6 months with a 10 cm visual analogue scale which ranged from 0 ('no pain') to 10 ('worst pain imaginable'), or by the documentation of a verbal description of pain."1.31Gabapentin for neuropathic pain following spinal cord injury. ( Brown, DJ; Cooper, N; Frauman, AG; Hill, ST; Kirsa, SW; Lim, TC; To, TP, 2002)
"Paradoxically, GABA agonists increased seizure occurrence while GABA antagonists decreased seizure occurrence."1.28Paradoxical role of GABA in a chronic model of petit mal (absence)-like epilepsy in the rat. ( Bierkamper, GG; Smith, KA, 1990)
"Muscimol was chronically administrated to the third ventricle of thalamic pigeons by means of osmotic minipumps at the rate of 0."1.27Effects of chronic intracerebroventricular GABAergic treatment on basal and chronic or acute stress-induced adrenocortical activities in the thalamic pigeon. ( Baylé, JD; Ramade, F, 1986)

Research

Studies (294)

TimeframeStudies, this research(%)All Research%
pre-199023 (7.82)18.7374
1990's27 (9.18)18.2507
2000's134 (45.58)29.6817
2010's103 (35.03)24.3611
2020's7 (2.38)2.80

Authors

AuthorsStudies
Pankowska, A1
Chudzik, A1
Słowik, T1
Łazorczyk, A1
Kochalska, K1
Andres-Mach, M1
Lam, WW1
Pietura, R1
Rola, R1
Stanisz, GJ1
Orzyłowska, A1
Dhanani, LY1
Totton, RR1
Jara-Quijada, E1
Pérez-Won, M1
Tabilo-Munizaga, G1
Lemus-Mondaca, R1
González-Cavieres, L1
Palma-Acevedo, A1
Herrera-Lavados, C1
Milovanovic, S1
Grzegorczyk, A1
Świątek, Ł1
Grzęda, A1
Dębczak, A1
Tyskiewicz, K1
Konkol, M1
Li, Y3
Chang, P1
Sankaran, S1
Jang, H1
Nie, Y1
Zeng, A1
Hussain, S1
Wu, JY1
Chen, X3
Shi, L2
Senapati, A1
Chetri, BK1
Mitra, S1
Shelke, RG1
Rangan, L1
Chauhan, AS1
Tiwari, M1
Indoliya, Y1
Mishra, SK1
Lavania, UC1
Chauhan, PS1
Chakrabarty, D1
Tripathi, RD1
Akaputra, R1
Hatta, M1
Massi, MN1
Djaharuddin, I1
Bukhari, A1
Aminuddin, A1
Santoso, A1
Natzir, R1
Bahar, B1
Fachri, M1
Farsida, F1
Fathimah, A1
Ubaidah, FM1
Sridiana, E1
Dwiyanti, R1
Syukri, A1
Junita, AR1
Febrianti, A1
Primaguna, MR1
Azhar, A1
Rajaure, YS1
Thapa, B1
Budhathoki, L1
Rana, SR1
Khadka, M1
Batchu, UR1
Surapaneni, JR1
Cheemalamarri, C1
Mandava, K1
Puvvada, N1
Shetty, PR1
Mv, S1
Ranjbarian, P1
Goudarzi, F1
Akya, A1
Heidarinia, H1
Farasat, A1
Rostamian, M1
Suri, K1
Rajput, N1
Sharma, P1
Omble, AD1
Kulkarni, K1
Gahlay, GK1
Fernandez Garcia, E1
Paudel, U1
Noji, MC1
Bowman, CE1
Rustgi, AK1
Pitarresi, JR1
Wellen, KE1
Arany, Z1
Weissenrieder, JS1
Foskett, JK1
Lee, MS1
Han, HJ1
Choi, TI1
Lee, KH1
Baasankhuu, A1
Kim, HT1
Kim, CH1
Redd, PS1
Payero, L1
Gilbert, DM1
Page, CA1
King, R1
McAssey, EV1
Bodie, D1
Diaz, S1
Hancock, CN1
Lee, HS1
Jung, S1
Lee, SW2
Kim, YT1
Lee, J1
Ren, T1
Yu, Z1
Yu, H1
Deng, K1
Wang, Z1
Li, X1
Wang, H3
Wang, L3
Xu, Y2
Lascano, J1
Riley, L1
Khodayari, N1
Brantly, M1
Gupta, R1
Pradhan, J1
Haldar, A1
Murapaka, C1
Chandra Mondal, P1
Gao, R1
Dai, TY1
Meng, Z1
Sun, XF1
Liu, DX1
Shi, MM1
Li, HR1
Kang, X1
Bi, B1
Zhang, YT1
Xu, TW1
Yan, JM1
Jiang, Q1
Helmchen, G1
Guo, H1
Xiang, W1
Fang, Y1
Li, J5
Lin, Y1
An, X1
Jiang, D1
Cao, Q1
Xu, F1
Shiigi, H1
Wang, W1
Chen, Z2
Akosman, I1
Kumar, N2
Mortenson, R1
Lans, A1
De La Garza Ramos, R1
Eleswarapu, A1
Yassari, R1
Fourman, MS1
Jana, S1
Evans, EGB1
Jang, HS1
Zhang, S3
Zhang, H2
Rajca, A1
Gordon, SE1
Zagotta, WN1
Stoll, S1
Mehl, RA1
Miller, S1
Lee, DA1
Muhimpundu, S1
Maxwell, CA1
Liu, Z1
Shen, F1
Tong, Q1
Tang, M1
Peng, M1
Jiao, Z1
Jiang, Y1
Ao, L1
Fu, W1
Lv, X1
Jiang, G1
Hou, L1
Tu, WC1
McManamen, AM1
Su, X1
Jeacopello, I1
Takezawa, MG1
Hieber, DL1
Hassan, GW1
Lee, UN1
Anana, EV1
Locknane, MP1
Stephenson, MW1
Shinkawa, VAM1
Wald, ER1
DeMuri, GP1
Adams, KN1
Berthier, E1
Thongpang, S1
Theberge, AB1
Jiang, L1
Li, Z1
Dong, Q1
Rong, X1
Dong, G1
Huang, J1
Liang, Y1
Sun, S1
Zhang, R2
Miao, Z1
Senju, C1
Nakazawa, Y1
Oso, T1
Shimada, M1
Kato, K1
Matsuse, M1
Tsujimoto, M1
Masaki, T1
Miyazaki, Y1
Fukushima, S1
Tateishi, S1
Utani, A1
Murota, H1
Tanaka, K1
Mitsutake, N1
Moriwaki, S1
Nishigori, C1
Ogi, T1
Liu, C1
Zhang, X1
Wang, B1
Luo, Z1
Qian, D1
Liu, J4
Waterhouse, GIN1
Barbosa, M1
Marques-Sá, J1
Carvalho, C1
Fernandes, V1
Grilli, D1
Smetana, V1
Ahmed, SJ1
Shtender, V1
Pani, M1
Manfrinetti, P1
Mudring, AV1
Kuang, Y1
Yang, D1
Gai, S1
He, F1
An, B1
Yang, P1
Notini, L1
Schulz, K1
Kubeneck, LJ1
Grigg, ARC1
Rothwell, KA1
Fantappiè, G1
ThomasArrigo, LK1
Kretzschmar, R1
Siswanto, FM1
Okukawa, K1
Tamura, A1
Oguro, A1
Imaoka, S1
Kim, CG1
Jung, M1
Kim, HS2
Lee, CK1
Jeung, HC1
Koo, DH1
Bae, WK1
Zang, DY1
Kim, BJ1
Kim, H1
Yun, UJ1
Che, J1
Park, S1
Kim, TS1
Kwon, WS1
Park, J1
Cho, SW1
Nam, CM1
Chung, HC1
Rha, SY1
Colombo, N1
Van Gorp, T1
Matulonis, UA1
Oaknin, A1
Grisham, RN1
Fleming, GF1
Olawaiye, AB1
Nguyen, DD1
Greenstein, AE1
Custodio, JM1
Pashova, HI1
Tudor, IC1
Lorusso, D1
Zhou, F1
Jiang, Z1
Liang, H1
Ru, S1
Bettiol, AA1
Gao, W1
Lipsyc-Sharf, M1
Jain, E1
Collins, LC1
Rosenberg, SM1
Ruddy, KJ1
Tamimi, RM1
Schapira, L1
Come, SE1
Peppercorn, JM1
Borges, VF1
Warner, E1
Snow, C1
Krop, IE1
Kim, D1
Weiss, J1
Zanudo, JGT1
Partridge, AH1
Wagle, N1
Waks, AG1
Moskowitz, A1
Berg, KM1
Grossestreuer, AV1
Balaji, L1
Liu, X1
Cocchi, MN1
Chase, M1
Gong, MN1
Gong, J1
Parikh, SM1
Ngo, L1
Berlin, N1
Donnino, MW1
Zhou, Y1
Chen, Q1
Zhong, S1
Liu, H2
Koh, K1
Chen, H1
He, J1
Chen, J1
Liu, S1
Lin, L1
Zhang, Y2
Xiao, S2
Cao, S1
Yan, B2
Deng, J1
Gu, J1
Tao, Y1
Huang, C1
Lai, C1
Yong, Q1
Shen, Y1
Gong, Z1
Cao, J1
Mao, W1
Yao, Y1
Zhao, J1
Li, Q2
Liu, K1
Liu, B1
Feng, S1
Chandran, V1
Kunjan, C1
Veerapandian, V1
Kannan, R1
Zhang, T2
von Gunten, U1
Caruso, FR1
Goulart, CDL1
Jr, JCB1
de Oliveira, CR1
Mendes, RG1
Arena, R1
Borghi-Silva, A1
Carrasco-Nuñes, N1
Romano, M1
Cabeza, M1
Jiang, B1
Chen, D1
Zhao, C1
Ma, Y1
Yang, W1
Shen, X1
Satheeshkumar, K1
Saravanakumar, P1
Kalavathi, A1
Vennila, KN1
Elango, KP1
Mues Genannt Koers, L1
Prevost, D1
Paulssen, E1
Hoehr, C1
Ulhassan, Z1
Yang, S1
He, D1
Khan, AR1
Salam, A1
Azhar, W1
Muhammad, S1
Ali, S1
Hamid, Y1
Khan, I1
Sheteiwy, MS1
Zhou, W1
Wang, X1
Xie, Q1
Wang, Y4
Lü, H1
Fu, M1
Wang, D1
Sun, H1
Zhu, Y1
Shen, Z1
Zhu, X1
Yao, PA1
Zhang, C1
Yu, W1
Wu, Z1
Sun, J1
Xu, C1
Du, J1
He, X1
Fang, J1
Shao, X1
Ma, K1
Wang, S2
Song, X1
Dong, Z1
Han, X1
Li, H1
Rahaman, A1
Baloch, Z1
Qin, X1
He, Y2
Wang, N1
Zou, JX1
Zhang, YM1
Cao, JL1
Pan, BX2
Zhang, WH1
Sun, T2
Luo, L1
Tian, QQ1
Wang, WJ1
Liu, QQ1
Yang, L1
Zhang, K1
Zhang, W1
Zhao, MG1
Yang, Q1
Heijmans, L1
Joosten, EA1
Yu, F1
Xu, H1
Chen, M1
Guo, L1
Zhou, C1
Wang, F1
Yu, J1
Wu, B1
Almeida, FB1
Pinna, G1
Barros, HMT1
Lee, HG1
Grossman, SK1
Valdes-Rodriguez, R1
Berenato, F1
Korbutov, J1
Chan, YH1
Lavery, MJ1
Yosipovitch, G2
Zhou, X1
Cheng, Y1
Li, G1
Yang, B1
Wu, J1
Qiuxia, Z1
Xinlong, M1
Yilong, Y1
Hui, Z1
Yali, W1
Xiaoquan, Y1
Lei, W1
Jiahui, C1
Haiyan, Z1
Wiffen, PJ7
Derry, S4
Bell, RF1
Rice, AS2
Tölle, TR1
Phillips, T1
Moore, RA7
Espinosa-Juárez, JV1
Jaramillo-Morales, OA1
López-Muñoz, FJ1
Kohse, EK1
Hollmann, MW1
Bardenheuer, HJ1
Kessler, J1
Giliberto, JP2
Dibildox, D1
Merati, A1
Rayner, HC1
Larkina, M1
Wang, M2
Graham-Brown, M1
van der Veer, SN1
Ecder, T1
Hasegawa, T1
Kleophas, W1
Bieber, BA1
Tentori, F1
Robinson, BM1
Pisoni, RL1
Bittencourt, S1
Ferrazoli, E1
Valente, MF1
Romariz, S1
Janisset, NRLL1
Macedo, CE1
Antonio, BB1
Barros, V1
Mundim, M1
Porcionatto, M1
Aarão, MC1
Miranda, MF1
Rodrigues, AM1
de Almeida, AG1
Longo, BM1
Mello, LE2
Hoggard, M1
Nocera, A1
Biswas, K1
Taylor, MW1
Douglas, RG1
Bleier, BS1
Miao, J1
Aboagye, DE1
Chulpayev, B1
Liu, L1
Ishkanian, G1
Kolanuvada, B1
Alaie, D1
Petrillo, RL1
Vincent, K1
Baranowski, A1
Bhattacharya, S1
Birch, J1
Cheong, Y1
Cregg, R1
Daniels, J1
Hewitt, CA1
Macfarlane, GJ1
Middleton, L1
Szubert, W1
Tracey, I1
Williams, ACC1
Horne, AW1
Reszke, R1
Szepietowski, JC1
Mooney, RA1
Ackerley, SJ1
Rajeswaran, DK1
Cirillo, J1
Barber, PA1
Stinear, CM1
Byblow, WD1
Chun, E1
Bumanglag, AV1
Burke, SN1
Sloviter, RS1
Severance, EG1
Viscidi, RP1
Yolken, RH1
Xiao, J1
Bernhard, JD1
Liu, Y1
Tang, F1
Fostini, AC1
Girolomoni, G1
Tessari, G1
Jo, A1
Heo, C1
Schwartz, TH1
Suh, M1
Kong, S1
Cheng, Z1
Liu, ZP1
Song, C1
Xu, XB1
Pan, HQ1
Chen, WB1
Peng, WJ1
Toelle, T1
Kim, SY1
Lee, DW1
-Kim, H1
Bang, E1
Chae, JH1
Choe, BY2
Parker, L1
Huelin, R1
Khankhel, Z1
Wasiak, R1
Mould, J1
Kalita, J1
Kohat, AK1
Misra, UK1
Bhoi, SK1
Wu, CH1
Gunasekara, K1
Hull, JH1
Bikov, A1
Morris, AJ1
Usmani, OS1
Hernández-Andrade, E1
Cortés-Camberos, AJ1
Díaz, NF1
Flores-Herrera, H1
García-López, G1
González-Jiménez, M1
Santamaría, A1
Molina-Hernández, A1
Ryan, NM2
Shao, B1
Zhou, YL1
Lin, YS1
MacKenzie, G2
Maguire, J2
Sierra-Paredes, G1
Loureiro, AI1
Wright, LC1
Sierra-Marcuño, G1
Soares-da-Silva, P1
Chutko, LS1
Surushkina, SIu1
Iakovenko, EA1
Nikishena, IS1
Anisimova, TI1
Bondarchuk, IuL1
Inkpen, H1
Soukupova, M1
Binaschi, A1
Falcicchia, C1
Palma, E1
Roncon, P1
Zucchini, S1
Simonato, M1
Gibson, PG3
Vertigan, AE2
Parekh, PJ1
Balart, LA1
Nakazato-Imasato, E2
Kurebayashi, Y1
Long, Q1
Hei, Y1
Luo, Q1
Tian, Y1
Yang, J1
Wei, L1
Liu, W1
Bonnet, U1
Ossowski, A1
Schubert, M1
Gall, H1
Steinkamp, I1
Richter, LE1
Khalil-Boutros, Y1
Nefedev, A1
Kuhlmann, R1
Nascimento-Alves, P1
Fernandes-Silva, H1
Aragão-Homem, C1
Geraldes, R1
Fonseca, AC1
Robertson, KL1
Marshman, LA1
Lee, V1
Hooper, A1
Matsuda, KM1
Sharma, D1
Schonfeld, AR1
Kwatra, SG1
McKlveen, JM1
Morano, RL1
Fitzgerald, M1
Zoubovsky, S1
Cassella, SN1
Scheimann, JR1
Ghosal, S1
Mahbod, P1
Packard, BA1
Myers, B1
Baccei, ML1
Herman, JP1
Pochwat, B1
Nowak, G1
Szewczyk, B1
Shepard, R1
Page, CE1
Coutellier, L1
Ward, RE1
Veerula, VL1
Ezra, N1
Travers, JB1
Mousdicas, N1
Cohen, SM2
Misono, S2
Rosa, AS1
Freitas, MF1
Rocha, IR1
Chacur, M1
Seidel, K1
Helmeke, C1
Poeggel, G1
Braun, K1
De Smedt, RH1
Jaarsma, T1
van den Broek, SA1
Haaijer-Ruskamp, FM1
Rossi, S1
De Chiara, V1
Musella, A1
Kusayanagi, H1
Mataluni, G1
Bernardi, G1
Usiello, A1
Centonze, D1
Forde, G2
Stanos, S1
Levy, BS1
Apgar, BS1
Liu, YH1
Huang, YG1
Chen, LW1
El-faramawy, YA1
El-banouby, MH1
Sergeev, P1
Mortagy, AK1
Amer, MS1
Abdel-tawab, AM1
Yamamoto, T1
Fürst, Z1
Blicher, JU1
Jakobsen, J1
Andersen, G1
Nielsen, JF1
Wolfe, D1
Mata, M1
Fink, DJ1
Chiechio, S1
Zammataro, M1
Caraci, F1
Rampello, L1
Copani, A1
Sabato, AF2
Nicoletti, F1
Gustafsson, H1
Sandin, J1
Landry, M1
Nagy, F1
Recla, JM1
Sarantopoulos, CD1
Sen, H3
Sizlan, A2
Yanarateş, O2
Senol, MG1
Inangil, G1
Sücüllü, I1
Ozkan, S2
Dağli, G2
Gatti, A1
Carucci, A1
Bertini, L1
Mammucari, M1
Occhioni, R1
Clarke, H1
Pereira, S1
Kennedy, D1
Andrion, J1
Mitsakakis, N1
Gollish, J1
Katz, J1
Kay, J1
Straube, S1
McQuay, HJ5
Jensen, TS1
Finnerup, NB1
Emirkadi, H1
Turan, A2
Buvanendran, A1
Kroin, JS1
Della Valle, CJ1
Kari, M1
Moric, M1
Tuman, KJ1
Romanò, CL1
Romanò, D1
Bonora, C1
Mineo, G1
Tsuda, M1
Inoue, K1
Bandiera, FC1
Arheart, KL1
Caban-Martinez, AJ1
Fleming, LE1
McCollister, K1
Dietz, NA1
Leblanc, WG1
Davila, EP1
Lewis, JE1
Serdar, B1
Lee, DJ1
Tayoshi, S1
Nakataki, M1
Sumitani, S1
Taniguchi, K1
Shibuya-Tayoshi, S1
Numata, S1
Iga, J1
Ueno, S1
Harada, M1
Ohmori, T1
Yildirim, K1
Deniz, O1
Gureser, G1
Karatay, S1
Ugur, M1
Erdal, A1
Senel, K1
Morris-Stiff, G1
Lewis, MH1
Collins, S2
Carroll, D2
Jadad, A2
Strauss, AC1
Dimitrakov, JD1
Greene, SM1
Simpson, CB1
Lampl, C1
Schweiger, C1
Haider, B1
Lechner, A1
Badawy, RA1
Macdonell, RA1
Jackson, GD1
Berkovic, SF1
Flatters, SJ1
Bender, G1
Florian, JA1
Bramwell, S1
Field, MJ2
Tan, KK1
Marshall, S1
DeJongh, J1
Bies, RR1
Danhof, M1
D'Amico, D1
Amr, YM1
Yousef, AA1
Bar Ad, V1
Hasbargen, T1
Ahmed, MM1
Miranpuri, G1
Li, L1
Kahle, KT1
Resnick, D1
Sun, D1
Heidelbaugh, JJ1
Llanes, M1
Weadock, WJ1
Ongür, D1
Prescot, AP1
McCarthy, J1
Cohen, BM1
Renshaw, PF1
Millecamps, M1
Tajerian, M1
Sage, EH1
Stone, LS1
Wamsteeker, JI1
Kuzmiski, JB1
Bains, JS1
Pontari, MA1
Krieger, JN1
Litwin, MS1
White, PC1
Anderson, RU1
McNaughton-Collins, M1
Nickel, JC1
Shoskes, DA1
Alexander, RB1
O'Leary, M1
Zeitlin, S1
Chuai, S1
Landis, JR1
Cen, L1
Propert, KJ1
Kusek, JW1
Nyberg, LM1
Schaeffer, AJ2
Vaysse, L1
Sol, JC1
Lazorthes, Y1
Courtade-Saidi, M1
Eaton, MJ1
Jozan, S1
Durkin, B1
Page, C1
Glass, P1
Tsukumo, Y1
Matsumoto, Y1
Miura, H1
Yano, H1
Manabe, H1
Lassen, CL1
Kleinjung, T1
Strutz, J1
Graf, BM1
Wiese, CH1
Ucak, A1
Onan, B1
Selcuk, I1
Yilmaz, AT1
Pal'tsev, AI1
Torgashov, MN1
Vorontsova, IuS1
Baiandina, EV1
Luniakina, SB1
Bockbrader, HN1
Burger, P1
Knapp, L1
Corrigan, BW1
Leke, R1
Bak, LK1
Iversen, P1
Sørensen, M1
Keiding, S1
Vilstrup, H1
Ott, P1
Portela, LV1
Schousboe, A1
Waagepetersen, HS1
Edwards, J1
Hey, M1
Wilson, I1
Johnson, MI1
Kanehira, T1
Nakamura, Y1
Nakamura, K1
Horie, K1
Horie, N1
Furugori, K1
Sauchi, Y1
Yokogoshi, H1
Buetefisch, C1
Heger, R1
Schicks, W1
Seitz, R1
Netz, J1
Obata, H2
Ogino, Y1
Hoekstra, CE1
Rynja, SP1
van Zanten, GA1
Rovers, MM1
Lantos, PM1
Gunduz, O1
Oltulu, C1
Guven, R1
Buldum, D1
Ulugol, A1
Lua, J1
Bellamy, CO1
Whitworth, C1
Dhaun, N1
Zhang, Z1
Cai, YQ1
Zou, F1
Bie, B1
Pan, ZZ1
Miklós, IH1
Kovács, KJ1
Park, JM1
Jwa, SW1
Song, M1
Ko, HC1
Kim, MB1
Kwon, KS1
Kim, BS1
Komoly, S1
Derks, NM1
Pintér, O1
Zuure, W1
Ledent, C1
Watanabe, M1
Molnár, CS1
Wei, Y1
Roubos, EW1
Wu, S1
Hrabovszky, E1
Zelena, D1
Kozicz, T1
Shavit, L1
Grenader, T1
Lifschitz, M1
Slotki, I1
Aboumarzouk, OM1
Nelson, RL1
Birring, SS1
Llano, DA1
Turner, J1
Caspary, DM1
Liu, HY1
Li, YX1
Hao, YJ1
Wang, HY1
Dai, XY1
Yu, JQ1
Wielage, R1
Bansal, M1
Wilson, K1
Klein, R1
Happich, M1
Wu, F1
Yang, N1
Touré, A1
Jin, Z1
Xu, X1
Diop, L1
Raymond, F1
Fargeau, H1
Petoux, F1
Chovet, M1
Doherty, AM1
Laughlin, TM1
Tram, KV1
Wilcox, GL1
Birnbaum, AK1
Surges, R1
Feuerstein, TJ1
Fassoulaki, A2
Patris, K1
Sarantopoulos, C2
Hogan, Q1
Bortalanza, LB1
Ferreira, J1
Hess, SC1
Delle Monache, F1
Yunes, RA1
Calixto, JB1
Xi, ZX1
Ramamoorthy, S1
Shen, H1
Lake, R1
Samuvel, DJ1
Kalivas, PW1
Duvilanski, BH1
Alvarez, MP1
Castrillón, PO1
Cano, P1
Esquifino, AI1
Agostoni, E1
Frigerio, R1
Santoro, P1
Polgár, E1
Hughes, DI1
Riddell, JS1
Maxwell, DJ1
Puskár, Z1
Todd, AJ1
Haller, H1
Leblhuber, F1
Trenkler, J1
Schmidhammer, R1
Laurén, HB1
Pitkänen, A1
Nissinen, J1
Soini, SL1
Korpi, ER2
Holopainen, IE1
Oefelein, MG1
Bayazit, Y1
Lockwood, PA1
Cook, JA1
Ewy, WE1
Mandema, JW1
Heinz, A1
Schäfer, M1
Higley, JD1
Krystal, JH1
Goldman, D1
Spira, PJ1
Beran, RG1
von Orelli, F1
White, WT1
Patel, N1
Drass, M1
Nalamachu, S1
Nicholson, BD1
Lotery, HE1
McClure, N1
Galask, RP1
Hong-Ju, Y1
He, L1
Wei-Guo, S1
Nan, Z1
Wei-Xiu, Y1
Zhong-Wei, J1
Jun-Wei, W1
Zheng-Hua, G1
Bo-Hua, Z1
Zhi-Pu, L1
Zhe-Hui, G1
Stahl, SM1
Loeliger, M1
Briscoe, T1
Lambert, G1
Caddy, J1
Rehn, A1
Dieni, S1
Rees, S1
Di, S1
Tasker, JG1
Allen, NJ1
Káradóttir, R1
Attwell, D1
Verkuyl, JM1
Hemby, SE1
Joëls, M2
Baldassano, CF1
Ballas, CA1
O'Reardon, JP1
Lin, TB1
Lo, MJ1
Huang, CY1
Ting, H1
Lee, SD1
Urban, MO1
Ren, K1
Park, KT1
Campbell, B1
Anker, N1
Stearns, B1
Aiyar, J1
Belley, M1
Cohen, C1
Bristow, L1
Garber, K1
Lauder, GR1
White, MC1
Heartsill, LG1
Brown, TM1
Karst, H1
Alfarez, D1
Heine, VM1
Qin, Y1
van Riel, E1
Verkuyl, M1
Lucassen, PJ1
Krugers, HJ1
Wiffen, P1
McQuay, H1
Moore, A1
Edwards, JE1
Weissenbacher, S1
Ring, J1
Hofmann, H1
Coderre, TJ1
Lefebvre, CD1
Yu, JS1
Triga, A1
Melemeni, A1
Toru, M1
Sator-Katzenschlager, SM1
Scharbert, G1
Kress, HG2
Frickey, N1
Ellend, A1
Gleiss, A1
Kozek-Langenecker, SA1
Persaud, R1
Frosh, A1
Baghdoyan, HA1
Baron, R1
Lu, VB1
Moran, TD1
Balasubramanyan, S1
Alier, KA1
Dryden, WF1
Colmers, WF1
Smith, PA1
Son, BC1
Choi, ES1
Sung, JH1
Hong, JT1
Vieira, DS1
Naffah-Mazacoratti, MG1
Zukerman, E1
Senne Soares, CA1
Alonso, EO1
Faulhaber, MH1
Cavalheiro, EA1
Peres, MF1
Mintz, S2
Lee, JK2
Kehlet, H1
Cohen, SP1
Sireci, A1
Wu, CL1
Larkin, TM1
Williams, KA1
Hurley, RW1
Bichuetti, DB1
Yamaoka, WY1
Bastos, JR1
Carvalho, Dde S1
Potes, CS1
Neto, FL2
Castro-Lopes, JM2
Cauli, O2
Llansola, M2
Erceg, S1
Felipo, V2
Kimos, P1
Biggs, C1
Mah, J1
Heo, G1
Rashiq, S1
Thie, NM1
Major, PW1
Bergasa, NV1
McGee, M1
Ginsburg, IH1
Engler, D1
Lefaucheur, JP1
Drouot, X1
Ménard-Lefaucheur, I1
Keravel, Y1
Nguyen, JP1
Ferreira-Gomes, J1
Pawlik, MT1
Ittner, KP1
Vadalouca, A1
Siafaka, I1
Argyra, E1
Vrachnou, E1
Moka, E1
Hauer, JM1
Wical, BS1
Charnas, L1
Yokoyama, T1
Maeda, Y1
Audette, KM1
Sluka, KA1
Manenti, L1
Vaglio, A1
Jatzko, A1
Stegmeier-Petroianu, A3
Petroianu, GA1
Melrose, HL1
Kinloch, RA1
Cox, PJ1
Collins, D1
Williams, D1
Mlili, N1
Solak, O2
Metin, M1
Esme, H1
Yaman, M1
Pekcolaklar, A1
Gurses, A1
Kavuncu, V1
Wu, DC1
Zhang, Q1
Wallace, JM1
Sinclair, AM1
Miller, B1
Lee, LK1
Petroianu, G3
Jerome, L1
Knake, S1
Klein, KM1
Hattemer, K1
Wellek, A1
Oertel, WH1
Hamer, HM1
Rosenow, F1
Kong, VK1
Irwin, MG1
Obermann, M1
Yoon, MS1
Sensen, K1
Maschke, M1
Diener, HC1
Katsarava, Z1
Hayashida, K1
Schuchmann, JA1
Browne, BA1
Zeilhofer, HU1
Ehrchen, J1
Ständer, S1
Tanimoto-Mori, S1
Toide, K1
Kita, Y1
Ketz, AK1
Rudick, CN1
Thumbikat, P1
Benbouzid, M1
Choucair-Jaafar, N1
Yalcin, I1
Waltisperger, E1
Muller, A1
Freund-Mercier, MJ1
Barrot, M1
Bras, M1
Haslam, C1
Nurmikko, T1
Logothetis, J1
Paraschos, A1
Frangos, E1
Snyder, SH1
Kausen, J1
Zimmermann, P1
Fünfgeld, EW1
Klenke, D1
Henkel, H1
Puca, FM1
Genco, S1
Minervini, MG1
Specchio, LM1
Napoletano, V1
Brancasi, B1
Reggio, F1
Skerritt, JH1
Trisdikoon, P1
Johnston, GA2
Eninia, GI1
Smeltere, ES1
Godlevska, MA1
Uzulinia, IP1
McCarthy, BW1
Gomes, UR1
Neethling, AC1
Shanley, BC1
Taljaard, JJ1
Potgieter, L1
Roux, JT1
Nazaretian, RA1
Babaian, EA1
Sarukhanian, ZhG1
Martirosian, AS1
Darbinian, GV1
Maddison, JE1
Watson, WE1
Acosta, GB1
Otero Losada, ME1
Rubio, MC1
Suh, TS1
Shinn, KS1
Lee, CW1
Lee, C1
Paik, IH1
Walker, MC1
Li, LM1
Sander, JW4
Hunter, JC1
Gogas, KR1
Hedley, LR1
Jacobson, LO1
Kassotakis, L1
Thompson, J1
Fontana, DJ1
Wilson, EA1
Brodie, MJ1
Nicolodi, M1
Del Bianco, PL1
Sicuteri, F1
Terranova, R1
Gilotta, SM1
Luca, S1
García-Albea, E1
Gibbs, JW1
Morton, LD1
Amaker, B1
Ward, JD1
Holloway, KL1
Coulter, DA1
Yamashiro, K1
Tomiyama, N1
Ishida, A1
Terada, Y1
Mukawa, J1
Yoshii, Y1
Tasker, RR1
Albe-Fessard, D1
Hein, G2
Petroianu, A1
Bergler, W2
Rüfer, R2
Schwartzkroin, PA1
Langan, Y1
Duncan, JS1
Ylinen, A1
Salmenperä, T1
Mumford, JP1
Riekkinen, PJ1
Hansen, HC1
Wasterlain, CG1
Mazarati, AM1
Shirasaka, Y1
Thompson, KW1
Penix, L1
Katsumori, H1
Law, RO1
Wong, IC2
Chadwick, DW1
Fenwick, PB1
Mawer, GE1
Ben-David, B1
Friedman, M1
Moretti, R1
Torre, P1
Antonello, RM1
Nasuelli, D1
Cazzato, G1
Kapadia, NP1
Harden, N1
Fragoso, YD1
Carrazana, EJ1
Grachev, ID1
Fredrickson, BE1
Apkarian, VA1
Lhatoo, SD1
Polizzi, G1
Ueda, Y1
Doi, T1
Tokumaru, J1
Yokoyama, H1
Nakajima, A1
Mitsuyama, Y1
Ohya-Nishiguchi, H1
Kamada, H1
Willmore, LJ1
Hulsebosch, CE2
Xu, GY1
Perez-Polo, JR1
Westlund, KN1
Taylor, CP1
McAdoo, DJ1
Guyot, LL1
Diaz, FG1
O'Regan, MH1
Song, D1
Phillis, JW1
Haywood, JR1
Mifflin, SW1
Craig, T1
Calderon, A1
Hensler, JG1
Hinojosa-Laborde, C1
Mills, CD1
Grady, JJ1
Farrar, JT1
Young, JP1
LaMoreaux, L1
Werth, JL1
Poole, MR1
Mtchedlishvili, Z1
Bertram, EH1
Kapur, J1
Suzuki, T1
Sundman-Eriksson, I1
Blennow, K1
Davidsson, P1
Dandenell, AK1
Marcusson, J1
Gustorff, B1
Nahlik, G1
Spacek, A1
Hamani, C1
Söderpalm, B1
Boz, C1
Velioglu, S1
Bulbul, I1
Ozmenoglu, M1
To, TP1
Lim, TC1
Hill, ST1
Frauman, AG1
Cooper, N1
Kirsa, SW1
Brown, DJ1
Bruins Slot, LA1
Tarayre, JP1
Koek, W1
Ribet, JP1
Colpaert, FC1
Tamminga, CA2
Neophytides, A1
Chase, TN1
Frohman, LA1
Garkusha, LG1
Kukhtevich, II1
Proskurkina, OA1
Smythies, JR1
Bradley, RJ1
Linton, PH1
Sytinsky, IA1
Guzikov, BM1
Gomanko, MV1
Eremin, VP1
Konovalova, NN1
Cassady, SL1
Thaker, GK1
Moran, M1
Birt, A1
Rönnbäck, L1
Hansson, E1
Mishunina, TM1
Kononenko, VIa1
Komissarenko, IV1
Smith, KA1
Bierkamper, GG1
Sil'vestrov, VP1
Kinitin, AV1
Chesnokova, IV1
Thirlby, RC1
Fenster, LF1
Coatsworth, JJ1
Petty, F1
Esclapez, M1
Trottier, S1
Levy, LJ1
Losowsky, MS1
Monteleone, P3
Maj, M2
Iovino, M2
Forziati, D1
Veltro, F1
Steardo, L3
Kleinman, JE1
Goodman, SI1
Wyatt, RJ1
Zontini, G1
Ramade, F1
Baylé, JD1
Bode, JC1
Schäfer, K1
Minuk, GY1
Winder, A1
Burgess, ED1
Sarjeant, EJ1
Van Leuven, F1
Weyne, J1
Brogden, RN1
Speight, TM1
Avery, GS1

Clinical Trials (71)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
GABA-WHY Study: Deprescription of Gabapentinoids in Medical Inpatients[NCT04855578]160 participants (Actual)Interventional2021-05-28Completed
The Treatment Effect of Chinese Medicine Formula on Uremic Pruritus[NCT04650750]Early Phase 160 participants (Anticipated)Interventional2020-12-01Not yet recruiting
Effectiveness of Sertraline in Alleviating Uremic Pruritis in Hemodialysis Patients[NCT05341843]Phase 260 participants (Actual)Interventional2022-05-01Completed
Biperiden for Prevention of Epilepsy in Patients With Traumatic Brain Injury[NCT04945213]Phase 3312 participants (Anticipated)Interventional2023-01-10Recruiting
A Double-Blind, Placebo-Controlled Study of Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors[NCT03530800]Phase 2/Phase 350 participants (Actual)Interventional2018-10-01Completed
Phenomics and Genomics of Clinically Relevant Chronic Postsurgical Pain: A Multicenter Prospective Study[NCT04798573]10,000 participants (Anticipated)Observational2012-08-03Active, not recruiting
Pre-Emptive Analgesia in Ano-Rectal Surgery[NCT02402543]90 participants (Actual)Interventional2014-06-30Completed
Use of Single Dose Pre-Operative Pregabalin for Post-Operative Analgesia in Bilateral Head and Neck Cancer Surgery: A Randomized, Double-Blinded, Placebo-Controlled Trial[NCT03714867]Phase 40 participants (Actual)Interventional2019-03-22Withdrawn (stopped due to Inability to recruit patients)
Cannabidiol for Fibromyalgia -The CANNFIB Trial Protocol for a Randomized, Double-blind, Placebo-controlled, Parallel-group, Single-center Trial[NCT04729179]Phase 3200 participants (Anticipated)Interventional2021-03-01Recruiting
The Effect of Intravenous Infusions of Lidocaine and Magnesium Versus Lidocaine and Ketamine Versus Lidocaine Alone on Recovery Profile and Postoperative Pain After Elective Gynecological Surgery[NCT04622904]90 participants (Anticipated)Interventional2020-11-14Recruiting
Effect of Ultra-low Dose Naloxone on Remifentanil-Induced Hyperalgesia[NCT03066739]Phase 2105 participants (Anticipated)Interventional2023-02-25Recruiting
A Prospective, Randomized Controlled Trial on Perioperative Pregabalin to Reduce Late-onset Complex Regional Pain Syndrome After Total Knee Arthroplasty[NCT00558753]Phase 2240 participants (Actual)Interventional2006-04-30Completed
Preemptive Analgesia With Amitryptyline for Prevention of Post-operative Pain in Women After Total Abdominal Hysterectomy: a Randomized Clinical Trial[NCT03587025]Phase 3150 participants (Actual)Interventional2015-06-01Completed
Efficacy of Different Doses of Pregabalin as a Multimodal Analgesic Agent in Postoperative Pain Control After Total Knee Arthroplasty - A Randomized Controlled Trial[NCT05447364]Phase 482 participants (Anticipated)Interventional2021-07-01Recruiting
Comparison of Oral Lamotrigine Versus Pregabalin for Control of Acute and Chronic Pain Following Modified Radical Mastectomy: Controlled Double-blind Study[NCT03419949]0 participants Expanded AccessAvailable
Diagnostic Challenges in IC (and Male CPPS)[NCT00672087]1,000 participants (Anticipated)Observational2003-09-30Completed
The Effect of Lidocaine to Prevent the Development of Chronic Post-Surgical Pain[NCT01619852]148 participants (Actual)Interventional2012-06-30Completed
Double Blind Trial Investigating the Role of Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients[NCT03847311]Phase 240 participants (Anticipated)Interventional2021-05-03Recruiting
A Randomized, Placebo-controlled Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Pregabalin for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)[NCT00371033]Phase 3318 participants (Anticipated)Interventional2006-03-31Active, not recruiting
Gabapentin Regimens and Their Effects on Opioid Consumption[NCT03334903]Phase 477 participants (Actual)Interventional2018-05-15Completed
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis[NCT05603702]Phase 124 participants (Anticipated)Interventional2023-03-17Recruiting
Regional Anesthesia and Valproate Sodium for the Prevention of Chronic Post-Amputation Pain[NCT01928849]Phase 2128 participants (Actual)Interventional2013-12-31Completed
Clinical Trial of Etanercept (TNF-α Blocker) for Treatment of Blast-Induced Tinnitus[NCT04066348]Phase 2310 participants (Anticipated)Interventional2022-07-01Recruiting
Comparison of Oral Gabapentin and Pregabalin in Postoperative Pain Control After Photorefractive Keratectomy: a Prospective, Randomized Study.[NCT00954187]8 participants (Actual)Interventional2009-11-30Terminated (stopped due to PI left institution)
Comparative Evaluation of Osteopathy Treatment Efficacy in Pain Support After Breast Surgery in Oncology[NCT01403168]28 participants (Actual)Interventional2011-04-30Terminated (stopped due to Recruitment difficulties)
Randomized Controlled Pilot Trial of Adjunct Group Acupuncture vs Usual Care Among Patients With Painful Diabetic Neuropathy[NCT02104466]40 participants (Actual)Interventional2015-03-31Completed
Radiofrequency Thoracic Sympathectomy for Chronic Postmastectomy Pain; Randomized Placebo Controlled Study[NCT03494426]70 participants (Actual)Interventional2018-04-01Completed
Erenumab as a Therapeutic Approach for the Management of Painful Chronic Temporomandibular Disorders (TMD)[NCT05162027]Phase 25 participants (Actual)Interventional2022-04-01Terminated (stopped due to Low enrollment rate)
Prospective, Cross Over Gabapentin vs Amitriptyline Study on Patients Suffering From Masticatory Muscle Pain[NCT02339662]Phase 450 participants (Anticipated)Interventional2015-02-28Recruiting
Study of Gabapentin for the Pruritus of Cholestasis[NCT00058890]Phase 315 participants (Actual)Interventional2000-11-30Completed
Comparison of the Analgesic Effect Between the Motor Cortex Stimulation (tDCS and rTMS) and the Trans-spinal Stimulation (tsDCS ) in the Algoneurodystrophy of Members. A Randomised Clinical Trial. tDCS : Transcranial Direct-current Stimulation rTMS : Repe[NCT02817880]36 participants (Actual)Interventional2016-07-25Completed
Primary Motor Cortex Plasticity and the Bottom up Effect of Deep Intramuscular Needling Stimulation Therapy (DIMST)in Osteoarthritis Chronic Pain[NCT01855958]26 participants (Actual)Interventional2012-02-29Completed
Effect of Transcranial Direct Current Stimulation and Electro Acupuncture in Pain, Functional Capability and Cortical Excitability in Patients With Osteoarthritis.[NCT01747070]60 participants (Actual)Interventional2014-03-31Completed
A Phase II, Randomized, Placebo-controlled, Double Blind, Cross-over, Study of the Effects of Gabapentin on Chronic Irritability in Neurologically Impaired Children[NCT01675960]Phase 22 participants (Actual)Interventional2012-04-30Terminated (stopped due to unable to enroll)
The Impact of Perioperative Gabapentin on Chronic Groin Pain After Inguinal Hernia Repair[NCT02419443]Phase 4100 participants (Anticipated)Interventional2011-08-31Active, not recruiting
Effect of Preoperative Pregabalin on Propofol Induction Dose[NCT01158859]Phase 450 participants (Anticipated)Interventional2010-04-30Completed
The Effect of Gabapentin on Acute Pain and PONV in Bariatric Surgical Patients[NCT00886236]62 participants (Actual)Interventional2008-02-29Completed
Phase III Study of the Use of Gabapentin and Osteopathic Manipulative Medicine to Treat Fibromyalgia[NCT01107574]Phase 341 participants (Actual)Interventional2004-04-30Completed
An Open Prospective Randomised Long-Term Effectiveness Study, Comparing Best Medical Practice With or Without Adjunctive VNS Therapy in Patients 16 Years and Older With Pharmaco-resistant Partial Epilepsy[NCT00522418]Phase 4122 participants (Actual)Interventional2006-02-28Terminated (stopped due to Insufficient enrollment)
A Double-Blind, Randomized, Placebo-Controlled, Three-Arm Trial Examining Sublingual Cannabinoid Tablets for the Treatment of Pain From Osteoarthritis of the Knee.[NCT04992962]Phase 266 participants (Anticipated)Interventional2021-07-29Recruiting
An Open-label, Single-centre, Parallel-group Clinical Investigation, to Evaluate the Effectiveness and In-use Tolerability of a Range of Four Orthotic Insoles on Target Areas of Pain in the Lower Body, Associated With Musculoskeletal Stress, Experienced b[NCT04746755]145 participants (Actual)Interventional2019-06-21Terminated (stopped due to Participants experienced data collection issues when using the eDiary, these issues increased the burden and lowered compliance. Updates to the eDiary were unsuccessful at resolving the issues so the decision was taken to terminate the Investigation.)
Effects of a Self-management Program for Temporomandibular Myalgia in Subjects With Fibromyalgia: a Single Arm Study[NCT05426655]40 participants (Anticipated)Interventional2022-06-16Recruiting
Side Effects of Two Different Mandibular Advancement Devices (MAD) in the Treatment of Snoring and Obstructive Sleep Apnea Syndrome (OSAS)[NCT04050514]65 participants (Actual)Interventional2019-12-01Completed
The Effect of Repetitive Transcranial Magnetic Stimulation on Diabetic Peripheral Neuropathic Pain: A Randomized Controlled Trial[NCT04833660]22 participants (Anticipated)Interventional2021-04-30Not yet recruiting
Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy[NCT04920097]240 participants (Anticipated)Interventional2021-07-08Recruiting
The Effectiveness of Radial Shockwave Therapy on Myofascial Pain Syndrome: A Mixed Method Study That Combines a Randomised Control Trial and Semi-Structured Interview.[NCT05381987]120 participants (Anticipated)Interventional2022-04-21Recruiting
Ultrasound Guided Platelet Rich Plasma Injections for Post Traumatic Greater Occipital Neuralgia: A Randomized Controlled Pilot Study[NCT04051203]Phase 135 participants (Anticipated)Interventional2019-02-01Active, not recruiting
NanaBis™ an Oro-buccal Administered Equimolar d9-THC & CBD Formulation as Monotherapy for Management of Opioid Requiring Bone Pain Due to Metastatic Cancer: Phase 3 Multi Centre Blinded Randomized Withdrawal Active & Placebo Controlled Trial[NCT04808531]Phase 3360 participants (Anticipated)Interventional2023-11-30Not yet recruiting
Assessment and Treatment Responses to Patient Education and Basic Body Awareness Therapy in Hip Osteoarthritis: a Randomized Controlled Trial[NCT02884531]101 participants (Actual)Interventional2015-10-31Completed
Effect of Muscle Energy Technique on Craniovertebral and Shoulder Angles in Forward Head Posture[NCT05642130]60 participants (Anticipated)Interventional2022-09-22Active, not recruiting
Multicentre Observational Study on the Wound Pain Relief Properties of ORTODERMINA®[NCT03720119]78 participants (Actual)Observational2015-01-27Completed
Erenumab as a Therapeutic Approach for the Management of Trigeminal Neuropathic Pain (TNP)[NCT05142228]Phase 25 participants (Actual)Interventional2022-04-01Terminated (stopped due to Low enrollment rate)
The Use of Virtual Reality for Lumbar Pain Management in an Outpatient Spine Clinic: An Exploratory Comparative Randomized Trial[NCT03819907]45 participants (Actual)Interventional2019-04-08Completed
A Double Blind, Randomized Crossover Study of Efficacy and Safety of Topical Menthol, With and Without Mannitol, in the Treatment of Painful Diabetic Peripheral Neuropathy[NCT02728687]Phase 1/Phase 272 participants (Actual)Interventional2017-03-15Completed
Randomized Controlled Trial of Fractional CO2 Laser vs Sham Laser for Women With Provoked Vestibulodynia Who Have Failed Conservative Management[NCT03390049]0 participants (Actual)Interventional2018-08-31Withdrawn (stopped due to No funding)
Clinical Validation of a Decompression Prototype Splint for Patients With Carpal Tunel Syndrome: a Multicentric Randomized Controlled Trial[NCT04043780]60 participants (Actual)Interventional2019-09-24Completed
Addressing Opioid Use Disorder With an External Multimodal Neuromodulation Device: Clinical Evaluation of DuoTherm for Opioid-Sparing in Chronic Low Back Pain[NCT04494698]100 participants (Anticipated)Interventional2022-06-23Recruiting
Addressing Opioid Use Disorder With an External Multimodal Neuromodulation Device: Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute Low Back Pain[NCT04491175]60 participants (Anticipated)Interventional2022-06-23Recruiting
Effects of Tele-prehabilitation on Clinical and Muscular Recover in Patients Waiting for Knee Replacement: a Randomized Controlled Trial[NCT05668312]58 participants (Anticipated)Interventional2023-01-01Not yet recruiting
Trigger Point Dry Needling vs Trigger Point Dry Needling With Intramuscular Electrical Stimulation for the Treatment of Sub-acute and Chronic Low Back Pain in a Military Population: A Randomized Crossover Design[NCT03539588]30 participants (Actual)Interventional2017-04-12Completed
A Randomised, Double-Blind, Double-Dummy, Parallel-Group, Multiple-Dose, Active and Placebo-Controlled Efficacy Study of Ibuprofen Prolonged-Release Tablets for the Treatment of Pain After Surgical Removal of Impacted Third Molars[NCT03785756]Phase 3280 participants (Anticipated)Interventional2019-04-29Recruiting
Perioperative Visual Therapy May Help Prevent Phantom Limb Pain[NCT02383979]Phase 4115 participants (Anticipated)Interventional2010-08-31Recruiting
Acupuncture for Female Interstitial Cystitis/Painful Bladder Syndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial[NCT02232282]22 participants (Actual)Interventional2014-10-31Completed
Does the Addition of Massage to Manual Therapy and Exercise Improve Outcome in Chronic Neck Pain?[NCT02313480]39 participants (Actual)Interventional2013-04-30Completed
A Retrospective Longitudinal Cohort Study to Determine the Effectiveness of Integrated a Clinical Pathway Approach for Chronic Pain Treatment With Acupuncture in a Pain Clinic[NCT04490798]3,245 participants (Actual)Observational2020-06-12Completed
A Randomised, Double-blind, Double-dummy, Parallel-group, Single Dose, Active and Placebo-controlled Efficacy and Pharmacokinetics/Pharmacodynamics Study of 2 x 200 mg Ibuprofen Liquid Capsules for the Treatment of Pain After Surgical Removal of Impacted [NCT05484401]Phase 3294 participants (Actual)Interventional2022-08-09Completed
Evaluation of Pain Before and After Removal of Non-obstructive Kidney Stones[NCT03657667]43 participants (Actual)Interventional2018-08-28Completed
Efficacy of an Internet-based Intervention for Dental Anxiety[NCT03680755]Phase 2450 participants (Anticipated)Interventional2019-07-24Active, not recruiting
Cryoneurolysis Outcome on Pain Experience (COPE) in Patients With Low-back Pain - a Single-blinded Randomized Controlled Trial[NCT04786145]120 participants (Anticipated)Interventional2020-02-15Active, not recruiting
Celiac Plexus Radiosurgery for Pain Management in Advanced Cancer Patients - a Phase II Trial[NCT02356406]Phase 252 participants (Anticipated)Interventional2014-01-31Recruiting
Effect of Scapula-focused Treatment With Additional Motor Control Exercises on Pain and Disability in Patients With Subacromial Pain Syndrome: A Randomized Controlled Trial[NCT02695524]60 participants (Actual)Interventional2016-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

NIMH Trichotillomania Symptom Severity Scale (NIMH-TSS)

The entire study lasts 10 weeks. Every two weeks subjects will take the NIMH-TSS. The change in scores from baseline to after 10 weeks will be assessed. The scale itself assesses severity of trichotillomania symptoms. The NIMH-TSS score ranges from 0 to 20, with 0 being no symptoms and 20 being the most severe. (NCT03530800)
Timeframe: Assessed every two weeks up to 10 weeks, baseline data reported

Interventionscore on a scale (Mean)
Dronabinol12.38
Placebo10.63

Skin Picking Symptom Assessment Scale (SP-SAS)

The entire study lasts 10 weeks. Every two weeks subjects will take the SP-SAS. The change in scores from baseline to after 10 weeks will be assessed. The scale itself assesses severity of skin-picking symptoms. The SP-SAS score ranges from 0 to 48, with 0 being no symptoms and 48 being the most severe. (NCT03530800)
Timeframe: Assessed every two weeks up to 10 weeks, baseline reported

Interventionscore on a scale (Mean)
Dronabinol24.44
Placebo28.5

Epidural Medication Consumption Rate

Epidural medication consumption was recorded for each 4-h interval from the completion of surgery to the time that the epidural was discontinued (same as the time to achieve hospital discharge criteria). Because the discontinuation time varied from patient to patient (as they achieved physical therapy criteria), the average hourly consumption (total analgesic used divided by the total infusion time) was used as the measure of epidural drug use. (NCT00558753)
Timeframe: 36 h

InterventionmL/h (Mean)
1 Placebo6.40
2 Pregabalin5.77

Knee Range of Motion (Active Flexion)

(NCT00558753)
Timeframe: 1-30 days

,
InterventionDegrees (Least Squares Mean)
Day 1Day 2Day 3Day 30
1 Placebo75.676.780.4103.0
2 Pregabalin77.881.084.2107.2

Neuropathic Pain (S-LANSS > 12)

Patients will be evaluated in blinded fashion for lower extremity Complex Regional Pain Syndrome(CRPS) at pre-op, 1, 3, and 6 months postsurgery based initially on telephone interviews. An S-LANSS score of 12 or more was an indication of chronic neuropathic pain. Patients with an Self-report version of the Leeds Assessment of Neuropathic Symptoms and Signs(S-LANSS) score of 12 or more at 6 mo came to the physician's office for a standardized physical examination, which included the S-LANSS examination items (allodynia and hyperalgesia) directly assessed by the physician, plus a pinprick evaluation. (NCT00558753)
Timeframe: 3 and 6 months post-surgery

,
Interventionparticipants (Number)
Neuropathic pain at 3 Month Follow upNeuropathic pain at 6 Month Follow up
1 Placebo106
2 Pregabalin00

Number of Participants With Chronic Persistent Pain 3 Months After Surgery as Determined by Character Severity (Yes/no).

The participants development of chronic persistent pain 3 months after surgery as determined by character severity (yes/no). (NCT01619852)
Timeframe: 3 months

Interventionparticipants (Number)
Group L2
.9% Normal Saline Placebo6

Opioid Consumption

The amount of opioid analgesics consumed was converted to an equivalent dose of intravenous morphine. (NCT01619852)
Timeframe: 24 hours

Interventionequivalent dose of intravenous morphine (Median)
Group L34
.9% Normal Saline Placebo39

Postoperative Pain

Postoperative pain within the first 24 hours. Area under the numeric rating scale for pain versus time curve during the first 24 hours after surgery (score * hr). Numeric rating scale for pain on a scale of 0-10 (0 is no pain and 10 is high pain) versus time curve during the first 24 hours ( score * hr). The pain scores were collected upon arrival to recovery area, 30 minutes, 1 hour and every 6 hours up to 24 hours following the procedure. Minimum score is 60, Maximum score is 170. A higher value indicates more pain. (NCT01619852)
Timeframe: 24 hours

Interventionscore on a scale (Median)
Group L116
.9% Normal Saline Placebo119

Quality of Recovery

Quality of recovery (QoR-40 instrument) is a 40-item questionnaire that provides a global score and sub-scores across five dimensions: patient support, comfort, emotions, physical independence, and pain. Score range: 40 to 200. A score of 40 demonstrates poor recovery and a maximum score of 200 represents good recovery. The higher the score the better recovery after surgery. (NCT01619852)
Timeframe: 24 hours post operative

Interventionunits on a scale (Median)
Lidocaine (Group L)158
.9% Normal Saline Placebo169

Post-surgical Persistent Pain Using Validated Questionnaires (S-LANNS Questionnaire, McGill Questionnaire, Brief Pain Inventory) to Assess Pain Qualities in Accordance With IMMPACT Recommendations.

The development of chronic pain 3 months after surgery determined by the Leads Assessment of Neuropathic Symptoms and Signs (LANSS) scale, a valid 7-item tool for identifying patients whose pain is dominated by neuropathic mechanisms. Each item is a binary response (yes or no) to the presence of symptoms (5 items) or clinical signs (2 items), range 0-24 points. A score ≥ 12, neuropathic mechanisms are likely to be contributing to the patient's pain. A score < 12 is unlikely to be contributing. McGill questionnaire (Sensory domain) - 11 descriptors rated on an intensity scale as 0=none, 1=mild, 2=moderate, 3=severe. The higher the score, greater the pain (range 0-33). McGill questionnaire (Motivational-affective) 4 affect descriptors rated on an intensity scale as 0=none, 1=mild, 2=moderate, 3=severe.The higher the score the greater the pain (range 0-12) Brief pain inventory - pain severity (0, no pain, 10 excruciating pain); Greater the score; greater the pain (range 0-10). (NCT01619852)
Timeframe: 3 months

,
Interventionunits on a scale (Median)
S-LANNSMcGill Questionaire-Sensory DiscrimationMcGill Questionaire-Motivational-affectiveBrief Pain Inventory
.9% Normal Saline Placebo3301
Group L3401

"VAS Score 1: How Much Pain do You Feel in Your Operative Site When Resting?"

Surgical site pain. Scale 0-10, with 0 best and 10 worst (NCT03334903)
Timeframe: 2-3 months after surgery (at 2nd postoperative appointment)

Interventionscore on 10-point scale (Mean)
Standard of Care2.26
Postoperative Gabapentin Regimen2.46

"VAS Score 2: How Much Pain do You Feel in Your Operative Site When Moving?"

Surgical site pain. Scale 0-10, with 0 best and 10 worst. (NCT03334903)
Timeframe: 2-3 months following surgery (measured at second postoperative appointment).

Interventionscore on a 10-point scale (Mean)
Standard of Care3.84
Postoperative Gabapentin Regimen3.54

"VAS Score 3: How Well Are You Sleeping?"

Sleep quality. Scale 0-10 with 0 worst and 10 best. (NCT03334903)
Timeframe: 2-3 months following surgery (measured at second postoperative appointment).

Interventionscore on a 10-point scale (Mean)
Standard of Care5.73
Postoperative Gabapentin Regimen6.38

"VAS Score 4: How Bad is Your Nausea?"

Nausea. Scale 0-10, with 0 best and 10 worst. (NCT03334903)
Timeframe: 2-3 months following surgery (measured at second postoperative appointment).

Interventionscore on a 10-point scale (Mean)
Standard of Care0.36
Postoperative Gabapentin Regimen0.17

"VAS Score 5: How Satisfied Are You With Your Pain Management?"

Satisfaction. Scale 0-10 with 0 worst and 10 best. (NCT03334903)
Timeframe: 2-3 months following surgery (measured at second postoperative appointment).

Interventionscore on a 10-point scale (Mean)
Standard of Care7.83
Postoperative Gabapentin Regimen8.48

Days Taking Opioids

Number of days until patients are finished consuming opioid medications after discharge. (NCT03334903)
Timeframe: 2-3 months following surgery (measured at second postoperative appointment).

Interventiondays (Mean)
Standard of Care14.8
Postoperative Gabapentin Regimen18.7

Opioid Consumption

Mean opioid consumption, measured in mg of morphine equivalents. (NCT03334903)
Timeframe: 2-3 months following surgery (total amount measured at second postoperative appointment; means assessed afterwards).

Interventionmorphine equivalents (Mean)
Standard of Care287.0
Postoperative Gabapentin Regimen281.1

Change in Self-Reported Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale (S-LANSS)

The S-LANSS is a self-reported version of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale. It aims to differentiate neuropathic pain from somatic or nociceptive pain. We will analyze the change in numeric average pain score during the past week (range from 0-10) from baseline. Higher scores indicate greater pain. (NCT01928849)
Timeframe: Assessments at enrollment and 3 months or time of final adjudication assessment (up to 6 months)

Interventionscore on a scale (Median)
Cherry Syrup-2
Valproic Acid-2

Number of Patients With Chronic Post-amputation Pain

The primary endpoint is the incidence of chronic pain after surgery. The study team will use the average pain score over the past week as noted on the Self-Reported Leeds Assessment of Neuropathic Symptoms and Signs pain scale (S-LANSS) for the assessment of pain, and define chronic pain as a score greater than or equal to 3. (NCT01928849)
Timeframe: 3 months or time of final adjudication assessment, up to 6 months

InterventionParticipants (Count of Participants)
Cherry Syrup37
Valproic Acid36

Brief Pain Inventory (BPI) Short Form Score

The BPI short form is a multidimensional patient-completed measure that assesses the sensory component of pain intensity. We will analyze the change in average pain score question (ranges 0-10) and the sum of the 7 interference questions (total range 0-70) from baseline. Higher score indicates greater pain and interference. (NCT01928849)
Timeframe: Assessments at enrollment and 3 months or time of final adjudication assessment (up to 6 months)

,
Interventionscore on a scale (Median)
BPI Average Pain ScoreBPI interference question sum
Cherry Syrup-2-15
Valproic Acid-1-7

Defense and Veterans Pain Rating Scale (DVPRS) Score

The DVPRS is a pain assessment tool developed by the military in an effort to improve reliability and interpretability of pain assessment in the military population. It has been found to be an effective and valid tool in this population. We will analyze the change in numeric pain response (range 0-10) and the sum of the four supplemental questions (range 0-40) from baseline. Higher scores indicate greater pain and functional limitations. (NCT01928849)
Timeframe: Assessments at enrollment and 3 months or time of final adjudication assessment (up to 6 months)

,
Interventionscore on a scale (Median)
DVPRS numeric painDVPRS Supplemental Question Sum
Cherry Syrup-2-9
Valproic Acid0-4.5

Effect on Analgesic Requirement

The effect of study drug on perioperative analgesic consumption and corresponding analysis of pain/sedation scales. Outcome defined as total opioid consumption (mg) during each 24-hour periods following surgery. (NCT01928849)
Timeframe: Assessments during hospitalization (0-24 hours and 24-48 hours post-surgery)

,
Interventionmorphine milligram equivalents (Median)
Postoperative hours 0-24Postoperative hours 24-48
Cherry Syrup5949
Valproic Acid3345

Incidence of Pain Sub-types

The incidence of neuropathic limb or post-amputation pain sub-types as defined by adjudication classification at each assessment time point. (NCT01928849)
Timeframe: Assessments at enrollment and 3 months or time of final adjudication assessment (up to 6 months)

,
InterventionParticipants (Count of Participants)
Residual limb painPhantom limb
Cherry Syrup2922
Valproic Acid3126

Richmond Agitation-Sedation Scale (RASS)

The RASS is a commonly used, valid and reliable assessment tool for use in hospitalized patients. Validity testing reveals good inter-rater reliability among medical, surgical, and intensive care units. We will analyze the numeric score at each assessment (range -5 (unarousable) to 4 (combative)). (NCT01928849)
Timeframe: during hospitalization (0-24 hours and 24-48 hours post-surgery)

,
Interventionscore on a scale (Median)
Post-op hours 0-24Post-op hours 24-48
Cherry Syrup00
Valproic Acid00

Conditioned Pain Modulation (CPM) After Intervention.

"PPT during cold water immersion (PPT+CPM): By measuring PPT during cold water immersion, we evaluated the degree to which pain perception is modulated by conditioned pain modulation (CPM) following the presentation of an initial heterotopic noxious stimulus. Subjects immersed their left hands into cold water (zero to 1°C) for 1 minute. During the last 30 seconds of cold-water immersion, the PPT procedure was administered at the right forearm. The temperature was held constant across during the experiment for each subject.~# Below the data after intervention." (NCT01855958)
Timeframe: Before and within one hour after intervention.

InterventionKgf / cm2 (Mean)
DIMST12.62
Placebo-sham9.15

Cortical Silent Period (CSP) After Intervention.

"To determine the cortical silent period (CSP), subjects were instructed to squeeze the dynamometer using their fingers at 20% of maximal force when a single pulse stimulus (130% rMT) was applied. The result was the average of five consecutive measurements. The CSP was determined by the interval between the stimulus and the motor response elicited in the subject.~# Below the data after intervention." (NCT01855958)
Timeframe: Evaluated before and within one hour after intervention.

Interventionms (milliseconds). (Mean)
DIMST, Deep Intramuscular Stimulation Therapy50.93
Placebo-sham, Rubber Electrodes With Electrostimulation48.92

Intracortical Facilitation (ICF) After Intervention.

"ICF was evaluated using an inter-stimuli intervals (ISIs) of 12 ms with paired-pulse and similar parameters for the conditioning and test stimuli. After a randomized protocol, thirty stimuli were assessed using a 2ms interval (ICI), a 12ms interval (ICF) and test-only trials (MEP). The resulting MEP amplitude was converted into the mean amplitude, and paired-pulse parameters were expressed as the amount of inhibition or facilitation. The calculation result of ICF was done by the ratio of the mean ICF by the mean MEP.~# Below the data after intervention." (NCT01855958)
Timeframe: Before and within one hour after intervention.

Interventionratio of amplitude (mV). (Mean)
DIMST, Deep Intramuscular Stimulation Therapy1.20
Placebo-sham, Rubber Electrodes With Electrostimulation0.78

Intracortical Inhibition (ICI) After Intervention.

"ICI was evaluated using inter-stimuli intervals (ISIs) of 2 ms with paired-pulse stimulation. The subthreshold stimulus was set at 80% of rMT (conditioning stimulus) , and the suprathreshold test stimulus was set at 130% of rMT. After a randomized protocol, thirty stimuli were assessed using a 2ms interval (ICI), a 12ms interval (ICF) and test-only trials (MEPs). The resulting MEP amplitude was converted into the mean amplitude, and paired-pulse parameters were expressed as the amount of inhibition or facilitation. The calculation result of ICI was done by the ratio of the mean ICI by the mean MEP.~# Below the data after intervention." (NCT01855958)
Timeframe: Evaluated in one day. The cortical excitability before and within an hour after intervention.

Interventionratio of amplitude (mV). (Mean)
DIMST, Deep Intramuscular Stimulation Therapy0.75
Placebo-sham, Rubber Electrodes With Electrostimulation0.57

Motor Evoked Potential (MEP) After Intervention.

"Cortical excitability was assessed using a MagPro X100 (MagVenture Company, Lucernemarken, Denmark) and a figure-of-8 coil centered over the left motor cortex (M1). Subjects were seated in a comfortable reclining chair with their arms and hands lying relaxed on the armrests. The investigators measured the resting motor threshold (rMT) of the right first dorsal interosseous (FDI) muscle. The MEPs were recorded by surface electromyography (EMG) using Ag-AgCl cup electrodes in a belly tendon montage. Resting motor threshold (rMT) was defined as the stimulus intensity at which peak-to-peak MEP amplitude of 50 µV (microvolts) was obtained in at least 5 of 10 consecutive trials.~MEP was defined as approximately 130% of the rMT or the stimulus intensity at which peak-to-peak MEP amplitude of at least 1 mV was obtained in 10 consecutive trials. The result of the MEP was the average of 10 curves (unconditioned MEP).~# Below the data after intervention." (NCT01855958)
Timeframe: Before and within one hour after intervention.

InterventionmV (millivolts). (Mean)
DIMST, Deep Intramuscular Stimulation Therapy1.14
Placebo-sham, Rubber Electrodes With Electrostimulation1.12

Pain Intensity After Intervention.

"The intensity of pain was measured by a 10-cm VAS. VAS scores ranged from no pain (zero) to the worst possible pain possible (10 cm). The pain score on VAS during the last 24 hours was used to classify the subjects into two groups: (1) absence of pain or mild pain (scores equal to or lower than 4 cm) and (2) moderate, intense, or worst possible pain (scores higher than 4 cm).~# Below the data after intervention." (NCT01855958)
Timeframe: Evaluated within twenty four hours before and within one hour after the intervention.

Interventioncm ( mean). (Mean)
DIMST, Deep Intramuscular Stimulation Therapy0.88
Placebo-sham, Rubber Electrodes With Electrostimulation3.36

Pain Pressure Threshold (PPT) After Intervention..

"PPT (alone): The patient was instructed to verbally report the perception of pain onset. The investigator assessed PPT using an electronic algometer (J Tech Medical Industries, USA). The device had a 1-cm2 hard-rubber probe, which was applied over structures at L1- L5 dermatome at the knee and at the contralateral forearm. The average values of PPT in kgf/cm2 for three successive readings taken at intervals of 3-5 min were used as the outcomes.~# Below, the data after intervention." (NCT01855958)
Timeframe: Before and within one hour after intervention.

InterventionKgf / cm2 (Mean)
DIMST, Deep Intramuscular Stimulation Therapy8.82
Placebo-sham, Rubber Electrodes With Electrostimulation6.66

Evaluate Incidence of Respiratory Depression as Evidenced by Pulse Oximetry Data

(NCT00886236)
Timeframe: 48 hours

Intervention% oxygen saturation (Mean)
1 Preoperative Gabapentin Liquid93
2 Preoperative and Postoperative Gabapentin Liquid94
3 Preoperative and Postoperative Placebo Liquid95

Evaluate the Amount of Diluadid Given Postoperatively

The amount of intraoperative and postoperative opioids used will be collected and analyzed for the three different arms. (NCT00886236)
Timeframe: 120 hours

Interventionml (Mean)
1 Preoperative Gabapentin Liquid11.035
2 Preoperative and Postoperative Gabapentin Liquid8.7
3 Preoperative and Postoperative Placebo Liquid12.4

Number of Participants Who Experience Incidence of Postoperative Nausea.

(NCT00886236)
Timeframe: 120 hours

InterventionParticipants (Count of Participants)
1 Preoperative Gabapentin Liquid12
2 Preoperative and Postoperative Gabapentin Liquid11
3 Preoperative and Postoperative Placebo Liquid12

Change From Baseline in Adverse Event Profile (AEP) Score

Adverse Events Profile (AEP) is a 19-item scale used as a systematic measure of adverse effects from antiepileptic drugs (AEDs). Scores range from 19-76; higher scores indicate high prevelance and severity of adverse events. (NCT00522418)
Timeframe: Mean change from baseline AEP Score at 12 months

InterventionUnits on a scale (Mean)
VNS Therapy-6.0
Best Medical Practice-3.2

Change From Baseline in Center for Epidemiologic Studies Depression Scale (CES-D) Score

The Center for Epidemiologic Studies Depression Scale (CES-D) includes 20 items comprising six scales reflecting major dimensions of depression: depressed mood, feelings of guilt and worthlessness, feelings of helplessness and hopelessness, psychomotor retardation, loss of appetite, and sleep disturbance. Possible range of scores is 0 to 60, higher scores indicate more depressive symptoms. (NCT00522418)
Timeframe: Mean change from baseline CES-D Score at 12 months

InterventionUnits on a Scale (Mean)
VNS Therapy-2.2
Best Medical Practice0.5

Change From Baseline in Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) Score

The Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) is a 6-item questionnaire validated to screen for depression in people with epilepsy. Scores range from 6 to 24, with higher scores indicating more depressive symptoms. (NCT00522418)
Timeframe: Mean change from baseline NDDI-E Score at 12 months

InterventionUnits on a Scale (Mean)
VNS Therapy-1.0
Best Medical Practice-0.2

Changes in Anti-epileptic Drugs (AEDs)

Change from baseline in number of AED medications by visit (NCT00522418)
Timeframe: Change from baseline in number of AEDs at 12 months

InterventionNumber of AEDs Taken (Median)
VNS Therapy0
Best Medical Practice0

Mean Change From Beginning of Intervention Clinical Global Impression-Improvement Scale (CGI-I) Score at 12 Months

The Clinical Global Impression scale (CGI-I) is a 7 point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention Scores range from 1-7: 1, very much improved; 2, much improved; 3, minimally improved; 4, no change; 5, minimally worse; 6, much worse; or 7, very much worse. (NCT00522418)
Timeframe: Mean change from baseline CGI-I Score at 12 months

InterventionUnits on a Scale (Mean)
VNS Therapy-0.8
Best Medical Practice-0.3

Mean Percent Change in Seizure Frequency

Percent change in total seizuires per week from baseline at 12 months (NCT00522418)
Timeframe: Mean percent change from baseline in seizure frequency at 12 months

InterventionPercent Change (Mean)
VNS Therapy-19.1
Best Medical Practice-1.0

Overall Quality of Life in Epilepsy-89 (QOLIE-89) Score in Patients With Baseline & at Least One Post-baseline QOLIE Assessment

QOLIE-89 contains 17 multi-item measures of overall quality of life, emotional well-being, role limitations due to emotional problems, social support, social isolation, energy/fatigue, worry about seizure, medication effects, health discouragement, work/driving/social function, attention/concentration, language, memory, physical function, pain, role limitations due to physical problems, and health perceptions. Range of values 0-100. Higher scores reflect better quality of life; lower ones, worse quality of life. (NCT00522418)
Timeframe: Mean change from baseline QOLIE-89 Overall Score at 12 months

Interventionunits on a scale (Mean)
VNS Therapy5.5
Best Medical Practice1.2

Response Rate

Response Rate is defined as the percent of participants who are responders. A Responder is defined as participants with a reduction of at least 50% or 75% in seizure frequency from baseline to the seizure count evaluation period. (NCT00522418)
Timeframe: Number of Responders at 12 Months

Interventionparticipants (Number)
VNS Therapy10
Best Medical Practice7

Change From Baseline in QOLIE-89 Measures: Subgroup Analysis of Population With Baseline Adverse Event Profile Score < 40

QOLIE-89 contains 17 multi-item measures of overall quality of life. Range of values 0-100. Higher scores reflect better quality of life; lower ones, worse quality of life. Adverse Events Profile (AEP) is a 19-item scale used as a systematic measure of adverse effects from antiepileptic drugs (AEDs). Scores range from 19-76; higher scores indicate high prevelance and severity of adverse events. (NCT00522418)
Timeframe: Change from baseline up to 12 months

Interventionunits on a scale (Least Squares Mean)
VNS TherapyBest Medical Practice
Baseline Adverse Event Profile Score < 403.30.5

Change From Baseline in QOLIE-89 Measures: Subgroup Analysis of Population With Baseline Adverse Event Profile Score >= 40

QOLIE-89 contains 17 multi-item measures of overall quality of life. Range of values 0-100. Higher scores reflect better quality of life; lower ones, worse quality of life. Adverse Events Profile (AEP) is a 19-item scale used as a systematic measure of adverse effects from antiepileptic drugs (AEDs). Scores range from 19-76; higher scores indicate high prevelance and severity of adverse events. (NCT00522418)
Timeframe: Change from baseline up to 12 months

InterventionUnits on a Scale (Least Squares Mean)
VNS TherapyBest Medical Practice
Baseline Adverse Event Profile Score >= 403.30.7

Change of Pain Intensity From Baseline to the End of Treatment Using the 11-point Numerical Pain Rating Scale (NPRS)

"The evaluation of the pain intensity was based on a 11-point Numerical Pain Rating Scale (NPRS score from 0= no pain to 10= the most intense pain imaginable). Patients recorded the NPRS score every day of treatment in their diary.~The improvement in the pain intensity is defined as a decrease in NPRS scores from baseline to the end of treatment." (NCT03720119)
Timeframe: Every day for 15 days

InterventionScore on a scale (Mean)
NPRS score of Day 1NPRS score of Day 2NPRS score of Day 3NPRS score of Day 4NPRS score of Day 5NPRS score of Day 6NPRS score of Day 7NPRS score of Day 8NPRS score of Day 9NPRS score of Day 10NPRS score of Day 11NPRS score of Day 12NPRS score of Day 13NPRS score of Day 14NPRS score of Day 15
Single Cohort6.75.45.04.74.13.93.63.63.63.43.23.23.33.02.8

Change of Pain Relief From Baseline to the End of Treatment Using the 5-point Visual Rating Scale (VRS)

"The evaluation of wound pain relief was based on a 5-point Visual Rating Scale (0 = none improvement; 4 = total relief).~Patients recorded the VRS score every day of treatment in their diary. The improvement in the pain relief was defined as a VRS scores at end of treatment significantly greater than 0." (NCT03720119)
Timeframe: Every day for 15 days

InterventionParticipants (Count of Participants)
Day 272404424Day 372404424Day 472404424Day 572404424Day 672404424Day 772404424Day 872404424Day 972404424Day 1072404424Day 1172404424Day 1272404424Day 1372404424Day 1472404424Day 1572404424
None reliefMildComplete reliefModerateA lot
Single Cohort23
Single Cohort28
Single Cohort20
Single Cohort24
Single Cohort30
Single Cohort18
Single Cohort2
Single Cohort31
Single Cohort5
Single Cohort17
Single Cohort39
Single Cohort6
Single Cohort21
Single Cohort33
Single Cohort9
Single Cohort16
Single Cohort35
Single Cohort7
Single Cohort25
Single Cohort10
Single Cohort22
Single Cohort12
Single Cohort14
Single Cohort11
Single Cohort3
Single Cohort13
Single Cohort15
Single Cohort4

Efficacy of Acupuncture to Reduce Pain in Women With Interstitial Cystitis/Painful Bladder Syndrome

Change in worst pain as measured by the Brief Pain Inventory-Short Form. Scores range from 0 to 10 and higher scores indicate more pain. Change is calculated as the 6 weeks score minus the baseline score. (NCT02232282)
Timeframe: 0 weeks, 6 weeks

Interventionscore on a scale (Least Squares Mean)
Minimal Acupuncture-2.08
Standard Acupuncture Treatment-2.91

Safety of Acupuncture in Women With Interstitial Cystitis/Painful Bladder Syndrome

The total number of adverse events experienced by women receiving acupuncture (NCT02232282)
Timeframe: 0 weeks, 12 weeks

Interventiontotal number of adverse events (Number)
Minimal Acupuncture0
Standard Acupuncture Treatment0

Tolerability of Acupuncture in Women With Interstitial Cystitis/Painful Bladder Syndrom

The total number of acupuncture sessions stopped due to poor tolerability of acupuncture (NCT02232282)
Timeframe: 0 weeks, 6 weeks

Interventiontotal number of sessions (Number)
Minimal Acupuncture0
Standard Acupuncture Treatment0

Change in Functionality Evaluated With Specific Questionnaire

The Brazilian version of Shoulder Pain and Disability Index ranging 0 to 100 points. Lower scores indicate better functionality (NCT02695524)
Timeframe: baseline, four and eight weeks and sixteen weeks after randomization

,
Interventionunits on a scale (Mean)
baseline4 weeks8 weeks16 weeks
Motor Control Exercises65.743.539.734.2
Scapula-focused Exercises63.349.837.132.8

Change in Intensity of Pain Evaluated by a Scale

Pain Numerical Rating Scale from 0 to 10. Lower values indicate improvement in pain (NCT02695524)
Timeframe: baseline, four and eight weeks and sixteen weeks after randomization

,
Interventionunits on a scale (Mean)
Baseline4 weeks8 weeks16 weeks
Motor Control Exercises3.91.51.31.2
Scapula-focused Exercises3.72.71.80.5

Change in Kinesiophobia Evaluated With Specific Questionnaire

Tampa Scale of Kinesiophobia ranging 17 to 68 points. High scores indicate high degree kinesiophobia (NCT02695524)
Timeframe: baseline, four and eight weeks and sixteen weeks after randomization

,
Interventionunits on a scale (Mean)
Kinesiophobia baselineKinesiophobia 4 weeksKinesiophobia 8 weeksKinesiophobia 16 weeks
Motor Control Exercises42.840.738.937.5
Scapula-focused Exercises42.139.840.238.7

Change in Strength Evaluated by Hand Held Dynamometer and the Measures Provided in Kilogram-force (KgF)

Strength of serratus anterior, trapezius muscles, abduction, adduction, internal and external rotation movements the arm with hand held Dynamometer. (NCT02695524)
Timeframe: baseline, four and eight weeks and sixteen weeks after randomization

,
InterventionKilogram-force (Mean)
Shoulder abduction baselineShoulder abduction 4 weeksShoulder abduction 8 weeksShoulder abduction 16 weeksShoulder adduction baselineShoulder adduction 4 weeksShoulder adduction 8 weeksShoulder adduction 16 weeksShoulder external rotation baselineShoulder external rotation 4 weeksShoulder external rotation 8 weeksShoulder external rotation 16 weeksShoulder Internal rotation baselineShoulder Internal rotation 4 weeksShoulder Internal rotation 8 weeksShoulder Internal rotation 16 weeksSerratus Anterior BaselineSerratus Anterior 4 weeksSerratus Anterior 8 weeksSerratus Anterior 16 weeksUpper Trapezius BaselineUpper Trapezius 4 weeksUpper Trapezius 8 weeksUpper Trapezius 16 weeksMiddle Trapezius BaselineMiddle Trapezius 4 weeksMiddle Trapezius 8 weeksMiddle Trapezius 16 weeksLower Trapezius baselineLower Trapezius 4 weeksLower Trapezius 8 weeksLower Trapezius 16 weeks
Motor Control Exercises5.56.37.177.999.295.76.16.56.49.410.411.410.76.81010.810.68.811.112.111.43.34.14.44.63.1444.1
Scapula-focused Exercises6.27.17.97.87.88.89.28.55.85.96.56.98.69.110.410.37.29.110.311.18.39.811.1114.44.95.15.44.34.655

Perceived Change Evaluated by Numerical Scale

Global Perceived Effect Scale ranging -5 to +5 points. Positive values indicate improvement and negative values indicate worsening of symptoms (NCT02695524)
Timeframe: four, eight weeks and sixteen weeks of randomization

,
Interventionunits on a scale (Mean)
4 weeks8 weeks16 weeks
Motor Control Exercises2.83.33.1
Scapula-focused Exercises22.93.3

Range of Motion Evaluated by Digital Inclinometer and the Measures Provided in Degrees

abduction, adduction, internal and external rotation of the shoulder (NCT02695524)
Timeframe: baseline, four and eight weeks and sixteen weeks after randomization

,
Interventiondegrees (Mean)
Shoulder Flexion BaselineShoulder Flexion 4 weeksShoulder Flexion 8 weeksShoulder Flexion 16 weeksShoulder Abduction BaselineShoulder Abduction 4 weeksShoulder Abduction 8 weeksShoulder Abduction 16 weeksShoulder External Rotation BaselineShoulder External Rotation 4 weeksShoulder External Rotation 8 weeksShoulder External Rotation 16 weeksShoulder Internal Rotation BaselineShoulder Internal Rotation 4 weeksShoulder Internal Rotation 8 weeksShoulder Internal Rotation 16 weeks
Motor Control Exercises129148.5147.8149.9120.2145.2145.5141.360.966.768.37048.653.454.654.8
Scapula-focused Exercises132.5140.4148146.6125.3139147.8143.260.166.473.771.449.253.959.257.1

Satisfaction With Treatment Evaluated With Specific Questionnaire

Medrisk Questionnaire ranging 13 to 80 points. High scores indicate satisfaction with treatment (NCT02695524)
Timeframe: four, eight weeks and sixteen weeks after randomization

,
Interventionunits on a scale (Mean)
Medrisk 4 weeksMedrisk 8 weeksMedrisk 16 weeks
Motor Control Exercises63.163.663.8
Scapula-focused Exercises60.861.362

Scapula Position Evaluated by Digital Inclinometer and the Measures Provided in Degrees

upward rotation and tilt of the scapula (NCT02695524)
Timeframe: baseline, four and eight weeks and sixteen weeks after randomization

,
Interventiondegrees (Mean)
Upward Rotation 0º BaselineUpward Rotation 0º 4 weeksUpward Rotation 0º 8 weeksUpward Rotation 0º 16 weeksUpward Rotation 90º baselineUpward Rotation 90º 4 weeksUpward Rotation 90º 8 weeksUpward Rotation 90º 16 weeksUpward Rotation 180º baselineUpward Rotation 180º 4 weeksUpward Rotation 180º 8 weeksUpward Rotation 180º 16 weeksAnterior Tilt 0º baselineAnterior Tilt 0º 4 weeksAnterior Tilt 0º 8 weeksAnterior Tilt 0º 16 weeksAnterior Tilt 90º baselineAnterior Tilt 90º 4 weeksAnterior Tilt 90º 8 weeksAnterior Tilt 90º 16 weeksAnterior Tilt 180º baselineAnterior Tilt 180º 4 weeksAnterior Tilt 180º 8 weeksAnterior Tilt 180º 16 weeks
Motor Control Exercises75.75.76.513.614.517.620.635.539.344.344.5191919.419.614.213.612.311.74.23.20.10.7
Scapula-focused Exercises5.65.355.112.813.31516.830.737.340.939.718.418.419.718.71514.615.113.24.323.10.6

Reviews

64 reviews available for gamma-aminobutyric acid and Chronic Disease

ArticleYear
Mechanisms and mode of action of spinal cord stimulation in chronic neuropathic pain.
    Postgraduate medicine, 2020, Volume: 132, Issue:sup3

    Topics: Chronic Disease; gamma-Aminobutyric Acid; Ganglia, Spinal; Humans; Neuralgia; Serotonin; Spinal Cord

2020
The Role of HPA Axis and Allopregnanolone on the Neurobiology of Major Depressive Disorders and PTSD.
    International journal of molecular sciences, 2021, May-23, Volume: 22, Issue:11

    Topics: Adaptation, Physiological; Animals; Antidepressive Agents; Chronic Disease; Corticosterone; Depressi

2021
Gabapentin for chronic neuropathic pain in adults.
    The Cochrane database of systematic reviews, 2017, 06-09, Volume: 6

    Topics: Adult; Amines; Analgesics; Chronic Disease; Chronic Pain; Cyclohexanecarboxylic Acids; Diabetic Neur

2017
Chronic Hiccups: An Underestimated Problem.
    Anesthesia and analgesia, 2017, Volume: 125, Issue:4

    Topics: Amines; Anesthesiology; Baclofen; Chronic Disease; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Am

2017
End-Stage Renal Disease Chronic Itch and Its Management.
    Dermatologic clinics, 2018, Volume: 36, Issue:3

    Topics: Amines; Analgesics, Opioid; Anticonvulsants; Antipruritics; Chronic Disease; Cyclohexanecarboxylic A

2018
Clinical practice. Chronic pruritus.
    The New England journal of medicine, 2013, Apr-25, Volume: 368, Issue:17

    Topics: Amines; Antidepressive Agents, Tricyclic; Behavior Therapy; Chronic Disease; Cyclohexanecarboxylic A

2013
Prurigo nodularis: an update on etiopathogenesis and therapy.
    The Journal of dermatological treatment, 2013, Volume: 24, Issue:6

    Topics: Amines; Chronic Disease; Cyclohexanecarboxylic Acids; Dermatologic Agents; Epidermis; Female; Gabape

2013
Gabapentin for chronic neuropathic pain and fibromyalgia in adults.
    The Cochrane database of systematic reviews, 2014, Apr-27, Issue:4

    Topics: Adult; Amines; Analgesics; Chronic Disease; Chronic Pain; Cyclohexanecarboxylic Acids; Fibromyalgia;

2014
A systematic review of pharmacoeconomic studies for pregabalin.
    Pain practice : the official journal of World Institute of Pain, 2015, Volume: 15, Issue:1

    Topics: Amines; Analgesics; Anticonvulsants; Chronic Disease; Cost-Benefit Analysis; Cyclohexanecarboxylic A

2015
A review on the efficacy and safety of gabapentin in the treatment of chronic cough.
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:1

    Topics: Amines; Antitussive Agents; Chronic Disease; Cough; Cyclohexanecarboxylic Acids; Gabapentin; gamma-A

2015
Gabapentin in chronic cough.
    Pulmonary pharmacology & therapeutics, 2015, Volume: 35

    Topics: Amines; Animals; Chronic Disease; Cough; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagoni

2015
Ammonia and Its Role in the Pathogenesis of Hepatic Encephalopathy.
    Clinics in liver disease, 2015, Volume: 19, Issue:3

    Topics: Ammonia; Animals; Astrocytes; Blood-Brain Barrier; Chronic Disease; gamma-Aminobutyric Acid; Glutami

2015
Management of chronic refractory cough.
    BMJ (Clinical research ed.), 2015, Dec-14, Volume: 351

    Topics: Adaptation, Psychological; Amines; Chronic Disease; Cough; Cyclohexanecarboxylic Acids; Gabapentin;

2015
Gabapentin and pregabalin for the treatment of chronic pruritus.
    Journal of the American Academy of Dermatology, 2016, Volume: 75, Issue:3

    Topics: Amines; Anti-Anxiety Agents; Chronic Disease; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma

2016
Are neuromodulating medications effective for the treatment of chronic neurogenic cough?
    The Laryngoscope, 2017, Volume: 127, Issue:5

    Topics: Amines; Amitriptyline; Chronic Disease; Cough; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminob

2017
Practical management strategies for the chronic pain patient.
    The Journal of family practice, 2007, Volume: 56, Issue:8 Suppl Ho

    Topics: Administration, Cutaneous; Amines; Analgesics; Antidepressive Agents, Tricyclic; Carbamazepine; Chro

2007
The complex nature of chronic pelvic pain.
    The Journal of family practice, 2007, Volume: 56, Issue:3 Suppl Di

    Topics: Adult; Amines; Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents,

2007
[Mechanisms of the development of neuropathic pain and its treatment].
    Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association, 2008, Volume: 77, Issue:3

    Topics: Amines; Analgesics, Opioid; Anticonvulsants; Antidepressive Agents, Tricyclic; Calcium Channel Block

2008
[Central and peripheral mechanisms in antinociception: current and future perspectives].
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2008, Volume: 10, Issue:3

    Topics: Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Bridged Bicyclo Compounds, Heterocycl

2008
A human trial of HSV-mediated gene transfer for the treatment of chronic pain.
    Gene therapy, 2009, Volume: 16, Issue:4

    Topics: Animals; Chronic Disease; Clinical Trials, Phase I as Topic; Enkephalins; gamma-Aminobutyric Acid; G

2009
Pregabalin in the treatment of chronic pain: an overview.
    Clinical drug investigation, 2009, Volume: 29, Issue:3

    Topics: Amines; Analgesics, Non-Narcotic; Animals; Calcium Channels; Chronic Disease; Cyclohexanecarboxylic

2009
[GABA(B) receptors and sensitization to pain].
    Journal de la Societe de biologie, 2009, Volume: 203, Issue:1

    Topics: 14-3-3 Proteins; Allosteric Regulation; Animals; Baclofen; Calcium Channels; Calcium-Binding Protein

2009
Pregabalin for acute and chronic pain in adults.
    The Cochrane database of systematic reviews, 2009, Jul-08, Issue:3

    Topics: Acute Disease; Adult; Analgesics; Chronic Disease; Diabetic Neuropathies; Fibromyalgia; gamma-Aminob

2009
Pregabalin for acute and chronic pain in adults.
    The Cochrane database of systematic reviews, 2009, Jul-08, Issue:3

    Topics: Acute Disease; Adult; Analgesics; Chronic Disease; Diabetic Neuropathies; Fibromyalgia; gamma-Aminob

2009
Pregabalin for acute and chronic pain in adults.
    The Cochrane database of systematic reviews, 2009, Jul-08, Issue:3

    Topics: Acute Disease; Adult; Analgesics; Chronic Disease; Diabetic Neuropathies; Fibromyalgia; gamma-Aminob

2009
Pregabalin for acute and chronic pain in adults.
    The Cochrane database of systematic reviews, 2009, Jul-08, Issue:3

    Topics: Acute Disease; Adult; Analgesics; Chronic Disease; Diabetic Neuropathies; Fibromyalgia; gamma-Aminob

2009
[Role of extracellular nucleotides and their receptors in chronic pain].
    Seikagaku. The Journal of Japanese Biochemical Society, 2009, Volume: 81, Issue:10

    Topics: Adenosine Triphosphate; Animals; Brain-Derived Neurotrophic Factor; Chronic Disease; Drug Design; ga

2009
WITHDRAWN. Anticonvulsant drugs for acute and chronic pain.
    The Cochrane database of systematic reviews, 2010, Jan-20, Issue:1

    Topics: Acute Disease; Amines; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topic; Cycloh

2010
New treatments for chronic prostatitis/chronic pelvic pain syndrome.
    Nature reviews. Urology, 2010, Volume: 7, Issue:3

    Topics: Amines; Chronic Disease; Cognitive Behavioral Therapy; Cyclohexanecarboxylic Acids; Gabapentin; gamm

2010
Evidence for sensory neuropathy and pharmacologic management.
    Otolaryngologic clinics of North America, 2010, Volume: 43, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Amines; Amitriptyline; Anticonvulsants; Chronic Disease; Cough; Cycloh

2010
Gabapentin for the treatment of cancer-related pain syndromes.
    Reviews on recent clinical trials, 2010, Volume: 5, Issue:3

    Topics: Amines; Analgesics; Chronic Disease; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Aci

2010
An algorithm for the treatment of chronic testicular pain.
    The Journal of family practice, 2010, Volume: 59, Issue:6

    Topics: Algorithms; Amines; Analgesics; Anesthetics; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive

2010
Pregabalin for the treatment of postsurgical pain.
    Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:16

    Topics: Acute Disease; Analgesics; Analgesics, Opioid; Chronic Disease; Dose-Response Relationship, Drug; ga

2010
WITHDRAWN: Gabapentin for acute and chronic pain.
    The Cochrane database of systematic reviews, 2011, Mar-16, Issue:3

    Topics: Acute Disease; Amines; Analgesics; Anticonvulsants; Chronic Disease; Cyclohexanecarboxylic Acids; ga

2011
Gabapentin for chronic neuropathic pain and fibromyalgia in adults.
    The Cochrane database of systematic reviews, 2011, Mar-16, Issue:3

    Topics: Amines; Analgesics; Chronic Disease; Cyclohexanecarboxylic Acids; Fibromyalgia; Gabapentin; gamma-Am

2011
[Molecular mechanisms and clinical pharmacology of chronic pain].
    Masui. The Japanese journal of anesthesiology, 2010, Volume: 59 Suppl

    Topics: Amines; Animals; Anterior Horn Cells; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanecarb

2010
Anticonvulsants for tinnitus.
    The Cochrane database of systematic reviews, 2011, Jul-06, Issue:7

    Topics: Administration, Oral; Amines; Anticonvulsants; Carbamazepine; Chronic Disease; Cyclohexanecarboxylic

2011
Pregabalin for chronic prostatitis.
    The Cochrane database of systematic reviews, 2012, Aug-15, Issue:8

    Topics: Analgesics; Chronic Disease; gamma-Aminobutyric Acid; Humans; Male; Pelvic Pain; Pregabalin; Prostat

2012
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.
    Spine, 2013, May-15, Volume: 38, Issue:11

    Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; C

2013
Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2013, Volume: 148, Issue:3

    Topics: Amines; Amitriptyline; Baclofen; Chronic Disease; Cough; Cyclohexanecarboxylic Acids; Gabapentin; ga

2013
Germinated brown rice and its role in human health.
    Critical reviews in food science and nutrition, 2013, Volume: 53, Issue:5

    Topics: Amino Acids, Essential; Antihypertensive Agents; Chronic Disease; Coumaric Acids; Dietary Fiber; Foo

2013
Mode of action of gabapentin in chronic neuropathic pain syndromes. A short review about its cellular mechanisms in nociceptive neurotransmission.
    Arzneimittel-Forschung, 2002, Volume: 52, Issue:8

    Topics: Acetates; Amines; Animals; Biogenic Monoamines; Calcium Channels; Chronic Disease; Cyclohexanecarbox

2002
Antiepileptic drugs in the treatment of chronic headaches.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2003, Volume: 24 Suppl 2

    Topics: Anticonvulsants; Chronic Disease; gamma-Aminobutyric Acid; Headache; Humans; Meta-Analysis as Topic

2003
Neurobiological correlates of the disposition and maintenance of alcoholism.
    Pharmacopsychiatry, 2003, Volume: 36 Suppl 3

    Topics: Acute Disease; Alcoholism; Brain; Chronic Disease; Dopamine; Drug Tolerance; Ethanol; gamma-Aminobut

2003
[Nonorganic pain -- only psychogenic?].
    Praxis, 2003, Nov-26, Volume: 92, Issue:48

    Topics: Acetates; Adult; Amines; Analgesics; Analgesics, Opioid; Anesthetics, Local; Back Pain; Chronic Dise

2003
Diagnosis and management of neuropathic pain: a balanced approach to treatment.
    Journal of the American Academy of Nurse Practitioners, 2003, Volume: 15, Issue:12 Suppl

    Topics: Acetates; Amines; Antidepressive Agents; Chronic Disease; Cyclohexanecarboxylic Acids; Gabapentin; g

2003
Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy.
    Pflugers Archiv : European journal of physiology, 2004, Volume: 449, Issue:2

    Topics: Acute Disease; Animals; Central Nervous System Diseases; Chronic Disease; gamma-Aminobutyric Acid; G

2004
Rethinking the treatment paradigm for bipolar depression: the importance of long-term management.
    CNS spectrums, 2004, Volume: 9, Issue:9 Suppl 9

    Topics: Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Ch

2004
Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus.
    Stress (Amsterdam, Netherlands), 2004, Volume: 7, Issue:4

    Topics: Animals; Chronic Disease; Dentate Gyrus; gamma-Aminobutyric Acid; Glutamates; Hippocampus; Hypothala

2004
Anticonvulsant drugs for acute and chronic pain.
    The Cochrane database of systematic reviews, 2005, Jul-20, Issue:3

    Topics: Acute Disease; Amines; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topic; Cycloh

2005
Gabapentin for acute and chronic pain.
    The Cochrane database of systematic reviews, 2005, Jul-20, Issue:3

    Topics: Acute Disease; Amines; Analgesics; Anticonvulsants; Chronic Disease; Cyclohexanecarboxylic Acids; Ga

2005
[Brain of patients with chronic schizophrenia and neurotransmitters].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2005, Volume: 107, Issue:10

    Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Chronic Disease; gamma-Aminobutyric

2005
Bilateral SUNCT syndrome associated to chronic maxillary sinus disease.
    Arquivos de neuro-psiquiatria, 2006, Volume: 64, Issue:2B

    Topics: Amines; Analgesics; Chronic Disease; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Aci

2006
Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment.
    Annals of the New York Academy of Sciences, 2006, Volume: 1088

    Topics: Amines; Analgesics; Antidepressive Agents, Tricyclic; Chronic Disease; Cyclohexanecarboxylic Acids;

2006
Adjuvant analgesics for the treatment of neuropathic pain: evaluating efficacy and safety profiles.
    The Journal of family practice, 2007, Volume: 56, Issue:2 Suppl Pa

    Topics: Administration, Cutaneous; Amines; Analgesics; Analgesics, Opioid; Antidepressive Agents; Arthritis;

2007
Update on pharmacotherapy guidelines for treatment of neuropathic pain.
    Current pain and headache reports, 2007, Volume: 11, Issue:3

    Topics: Analgesics; Animals; Cannabidiol; Chronic Disease; Dronabinol; Duloxetine Hydrochloride; gamma-Amino

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
Gabapentin: a multimodal perioperative drug?
    British journal of anaesthesia, 2007, Volume: 99, Issue:6

    Topics: Amines; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Blood Pressure; Chronic Disease; Cyclohexanec

2007
[Alpha2-adrenergic receptors in the dorsal horn of the spinal cord--their function and the descending inhibitory systems].
    Masui. The Japanese journal of anesthesiology, 2007, Volume: 56 Suppl

    Topics: Acetylcholine; Adrenergic alpha-2 Receptor Agonists; Amines; Analgesics; Animals; Brain-Derived Neur

2007
Persistent hiccups during rehabilitation hospitalization: three case reports and review of the literature.
    American journal of physical medicine & rehabilitation, 2007, Volume: 86, Issue:12

    Topics: Aged; Amines; Anti-Anxiety Agents; Anticonvulsants; Cerebral Infarction; Chlorpromazine; Chronic Dis

2007
Loss of glycinergic and GABAergic inhibition in chronic pain--contributions of inflammation and microglia.
    International immunopharmacology, 2008, Volume: 8, Issue:2

    Topics: Animals; Chronic Disease; Dinoprostone; gamma-Aminobutyric Acid; Glycine; Humans; Inflammation; Micr

2008
Pain management in the traumatic amputee.
    Critical care nursing clinics of North America, 2008, Volume: 20, Issue:1

    Topics: Acute Disease; Afghanistan; Amines; Amputation, Traumatic; Analgesia; Analgesics; Benchmarking; Caus

2008
[Psychopharmacotherapy in psychiatric comorbidities among patients with chronic pain].
    L'Encephale, 2007, Volume: 33, Issue:Pt 3

    Topics: Amines; Analgesics; Anticonvulsants; Bupropion; Chronic Disease; Cyclohexanecarboxylic Acids; Dopami

2007
Treatment of chronic pain with antiepileptic drugs: a new era.
    Southern medical journal, 1999, Volume: 92, Issue:7

    Topics: Acetates; Amines; Analgesics; Anticonvulsants; Chronic Disease; Cyclohexanecarboxylic Acids; Gabapen

1999
[Modification of morphine dependence under chronic pain and its mechanism].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2001, Volume: 121, Issue:12

    Topics: Animals; Brain; Chronic Disease; gamma-Aminobutyric Acid; Male; Morphine Dependence; Pain; Rats; Rat

2001
Anticonvulsants: aspects of their mechanisms of action.
    European journal of pain (London, England), 2002, Volume: 6 Suppl A

    Topics: Animals; Anticonvulsants; Central Nervous System; Chronic Disease; Epilepsy; gamma-Aminobutyric Acid

2002
Pathophysiology of chronic hepatic encephalopathy.
    Hepato-gastroenterology, 1985, Volume: 32, Issue:6

    Topics: Amines; Amino Acids; Ammonia; Animals; Blood-Brain Barrier; Chronic Disease; Dogs; gamma-Aminobutyri

1985
Baclofen: a preliminary report of its pharmacological properties and therapeutic efficacy in spasticity.
    Drugs, 1974, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Aminobutyrates; Animals; Chlorobenzenes; Chronic Disease; Clinical Trials as Topi

1974

Trials

39 trials available for gamma-aminobutyric acid and Chronic Disease

ArticleYear
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Sexuality research & social policy : journal of NSRC : SR & SP, 2023, Apr-05

    Topics: Acute Kidney Injury; Adult; Aged; Albumins; Alloys; Amides; Amino Acids; Animals; Antineoplastic Com

2023
GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol.
    BMJ open, 2018, 01-31, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Amines; Analgesics; Chronic Disease; Chronic Pain; Cyclohexanecarboxylic Acids; D

2018
An open labeled randomized controlled trial of pregabalin versus amitriptyline in chronic low backache.
    Journal of the neurological sciences, 2014, Jul-15, Volume: 342, Issue:1-2

    Topics: Adolescent; Adult; Aged; Amitriptyline; Analgesics, Non-Narcotic; Chronic Disease; Disability Evalua

2014
Gabapentin Superadded to a Pre-Existent Regime Containing Amytriptyline for Chronic Sciatica.
    Pain medicine (Malden, Mass.), 2016, Volume: 17, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Amines; Amitriptyline; Analgesics; Chronic Disease; Cohort Studies;

2016
The effects of gabapentin on acute and chronic pain after inguinal herniorrhaphy.
    European journal of anaesthesiology, 2009, Volume: 26, Issue:9

    Topics: Adult; Amines; Analgesics; Anesthesia, Spinal; Chronic Disease; Cyclohexanecarboxylic Acids; Double-

2009
Adequacy assessment of oxycodone/paracetamol (acetaminophen) in multimodal chronic pain : a prospective observational study.
    Clinical drug investigation, 2009, Volume: 29 Suppl 1

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Amines; Analgesics, Non-Narcotic; Analgesics, Opioid;

2009
Adding gabapentin to a multimodal regimen does not reduce acute pain, opioid consumption or chronic pain after total hip arthroplasty.
    Acta anaesthesiologica Scandinavica, 2009, Volume: 53, Issue:8

    Topics: Acute Disease; Aged; Amines; Analgesics; Analgesics, Opioid; Anesthesia, Spinal; Arthroplasty, Repla

2009
Adding gabapentin to a multimodal regimen does not reduce acute pain, opioid consumption or chronic pain after total hip arthroplasty.
    Acta anaesthesiologica Scandinavica, 2009, Volume: 53, Issue:8

    Topics: Acute Disease; Aged; Amines; Analgesics; Analgesics, Opioid; Anesthesia, Spinal; Arthroplasty, Repla

2009
Adding gabapentin to a multimodal regimen does not reduce acute pain, opioid consumption or chronic pain after total hip arthroplasty.
    Acta anaesthesiologica Scandinavica, 2009, Volume: 53, Issue:8

    Topics: Acute Disease; Aged; Amines; Analgesics; Analgesics, Opioid; Anesthesia, Spinal; Arthroplasty, Repla

2009
Adding gabapentin to a multimodal regimen does not reduce acute pain, opioid consumption or chronic pain after total hip arthroplasty.
    Acta anaesthesiologica Scandinavica, 2009, Volume: 53, Issue:8

    Topics: Acute Disease; Aged; Amines; Analgesics; Analgesics, Opioid; Anesthesia, Spinal; Arthroplasty, Repla

2009
A comparison of gabapentin and ketamine in acute and chronic pain after hysterectomy.
    Anesthesia and analgesia, 2009, Volume: 109, Issue:5

    Topics: Acute Disease; Administration, Oral; Adult; Amines; Analgesia, Patient-Controlled; Analgesics; Analg

2009
A comparison of gabapentin and ketamine in acute and chronic pain after hysterectomy.
    Anesthesia and analgesia, 2009, Volume: 109, Issue:5

    Topics: Acute Disease; Administration, Oral; Adult; Amines; Analgesia, Patient-Controlled; Analgesics; Analg

2009
A comparison of gabapentin and ketamine in acute and chronic pain after hysterectomy.
    Anesthesia and analgesia, 2009, Volume: 109, Issue:5

    Topics: Acute Disease; Administration, Oral; Adult; Amines; Analgesia, Patient-Controlled; Analgesics; Analg

2009
A comparison of gabapentin and ketamine in acute and chronic pain after hysterectomy.
    Anesthesia and analgesia, 2009, Volume: 109, Issue:5

    Topics: Acute Disease; Administration, Oral; Adult; Amines; Analgesia, Patient-Controlled; Analgesics; Analg

2009
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
    Anesthesia and analgesia, 2010, Jan-01, Volume: 110, Issue:1

    Topics: Aged; Analgesics; Anesthesia, Epidural; Arthroplasty, Replacement, Knee; Chronic Disease; Double-Bli

2010
Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain.
    Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology, 2009, Volume: 10, Issue:4

    Topics: Adult; Aged; Analgesics; Celecoxib; Chronic Disease; Cyclooxygenase 2 Inhibitors; Drug Therapy, Comb

2009
Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality.
    Journal of back and musculoskeletal rehabilitation, 2009, Volume: 22, Issue:1

    Topics: Administration, Oral; Adult; Amines; Anticonvulsants; Chronic Disease; Cyclohexanecarboxylic Acids;

2009
Pregabalin as mono- or add-on therapy for patients with refractory chronic neuropathic pain: a post-marketing prescription-event monitoring study.
    Journal of neurology, 2010, Volume: 257, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Analgesics; Chronic Disease; Cohort Studies; Drug Prescriptions; Dru

2010
Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain.
    The Clinical journal of pain, 2010, Volume: 26, Issue:5

    Topics: Acute Disease; Adult; Amines; Analgesics; Breast Neoplasms; Chronic Disease; Cyclohexanecarboxylic A

2010
Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial.
    Archives of internal medicine, 2010, Sep-27, Volume: 170, Issue:17

    Topics: Adult; Aged; Analgesics; Canada; Chronic Disease; Double-Blind Method; gamma-Aminobutyric Acid; Hosp

2010
The effects of gabapentin on acute and chronic postoperative pain after coronary artery bypass graft surgery.
    Journal of cardiothoracic and vascular anesthesia, 2011, Volume: 25, Issue:5

    Topics: Acute Disease; Aged; Amines; Analgesics; Analgesics, Opioid; Chronic Disease; Chronic Pain; Coronary

2011
Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures.
    Epilepsia, 2011, Volume: 52, Issue:2

    Topics: Adult; Aged; Algorithms; Analgesics; Anticonvulsants; Chronic Disease; Databases, Factual; Dose-Resp

2011
Use of pregabalin in the management of chronic uremic pruritus.
    Journal of pain and symptom management, 2013, Volume: 45, Issue:4

    Topics: Aged; Analgesics; Anticonvulsants; Chronic Disease; Female; gamma-Aminobutyric Acid; Humans; Male; P

2013
Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial.
    Lancet (London, England), 2012, Nov-03, Volume: 380, Issue:9853

    Topics: Adolescent; Adult; Amines; Anticonvulsants; Central Nervous System; Chronic Disease; Cough; Cyclohex

2012
The analgesic effect of gabapentin and mexiletine after breast surgery for cancer.
    Anesthesia and analgesia, 2002, Volume: 95, Issue:4

    Topics: Acetates; Aged; Amines; Analgesics; Analgesics, Opioid; Antineoplastic Agents; Breast Neoplasms; Chr

2002
The analgesic effect of gabapentin and mexiletine after breast surgery for cancer.
    Anesthesia and analgesia, 2002, Volume: 95, Issue:4

    Topics: Acetates; Aged; Amines; Analgesics; Analgesics, Opioid; Antineoplastic Agents; Breast Neoplasms; Chr

2002
The analgesic effect of gabapentin and mexiletine after breast surgery for cancer.
    Anesthesia and analgesia, 2002, Volume: 95, Issue:4

    Topics: Acetates; Aged; Amines; Analgesics; Analgesics, Opioid; Antineoplastic Agents; Breast Neoplasms; Chr

2002
The analgesic effect of gabapentin and mexiletine after breast surgery for cancer.
    Anesthesia and analgesia, 2002, Volume: 95, Issue:4

    Topics: Acetates; Aged; Amines; Analgesics; Analgesics, Opioid; Antineoplastic Agents; Breast Neoplasms; Chr

2002
Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study.
    Neurology, 2003, Dec-23, Volume: 61, Issue:12

    Topics: Acetates; Adolescent; Adult; Aged; Amines; Analgesics; Anticonvulsants; Ataxia; Chronic Disease; Cro

2003
Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain.
    Pain medicine (Malden, Mass.), 2003, Volume: 4, Issue:4

    Topics: Acetates; Activities of Daily Living; Aged; Aged, 80 and over; Amines; Analgesics; Anesthetics, Loca

2003
Gabapentin for the symptomatic treatment of chronic neuropathic pain in patients with late-stage lyme borreliosis: a pilot study.
    Dermatology (Basel, Switzerland), 2005, Volume: 211, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Amines; Chronic Disease; Cyclohexanecarboxylic Acids;

2005
Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer.
    Anesthesia and analgesia, 2005, Volume: 101, Issue:5

    Topics: Acute Disease; Adult; Amines; Analgesia; Anesthetics, Local; Breast Neoplasms; Chronic Disease; Cycl

2005
Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study.
    Wiener klinische Wochenschrift, 2005, Volume: 117, Issue:21-22

    Topics: Adult; Amines; Amitriptyline; Austria; Chronic Disease; Cyclohexanecarboxylic Acids; Drug Combinatio

2005
Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial.
    Pain, 2007, Volume: 127, Issue:1-2

    Topics: Adolescent; Adult; Amines; Analgesics; Anticonvulsants; Chronic Disease; Cyclohexanecarboxylic Acids

2007
Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial.
    Pain, 2007, Volume: 127, Issue:1-2

    Topics: Adolescent; Adult; Amines; Analgesics; Anticonvulsants; Chronic Disease; Cyclohexanecarboxylic Acids

2007
Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial.
    Pain, 2007, Volume: 127, Issue:1-2

    Topics: Adolescent; Adult; Amines; Analgesics; Anticonvulsants; Chronic Disease; Cyclohexanecarboxylic Acids

2007
Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial.
    Pain, 2007, Volume: 127, Issue:1-2

    Topics: Adolescent; Adult; Amines; Analgesics; Anticonvulsants; Chronic Disease; Cyclohexanecarboxylic Acids

2007
Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial.
    Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:5

    Topics: Adult; Amines; Analgesics; Cholestasis; Chronic Disease; Cyclohexanecarboxylic Acids; Double-Blind M

2006
Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain.
    Neurology, 2006, Nov-14, Volume: 67, Issue:9

    Topics: Adult; Aged; Analgesia; Chronic Disease; Evoked Potentials, Motor; Female; Functional Laterality; ga

2006
Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain.
    Neurology, 2006, Nov-14, Volume: 67, Issue:9

    Topics: Adult; Aged; Analgesia; Chronic Disease; Evoked Potentials, Motor; Female; Functional Laterality; ga

2006
Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain.
    Neurology, 2006, Nov-14, Volume: 67, Issue:9

    Topics: Adult; Aged; Analgesia; Chronic Disease; Evoked Potentials, Motor; Female; Functional Laterality; ga

2006
Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain.
    Neurology, 2006, Nov-14, Volume: 67, Issue:9

    Topics: Adult; Aged; Analgesia; Chronic Disease; Evoked Potentials, Motor; Female; Functional Laterality; ga

2006
Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain.
    Neurology, 2006, Nov-14, Volume: 67, Issue:9

    Topics: Adult; Aged; Analgesia; Chronic Disease; Evoked Potentials, Motor; Female; Functional Laterality; ga

2006
Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain.
    Neurology, 2006, Nov-14, Volume: 67, Issue:9

    Topics: Adult; Aged; Analgesia; Chronic Disease; Evoked Potentials, Motor; Female; Functional Laterality; ga

2006
Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain.
    Neurology, 2006, Nov-14, Volume: 67, Issue:9

    Topics: Adult; Aged; Analgesia; Chronic Disease; Evoked Potentials, Motor; Female; Functional Laterality; ga

2006
Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain.
    Neurology, 2006, Nov-14, Volume: 67, Issue:9

    Topics: Adult; Aged; Analgesia; Chronic Disease; Evoked Potentials, Motor; Female; Functional Laterality; ga

2006
Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain.
    Neurology, 2006, Nov-14, Volume: 67, Issue:9

    Topics: Adult; Aged; Analgesia; Chronic Disease; Evoked Potentials, Motor; Female; Functional Laterality; ga

2006
Effectiveness of gabapentin in the treatment of chronic post-thoracotomy pain.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2007, Volume: 32, Issue:1

    Topics: Adult; Amines; Analgesics; Chronic Disease; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-A

2007
Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy.
    Investigative radiology, 1996, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Antipsychotic Agents; Chronic Disease; Creatine; Female; Follow-Up Studies; Front

1996
Clinical evaluation of the efficacy of pivagabine in the treatment of mood and adjustment disorders.
    Arzneimittel-Forschung, 1997, Volume: 47, Issue:11A

    Topics: Adjustment Disorders; Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Double-Blind Meth

1997
An audit of the perceived efficacy and tolerability of gabapentin therapy in an out-patient cohort with chronic epilepsy.
    European neurology, 1999, Volume: 41, Issue:2

    Topics: Acetates; Adult; Ambulatory Care; Amines; Anticonvulsants; Chronic Disease; Cohort Studies; Cyclohex

1999
Treatment of chronic: new perspectives.
    European journal of neurology, 1999, Volume: 6, Issue:5

    Topics: Acetates; Aged; Amines; Cerebral Infarction; Chronic Disease; Cyclohexanecarboxylic Acids; Excitator

1999
Low doses of gabapentin may be helpful in the management of chronic daily headache.
    MedGenMed : Medscape general medicine, 2000, Aug-21, Volume: 2, Issue:3

    Topics: Acetates; Adult; Aged; Aged, 80 and over; Amines; Analgesics; Chronic Disease; Cyclohexanecarboxylic

2000
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Pain, 2001, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topi

2001
Baclofen is effective in intractable hiccups induced by brainstem lesions.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:5

    Topics: Adult; Aged; Baclofen; Brain Stem; Brain Stem Infarctions; Chronic Disease; GABA Agonists; gamma-Ami

2001
GABA agonist-induced changes in motor, oculomotor, and attention measures correlate in schizophrenics with tardive dyskinesia.
    Biological psychiatry, 1992, Aug-15, Volume: 32, Issue:4

    Topics: Adult; Antipsychotic Agents; Attention; Chronic Disease; Double-Blind Method; Dyskinesia, Drug-Induc

1992
Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia.
    Psychiatry research, 1988, Volume: 26, Issue:1

    Topics: Adult; Aged; Baclofen; Brain; Chronic Disease; gamma-Aminobutyric Acid; Growth Hormone; Humans; Male

1988
Growth hormone response to sodium valproate in chronic schizophrenia.
    Biological psychiatry, 1986, Volume: 21, Issue:7

    Topics: Adult; Brain; Chronic Disease; Double-Blind Method; gamma-Aminobutyric Acid; Growth Hormone; Humans;

1986
Baclofen: a preliminary report of its pharmacological properties and therapeutic efficacy in spasticity.
    Drugs, 1974, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Aminobutyrates; Animals; Chlorobenzenes; Chronic Disease; Clinical Trials as Topi

1974

Other Studies

192 other studies available for gamma-aminobutyric acid and Chronic Disease

ArticleYear
Saturation transfer MRI is sensitive to neurochemical changes in the rat brain due to chronic unpredictable mild stress.
    Scientific reports, 2021, 09-24, Volume: 11, Issue:1

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Animals; Cerebral Cortex; Chronic Disease

2021
Electroacupuncture alleviates the relapse of pain-related aversive memory by activating KOR and inhibiting GABAergic neurons in the insular cortex.
    Cerebral cortex (New York, N.Y. : 1991), 2023, 10-09, Volume: 33, Issue:20

    Topics: Animals; Carrageenan; Chronic Disease; Chronic Pain; Electroacupuncture; GABAergic Neurons; gamma-Am

2023
The molecular mechanism underlying GABAergic dysfunction in nucleus accumbens of depression-like behaviours in mice.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:10

    Topics: Animals; Behavior, Animal; Chronic Disease; Depressive Disorder; GABAergic Neurons; gamma-Aminobutyr

2019
Moderate maternal separation mitigates the altered synaptic transmission and neuronal activation in amygdala by chronic stress in adult mice.
    Molecular brain, 2019, 12-18, Volume: 12, Issue:1

    Topics: Aging; Amygdala; Animals; Anxiety; Behavior, Animal; Chronic Disease; Excitatory Postsynaptic Potent

2019
Anxiolytic Effects of 8-O-Acetyl Shanzhiside Methylester on Acute and Chronic Anxiety via Inflammatory Response Inhibition and Excitatory/Inhibitory Transmission Imbalance.
    Neurotoxicity research, 2020, Volume: 38, Issue:4

    Topics: Acute Disease; Animals; Anti-Anxiety Agents; Anxiety; Chronic Disease; Dose-Response Relationship, D

2020
Dysregulation of REV-ERBα impairs GABAergic function and promotes epileptic seizures in preclinical models.
    Nature communications, 2021, 02-22, Volume: 12, Issue:1

    Topics: Acute Disease; Animals; Basic-Leucine Zipper Transcription Factors; Chronic Disease; Disease Models,

2021
Topical ketamine-amitriptyline-lidocaine for chronic pruritus: A retrospective study assessing efficacy and tolerability.
    Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:4

    Topics: Aged; Amines; Amitriptyline; Analgesics; Chronic Disease; Cyclohexanecarboxylic Acids; Drug Therapy,

2017
Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model.
    Scientific reports, 2017, 05-11, Volume: 7, Issue:1

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzamides; Bridged Bicyclo Compounds; Cell Surviv

2017
JIEYUANSHEN DECOCTION EXERTS ANTIDEPRESSANT EFFECTS ON DEPRESSIVE RAT MODEL VIA REGULATING HPA AXIS AND THE LEVEL OF AMINO ACIDS NEUROTRANSMITTER.
    African journal of traditional, complementary, and alternative medicines : AJTCAM, 2017, Volume: 14, Issue:2

    Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Chronic Disease; Corticosterone; Cortic

2017
Haloperidol Decreases Hyperalgesia and Allodynia Induced by Chronic Constriction Injury.
    Basic & clinical pharmacology & toxicology, 2017, Volume: 121, Issue:6

    Topics: Amines; Analgesics; Animals; Antipsychotic Agents; Chronic Disease; Constriction, Pathologic; Cycloh

2017
Unilateral Laryngoscopic Findings Associated With Response to Gabapentin in Patients With Chronic Cough.
    JAMA otolaryngology-- head & neck surgery, 2017, 11-01, Volume: 143, Issue:11

    Topics: Amines; Calcium Channel Blockers; Chronic Disease; Cough; Cyclohexanecarboxylic Acids; Female; Gabap

2017
International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis.
    Clinical journal of the American Society of Nephrology : CJASN, 2017, Dec-07, Volume: 12, Issue:12

    Topics: Aged; Aged, 80 and over; Amines; Antipruritics; Chronic Disease; Cyclohexanecarboxylic Acids; Female

2017
International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis.
    Clinical journal of the American Society of Nephrology : CJASN, 2017, Dec-07, Volume: 12, Issue:12

    Topics: Aged; Aged, 80 and over; Amines; Antipruritics; Chronic Disease; Cyclohexanecarboxylic Acids; Female

2017
International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis.
    Clinical journal of the American Society of Nephrology : CJASN, 2017, Dec-07, Volume: 12, Issue:12

    Topics: Aged; Aged, 80 and over; Amines; Antipruritics; Chronic Disease; Cyclohexanecarboxylic Acids; Female

2017
International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis.
    Clinical journal of the American Society of Nephrology : CJASN, 2017, Dec-07, Volume: 12, Issue:12

    Topics: Aged; Aged, 80 and over; Amines; Antipruritics; Chronic Disease; Cyclohexanecarboxylic Acids; Female

2017
Modification of the natural progression of epileptogenesis by means of biperiden in the pilocarpine model of epilepsy.
    Epilepsy research, 2017, Volume: 138

    Topics: Action Potentials; Animals; Autonomic Nervous System; Biperiden; Chronic Disease; Cytokines; Disease

2017
The sinonasal microbiota, neural signaling, and depression in chronic rhinosinusitis.
    International forum of allergy & rhinology, 2018, Volume: 8, Issue:3

    Topics: Adult; Aged; Bacteria; Bacterial Load; Chronic Disease; Depression; DNA, Bacterial; Dopamine; Female

2018
Importance of Regular and Maintenance Therapy Adherence in Neuromyelitis Optica (NMO): Lessons from a Repeating Relapse Case.
    The American journal of case reports, 2018, Jan-11, Volume: 19

    Topics: Amines; Analgesics; Autoantibodies; Biomarkers; Chronic Disease; Cyclohexanecarboxylic Acids; Female

2018
The Influence of Primary Motor Cortex Inhibition on Upper Limb Impairment and Function in Chronic Stroke: A Multimodal Study.
    Neurorehabilitation and neural repair, 2019, Volume: 33, Issue:2

    Topics: Aged; Aged, 80 and over; Chronic Disease; Electromyography; Evoked Potentials, Motor; Female; gamma-

2019
Targeted hippocampal GABA neuron ablation by Stable Substance P-saporin causes hippocampal sclerosis and chronic epilepsy in rats.
    Epilepsia, 2019, Volume: 60, Issue:5

    Topics: Animals; Chronic Disease; Dentate Gyrus; Epilepsy, Temporal Lobe; GABAergic Neurons; gamma-Aminobuty

2019
Persistent
    Infection and immunity, 2019, Volume: 87, Issue:8

    Topics: Animals; Brain; Chemokine CX3CL1; Chronic Disease; Complement Activation; Disease Models, Animal; Fe

2019
[Survival of calbindin, calretinin and parvalbumin positive neurons in mouse hippocampal CA area at chronic stage of pilocarpine-induced epilepsy].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2013, Volume: 38, Issue:5

    Topics: Animals; Calbindin 2; Calbindins; Cell Survival; Chronic Disease; Epilepsy; gamma-Aminobutyric Acid;

2013
Nanoscale intracortical iron injection induces chronic epilepsy in rodent.
    Journal of neuroscience research, 2014, Volume: 92, Issue:3

    Topics: Animals; Anticonvulsants; Cell Count; Cerebral Cortex; Cerebrovascular Circulation; Chronic Disease;

2014
Downregulated GABA and BDNF-TrkB pathway in chronic cyclothiazide seizure model.
    Neural plasticity, 2014, Volume: 2014

    Topics: 4-Aminobutyrate Transaminase; Animals; Behavior, Animal; Benzothiadiazines; Brain-Derived Neurotroph

2014
Chronic stress impairs GABAergic control of amygdala through suppressing the tonic GABAA receptor currents.
    Molecular brain, 2014, Apr-24, Volume: 7

    Topics: Action Potentials; Amygdala; Animals; Chronic Disease; Corticosterone; gamma-Aminobutyric Acid; Immo

2014
Chronic repetitive transcranial magnetic stimulation enhances GABAergic and cholinergic metabolism in chronic unpredictable mild stress rat model: ¹H-NMR spectroscopy study at 11.7T.
    Neuroscience letters, 2014, Jun-20, Volume: 572

    Topics: Animals; Choline; Chronic Disease; Depression; Food Preferences; gamma-Aminobutyric Acid; Hippocampu

2014
Gabapentin as a potential treatment for cough syncope.
    Respiratory care, 2015, Volume: 60, Issue:2

    Topics: Amines; Antitussive Agents; Chronic Disease; Cough; Cyclohexanecarboxylic Acids; Gabapentin; gamma-A

2015
Altered levels of brain neurotransmitter from new born rabbits with intrauterine restriction.
    Neuroscience letters, 2015, Jan-01, Volume: 584

    Topics: Animals; Animals, Newborn; Brain; Cerebral Cortex; Chronic Disease; Corpus Striatum; Dopamine; Fetal

2015
The role of calcitonin gene-related peptide in post-stroke depression in chronic mild stress-treated ischemic rats.
    Physiology & behavior, 2015, Volume: 139

    Topics: Anhedonia; Animals; Antidepressive Agents; Brain Ischemia; Calcitonin Gene-Related Peptide; Chronic

2015
Chronic stress shifts the GABA reversal potential in the hippocampus and increases seizure susceptibility.
    Epilepsy research, 2015, Volume: 109

    Topics: Acute Disease; Animals; Bumetanide; Chronic Disease; Corticosterone; Disease Models, Animal; gamma-A

2015
Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus.
    BMC neuroscience, 2014, Dec-20, Volume: 15

    Topics: Acute Disease; Amino Acids; Animals; Anticonvulsants; Aspartic Acid; Bridged Bicyclo Compounds, Hete

2014
[Cognitive and emotional impairments in patients with protracted anxiety-phobic disorders].
    Terapevticheskii arkhiv, 2014, Volume: 86, Issue:12

    Topics: Acute Disease; Adolescent; Adult; Chronic Disease; Cognition Disorders; gamma-Aminobutyric Acid; Hum

2014
Chronic progressive polyarthritis in a domestic shorthair cat.
    The Canadian veterinary journal = La revue veterinaire canadienne, 2015, Volume: 56, Issue:6

    Topics: Amines; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Buprenorphine; Cat Diseases; Cats;

2015
Increased extracellular levels of glutamate in the hippocampus of chronically epileptic rats.
    Neuroscience, 2015, Aug-20, Volume: 301

    Topics: Animals; Chromatography, High Pressure Liquid; Chronic Disease; Disease Models, Animal; Electroencep

2015
Pharmacological characteristics of the hind paw weight bearing difference induced by chronic constriction injury of the sciatic nerve in rats.
    Life sciences, 2009, Apr-24, Volume: 84, Issue:17-18

    Topics: Amines; Analgesics; Animals; Chronic Disease; Cyclohexanecarboxylic Acids; Disease Models, Animal; G

2009
BMSCs transplantation improves cognitive impairment via up-regulation of hippocampal GABAergic system in a rat model of chronic cerebral hypoperfusion.
    Neuroscience, 2015, Dec-17, Volume: 311

    Topics: Animals; Bone Marrow Transplantation; Brain Ischemia; Carotid Artery Diseases; Cell Movement; Chroni

2015
[On the Differential Diagnosis of Intractable Psychogenic Chronic Cough: Neuropathic Larynx Irritable - Gabapentin's Antitussive Action].
    Fortschritte der Neurologie-Psychiatrie, 2015, Volume: 83, Issue:10

    Topics: Aged; Amines; Avitaminosis; Chronic Disease; Cough; Cyclohexanecarboxylic Acids; Depressive Disorder

2015
IV and V cranial nerves dysfunction as initial manifestations of superficial siderosis of the central nervous system.
    Revista de neurologia, 2016, Apr-01, Volume: 62, Issue:7

    Topics: Aged; Amines; Angiography, Digital Subtraction; Atrophy; Central Nervous System Diseases; Cerebellum

2016
Reduced tonic inhibition in the dentate gyrus contributes to chronic stress-induced impairments in learning and memory.
    Hippocampus, 2016, Volume: 26, Issue:10

    Topics: Animals; Chronic Disease; Dentate Gyrus; Female; gamma-Aminobutyric Acid; Learning; Learning Disabil

2016
Chronic Stress Increases Prefrontal Inhibition: A Mechanism for Stress-Induced Prefrontal Dysfunction.
    Biological psychiatry, 2016, 11-15, Volume: 80, Issue:10

    Topics: Animals; Behavior, Animal; Chronic Disease; Disease Models, Animal; gamma-Aminobutyric Acid; Glutami

2016
Brain glutamic acid decarboxylase-67kDa alterations induced by magnesium treatment in olfactory bulbectomy and chronic mild stress models in rats.
    Pharmacological reports : PR, 2016, Volume: 68, Issue:5

    Topics: Animals; Antidepressive Agents; Brain; Chronic Disease; Depression; Disease Models, Animal; gamma-Am

2016
Sensitivity of the prefrontal GABAergic system to chronic stress in male and female mice: Relevance for sex differences in stress-related disorders.
    Neuroscience, 2016, 09-22, Volume: 332

    Topics: Amygdala; Animals; Anxiety; Chronic Disease; Depression; Disease Models, Animal; Female; gamma-Amino

2016
Multilevel symmetric neuropathic pruritus (MSNP) presenting as recalcitrant "generalized" pruritus.
    Journal of the American Academy of Dermatology, 2016, Volume: 75, Issue:4

    Topics: Age Distribution; Aged; Amines; Chronic Disease; Cohort Studies; Cyclohexanecarboxylic Acids; Diseas

2016
Gabapentin decreases microglial cells and reverses bilateral hyperalgesia and allodynia in rats with chronic myositis.
    European journal of pharmacology, 2017, Mar-15, Volume: 799

    Topics: Amines; Animals; Astrocytes; Behavior, Animal; Cell Count; Chronic Disease; Cyclohexanecarboxylic Ac

2017
Repeated neonatal separation stress alters the composition of neurochemically characterized interneuron subpopulations in the rodent dentate gyrus and basolateral amygdala.
    Developmental neurobiology, 2008, Volume: 68, Issue:9

    Topics: Amygdala; Animals; Animals, Newborn; Brain; Calbindins; Chronic Disease; Dentate Gyrus; gamma-Aminob

2008
Decompensation of chronic heart failure associated with pregabalin in a 73-year-old patient with postherpetic neuralgia: a case report.
    British journal of clinical pharmacology, 2008, Volume: 66, Issue:2

    Topics: Aged; Anticonvulsants; Bumetanide; Chronic Disease; gamma-Aminobutyric Acid; Heart Failure; Herpes Z

2008
Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Jul-16, Volume: 28, Issue:29

    Topics: Animals; Chronic Disease; Corpus Striatum; Dronabinol; Excitatory Amino Acid Antagonists; Excitatory

2008
Challenges of fragmented care in long-term management of pelvic pain.
    The Journal of family practice, 2007, Volume: 56, Issue:3 Suppl Di

    Topics: Acetaminophen; Adult; Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Chr

2007
Time-course of neuronal death in the mouse pilocarpine model of chronic epilepsy using Fluoro-Jade C staining.
    Brain research, 2008, Nov-19, Volume: 1241

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain; Cerebral Cortex; Chronic Disease; Convulsa

2008
Changes in glutamate decarboxylase enzyme activity and tau-protein phosphorylation in the hippocampus of old rats exposed to chronic mild stress: reversal with the neuronal nitric oxide synthase inhibitor 7-nitroindazole.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 91, Issue:3

    Topics: Aging; Animals; Blotting, Western; Chromatography, High Pressure Liquid; Chronic Disease; Enzyme Inh

2009
Cortical excitability in chronic stroke and modulation by training: a TMS study.
    Neurorehabilitation and neural repair, 2009, Volume: 23, Issue:5

    Topics: Adult; Aged; Brain Mapping; Cerebral Cortex; Chronic Disease; Electromyography; Evoked Potentials, M

2009
Oral pregabalin reverses cold allodynia in two distinct models of peripheral neuropathic pain.
    European journal of pharmacology, 2009, Mar-01, Volume: 605, Issue:1-3

    Topics: Administration, Oral; Analgesics; Animals; Behavior, Animal; Chronic Disease; Cold Temperature; Dise

2009
Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: a novel analgesic and neuroprotective strategy?
    Medical hypotheses, 2009, Volume: 73, Issue:2

    Topics: Analgesics; Chronic Disease; Drug Therapy, Combination; Fibromyalgia; gamma-Aminobutyric Acid; Human

2009
Fibromyalgia: poorly understood; treatments are disappointing.
    Prescrire international, 2009, Volume: 18, Issue:102

    Topics: Acetaminophen; Acupuncture Therapy; Amines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Ant

2009
Neuropathic pain treatment: a further step forward.
    Lancet (London, England), 2009, Oct-10, Volume: 374, Issue:9697

    Topics: Amines; Analgesics; Antidepressive Agents, Tricyclic; Chronic Disease; Cyclohexanecarboxylic Acids;

2009
Secondhand smoke exposure and depressive symptoms.
    Psychosomatic medicine, 2010, Volume: 72, Issue:1

    Topics: Air Pollution, Indoor; Chronic Disease; Cotinine; Depression; Depressive Disorder, Major; Environmen

2010
GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study.
    Schizophrenia research, 2010, Volume: 117, Issue:1

    Topics: Adult; Antipsychotic Agents; Brain; Chronic Disease; Female; gamma-Aminobutyric Acid; Humans; Magnet

2010
Gabapentin (Neurontin) improves pain scores of patients with critical limb ischaemia: an observational study.
    International journal of surgery (London, England), 2010, Volume: 8, Issue:3

    Topics: Aged; Amines; Analgesics; Analgesics, Opioid; Chronic Disease; Cyclohexanecarboxylic Acids; Female;

2010
Can changes in cortical excitability distinguish progressive from juvenile myoclonic epilepsy?
    Epilepsia, 2010, Volume: 51, Issue:10

    Topics: Adult; Anticonvulsants; Cerebral Cortex; Chronic Disease; Diagnosis, Differential; Drug Resistance;

2010
Effect of analgesic standards on persistent postoperative pain evoked by skin/muscle incision and retraction (SMIR).
    Neuroscience letters, 2010, Jun-14, Volume: 477, Issue:1

    Topics: Amines; Analgesics; Animals; Chronic Disease; Cyclohexanecarboxylic Acids; Dermatologic Surgical Pro

2010
Pharmacokinetic-pharmacodynamic analysis of the static allodynia response to pregabalin and sildenafil in a rat model of neuropathic pain.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 334, Issue:2

    Topics: Analgesics; Animals; Calcium Channels; Chronic Disease; Drug Interactions; gamma-Aminobutyric Acid;

2010
Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2010, Volume: 31 Suppl 1

    Topics: Amines; Analgesics; Chronic Disease; Clonidine; Cyclohexanecarboxylic Acids; Diagnosis, Differential

2010
Role of NKCC1 and KCC2 in the development of chronic neuropathic pain following spinal cord injury.
    Annals of the New York Academy of Sciences, 2010, Volume: 1198

    Topics: Animals; Bumetanide; Chronic Disease; gamma-Aminobutyric Acid; Hyperalgesia; Inflammation; K Cl- Cot

2010
Elevated gamma-aminobutyric acid levels in chronic schizophrenia.
    Biological psychiatry, 2010, Oct-01, Volume: 68, Issue:7

    Topics: Adult; Analysis of Variance; Aspartic Acid; Case-Control Studies; Chronic Disease; Creatine; Female;

2010
Behavioral signs of chronic back pain in the SPARC-null mouse.
    Spine, 2011, Jan-15, Volume: 36, Issue:2

    Topics: Age Factors; Amines; Analgesics; Animals; Anti-Inflammatory Agents; Behavior, Animal; Chronic Diseas

2011
Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Aug-18, Volume: 30, Issue:33

    Topics: Animals; Cannabinoid Receptor Modulators; Chronic Disease; Endocannabinoids; gamma-Aminobutyric Acid

2010
GABAergic pathway in a rat model of chronic neuropathic pain: modulation after intrathecal transplantation of a human neuronal cell line.
    Neuroscience research, 2011, Volume: 69, Issue:2

    Topics: Animals; Cell Line; Chronic Disease; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamate Deca

2011
Gabapentin and pregabalin inhibit the itch-associated response induced by the repeated application of oxazolone in mice.
    Journal of pharmacological sciences, 2011, Volume: 115, Issue:1

    Topics: Amines; Animals; Calcium Channels; Chronic Disease; Cyclohexanecarboxylic Acids; Disease Models, Ani

2011
[Glossopharyngeal neuralgia after resection of a glossopharyngeal schwannoma].
    Schmerz (Berlin, Germany), 2011, Volume: 25, Issue:1

    Topics: Administration, Oral; Adult; Analgesics; Analgesics, Opioid; Autonomic Nerve Block; Buprenorphine; C

2011
[The role of combat stress in the development of chronic pain syndrom in veterans and its treatment by pantogam active].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:9

    Topics: Adult; Aged; Chronic Disease; Combat Disorders; gamma-Aminobutyric Acid; Humans; Male; Middle Aged;

2010
Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy.
    Journal of neurochemistry, 2011, Volume: 117, Issue:5

    Topics: Acetates; Ammonia; Animals; Astrocytes; Brain Chemistry; Chromatography, High Pressure Liquid; Chron

2011
Stellate ganglion blockade (SGB) for refractory index finger pain - a case report.
    Annals of physical and rehabilitation medicine, 2011, Volume: 54, Issue:3

    Topics: Abdominal Pain; Accidental Falls; Acetaminophen; Adult; Amines; Autonomic Nerve Block; Chronic Disea

2011
Relieving occupational fatigue by consumption of a beverage containing γ-amino butyric acid.
    Journal of nutritional science and vitaminology, 2011, Volume: 57, Issue:1

    Topics: Adult; Beverages; Chromogranin A; Chronic Disease; Fatigue; Female; gamma-Aminobutyric Acid; Humans;

2011
Hebbian-type stimulation during robot-assisted training in patients with stroke.
    Neurorehabilitation and neural repair, 2011, Volume: 25, Issue:7

    Topics: Aged; Chronic Disease; Evoked Potentials, Motor; Female; Functional Laterality; gamma-Aminobutyric A

2011
Chronic Lyme disease: the controversies and the science.
    Expert review of anti-infective therapy, 2011, Volume: 9, Issue:7

    Topics: Amines; Analgesics; Anti-Bacterial Agents; Arthritis, Rheumatoid; Borrelia burgdorferi; Chronic Dise

2011
Pharmacological and behavioral characterization of the saphenous chronic constriction injury model of neuropathic pain in rats.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2011, Volume: 32, Issue:6

    Topics: Amines; Amitriptyline; Analgesics; Animals; Benzoxazines; Chronic Disease; Constriction; Cyclohexane

2011
Quiz Page October 2011: An under-recognized cause of CKD.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2011, Volume: 58, Issue:4

    Topics: Acidosis; Amines; Anorexia Nervosa; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Creati

2011
Epigenetic suppression of GAD65 expression mediates persistent pain.
    Nature medicine, 2011, Oct-09, Volume: 17, Issue:11

    Topics: Animals; Chronic Disease; Epigenesis, Genetic; gamma-Aminobutyric Acid; Gene Expression Regulation,

2011
Reorganization of synaptic inputs to the hypothalamic paraventricular nucleus during chronic psychogenic stress in rats.
    Biological psychiatry, 2012, Feb-15, Volume: 71, Issue:4

    Topics: Animals; Behavioral Symptoms; Chronic Disease; Corticosterone; Corticotropin-Releasing Hormone; Depr

2012
Efficacy and safety of pregabalin for the treatment of chronic pruritus in Korea.
    The Journal of dermatology, 2012, Volume: 39, Issue:9

    Topics: Adult; Aged; Antipruritics; Chronic Disease; Female; gamma-Aminobutyric Acid; Humans; Male; Middle A

2012
[About the neuropathic component of back pain].
    Ideggyogyaszati szemle, 2012, May-30, Volume: 65, Issue:5-6

    Topics: Acute Disease; Analgesics; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chroni

2012
Cannabinoid modulation of midbrain urocortin 1 neurones during acute and chronic stress.
    Journal of neuroendocrinology, 2012, Volume: 24, Issue:11

    Topics: Acute Disease; Animals; Anxiety; Behavior, Animal; Chronic Disease; Endocannabinoids; gamma-Aminobut

2012
Diminished cortical inhibition in an aging mouse model of chronic tinnitus.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Nov-14, Volume: 32, Issue:46

    Topics: Acoustic Stimulation; Aging; Animals; Auditory Cortex; Auditory Threshold; Cerebral Cortex; Chronic

2012
Effects of oxymatrine on the neuropathic pain induced by chronic constriction injury in mice.
    CNS neuroscience & therapeutics, 2012, Volume: 18, Issue:12

    Topics: Alkaloids; Animals; Chronic Disease; Constriction; Disease Models, Animal; Dose-Response Relationshi

2012
Pregabalin (CI-1008) inhibits the trinitrobenzene sulfonic acid-induced chronic colonic allodynia in the rat.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:3

    Topics: Analgesics, Opioid; Animals; Chronic Disease; Colon; Colonic Diseases; gamma-Aminobutyric Acid; Hype

2002
Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:3

    Topics: Acetates; Acute Disease; Adrenergic alpha-Agonists; Amines; Analgesics, Non-Narcotic; Analgesics, Op

2002
Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice.
    European journal of pharmacology, 2002, Oct-25, Volume: 453, Issue:2-3

    Topics: Acetates; Amines; Analgesics; Animals; Chronic Disease; Cyclohexanecarboxylic Acids; Female; Freund'

2002
GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003, Apr-15, Volume: 23, Issue:8

    Topics: Animals; Binding, Competitive; Chronic Disease; Cocaine; Cocaine-Related Disorders; Disease Models,

2003
Daily changes of GABA and taurine concentrations in various hypothalamic areas are affected by chronic hyperprolactinemia.
    Chronobiology international, 2003, Volume: 20, Issue:2

    Topics: Animals; Chronic Disease; Circadian Rhythm; gamma-Aminobutyric Acid; Hyperprolactinemia; Hypothalamu

2003
Selective loss of spinal GABAergic or glycinergic neurons is not necessary for development of thermal hyperalgesia in the chronic constriction injury model of neuropathic pain.
    Pain, 2003, Volume: 104, Issue:1-2

    Topics: Animals; Chronic Disease; gamma-Aminobutyric Acid; Glycine; Hot Temperature; Hyperalgesia; Male; Pai

2003
Treatment of chronic neuropathic pain after traumatic central cervical cord lesion with gabapentin.
    Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:9

    Topics: Acetates; Amines; Amitriptyline; Analgesics; Arm; Carbamazepine; Central Cord Syndrome; Cervical Ver

2003
Selective changes in gamma-aminobutyric acid type A receptor subunits in the hippocampus in spontaneously seizing rats with chronic temporal lobe epilepsy.
    Neuroscience letters, 2003, Sep-25, Volume: 349, Issue:1

    Topics: Animals; Chronic Disease; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; gamma-Aminobuty

2003
Chronic pain syndrome after laparoscopic radical nephrectomy.
    The Journal of urology, 2003, Volume: 170, Issue:5

    Topics: Acetates; Aged; Amines; Analgesics; Analgesics, Opioid; Carcinoma, Renal Cell; Carcinoma, Transition

2003
[Unclear chronic aches. Often depression plays a part therein].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Acetates; Amines; Analgesics, Opioid; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Age

2003
The use of clinical trial simulation to support dose selection: application to development of a new treatment for chronic neuropathic pain.
    Pharmaceutical research, 2003, Volume: 20, Issue:11

    Topics: Acetates; Amines; Analgesics; Chronic Disease; Clinical Trials, Phase II as Topic; Computer Simulati

2003
Vulvodynia.
    Lancet (London, England), 2004, Mar-27, Volume: 363, Issue:9414

    Topics: Acetates; Amines; Anticonvulsants; Antidepressive Agents, Tricyclic; Biofeedback, Psychology; Chroni

2004
Gabapentin (Neurontin) for chronic pain.
    The Medical letter on drugs and therapeutics, 2004, Apr-12, Volume: 46, Issue:1180

    Topics: Acetates; Amines; Analgesics; Chronic Disease; Cyclohexanecarboxylic Acids; Drug Costs; Drug Interac

2004
Effect of gabapentin derivates on mechanical allodynia-like behaviour in a rat model of chronic sciatic constriction injury.
    Bioorganic & medicinal chemistry letters, 2004, May-17, Volume: 14, Issue:10

    Topics: Amines; Animals; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal

2004
Anticonvulsants and the relief of chronic pain: pregabalin and gabapentin as alpha(2)delta ligands at voltage-gated calcium channels.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:5

    Topics: Acetates; Amines; Anticonvulsants; Calcium Channels; Chronic Disease; Cyclohexanecarboxylic Acids; G

2004
Chronic placental insufficiency affects retinal development in the guinea pig.
    Investigative ophthalmology & visual science, 2004, Volume: 45, Issue:7

    Topics: Amacrine Cells; Animals; Blotting, Western; Body Weight; Calbindin 2; Calbindins; Catecholamines; Ch

2004
Dehydration-induced synaptic plasticity in magnocellular neurons of the hypothalamic supraoptic nucleus.
    Endocrinology, 2004, Volume: 145, Issue:11

    Topics: Animals; Chronic Disease; Dehydration; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid;

2004
Chronic stress attenuates GABAergic inhibition and alters gene expression of parvocellular neurons in rat hypothalamus.
    The European journal of neuroscience, 2004, Volume: 20, Issue:6

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anim

2004
GABAergic modulation of ventilatory response to acute and sustained hypoxia in obese Zucker rats.
    International journal of obesity (2005), 2005, Volume: 29, Issue:2

    Topics: Acute Disease; Animals; Bicuculline; Carbon Dioxide; Chronic Disease; GABA Antagonists; gamma-Aminob

2005
Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: implications for mechanism of action.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 313, Issue:3

    Topics: Acetates; Acute Disease; Amines; Analgesics; Animals; Benzylamines; Chronic Disease; Cyclohexanecarb

2005
Peptide leads new class of chronic pain drugs.
    Nature biotechnology, 2005, Volume: 23, Issue:4

    Topics: Calcium Channel Blockers; Calcium Channels, N-Type; Chronic Disease; gamma-Aminobutyric Acid; Humans

2005
Neuropathic pain following multilevel surgery in children with cerebral palsy: a case series and review.
    Paediatric anaesthesia, 2005, Volume: 15, Issue:5

    Topics: Adolescent; Amines; Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Cerebral Palsy; Chi

2005
Use of gabapentin for rest pain in chronic critical limb ischemia.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:6

    Topics: Amines; Analgesics; Bed Rest; Chronic Disease; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminob

2005
Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate.
    Journal of neurochemistry, 2005, Volume: 94, Issue:4

    Topics: Amines; Analgesics; Animals; Aspartic Acid; Chronic Disease; Cyclohexanecarboxylic Acids; Excitatory

2005
[Refractory chronic backache. Neuropathic pain contributions ignored?].
    MMW Fortschritte der Medizin, 2005, Dec-01, Volume: 147, Issue:48

    Topics: Algorithms; Analgesics; Anticonvulsants; Back Pain; Chronic Disease; Cross-Sectional Studies; Diagno

2005
The aetiology of chronic cough: a review of current theories for the otorhinolaryngologists.
    The Journal of laryngology and otology, 2006, Volume: 120, Issue:2

    Topics: Amines; Anticonvulsants; Chronic Disease; Cough; Cranial Nerve Diseases; Cyclohexanecarboxylic Acids

2006
Hyperalgesia induced by REM sleep loss: a phenomenon in search of a mechanism.
    Sleep, 2006, Volume: 29, Issue:2

    Topics: Acetylcholine; Adenosine; Anxiety; Chronic Disease; Depression; Drug Therapy; Drug-Related Side Effe

2006
[Pregabalin--clinical evidence and experiences].
    Krankenpflege Journal, 2005, Volume: 43, Issue:7-10

    Topics: Anticonvulsants; Chronic Disease; Controlled Clinical Trials as Topic; Drug Interactions; Epilepsy;

2005
Substantia Gelatinosa neurons in defined-medium organotypic slice culture are similar to those in acute slices from young adult rats.
    Pain, 2006, Volume: 121, Issue:3

    Topics: Action Potentials; Afferent Pathways; Aging; Animals; Chronic Disease; Culture Media; Electric Stimu

2006
Motor cortex stimulation for central pain following a traumatic brain injury.
    Pain, 2006, Volume: 123, Issue:1-2

    Topics: Accidental Falls; Adult; Amines; Amitriptyline; Analgesics, Non-Narcotic; Aphasia, Broca; Brain Inju

2006
Cerebrospinal fluid GABA levels in chronic migraine with and without depression.
    Brain research, 2006, May-23, Volume: 1090, Issue:1

    Topics: Brain; Chromatography, High Pressure Liquid; Chronic Disease; Comorbidity; Depressive Disorder; Fema

2006
Gabapentin in the treatment of intractable idiopathic chronic cough: case reports.
    The American journal of medicine, 2006, Volume: 119, Issue:5

    Topics: Adult; Aged; Amines; Calcium Channel Blockers; Chronic Disease; Cough; Cyclohexanecarboxylic Acids;

2006
Perioperative analgesia to prevent chronic postmastectomy pain.
    Anesthesia and analgesia, 2006, Volume: 103, Issue:2

    Topics: Amines; Anesthetics, Local; Breast Neoplasms; Chronic Disease; Cyclohexanecarboxylic Acids; Female;

2006
Pulsed radiofrequency of the dorsal root ganglia is superior to pharmacotherapy or pulsed radiofrequency of the intercostal nerves in the treatment of chronic postsurgical thoracic pain.
    Pain physician, 2006, Volume: 9, Issue:3

    Topics: Adult; Amines; Analgesics; Anticonvulsants; Carbamazepine; Catheter Ablation; Chronic Disease; Cyclo

2006
Inhibition of pain behavior by GABA(B) receptors in the thalamic ventrobasal complex: effect on normal rats subjected to the formalin test of nociception.
    Brain research, 2006, Oct-18, Volume: 1115, Issue:1

    Topics: Acute Disease; Analgesics; Animals; Baclofen; Behavior, Animal; Chronic Disease; Disease Models, Ani

2006
Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra.
    Journal of hepatology, 2006, Volume: 45, Issue:5

    Topics: Animals; Basal Ganglia; Chromones; Chronic Disease; GABA Antagonists; gamma-Aminobutyric Acid; Gluta

2006
GABA(B2) receptor subunit mRNA decreases in the thalamus of monoarthritic animals.
    Brain research bulletin, 2006, Dec-11, Volume: 71, Issue:1-3

    Topics: Afferent Pathways; Animals; Arthralgia; Arthritis; Chronic Disease; Disease Models, Animal; Down-Reg

2006
[Post-operative pain therapy of a chronic pain patient].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2006, Volume: 41, Issue:11

    Topics: Adult; Amines; Analgesics; Analgesics, Opioid; Chronic Disease; Cyclohexanecarboxylic Acids; Drug Co

2006
Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment.
    The Annals of otology, rhinology, and laryngology, 2006, Volume: 115, Issue:11

    Topics: Amines; Chronic Disease; Cough; Cranial Nerve Diseases; Cyclohexanecarboxylic Acids; Diagnosis, Diff

2006
Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment.
    Pediatrics, 2007, Volume: 119, Issue:2

    Topics: Adolescent; Adult; Amines; Analgesics; Child; Child, Preschool; Chronic Disease; Cyclohexanecarboxyl

2007
Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats.
    The journal of pain, 2007, Volume: 8, Issue:5

    Topics: Analgesics; Animals; Carrageenan; Chronic Disease; Disease Models, Animal; Dose-Response Relationshi

2007
Gabapentin use in chronic uraemic itch is in line with emerging pathogenetic hypothesis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:12

    Topics: Amines; Chronic Disease; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; P

2007
Alpha-2-delta ligands for singultus (hiccup) treatment: three case reports.
    Journal of pain and symptom management, 2007, Volume: 33, Issue:6

    Topics: Aged; Amines; Anticonvulsants; Calcium Channels; Chronic Disease; Cyclohexanecarboxylic Acids; Gabap

2007
[3H] pregabalin binding is increased in ipsilateral dorsal horn following chronic constriction injury.
    Neuroscience letters, 2007, May-01, Volume: 417, Issue:2

    Topics: Afferent Pathways; Analgesics; Animals; Binding, Competitive; Calcium Channel Blockers; Calcium Chan

2007
Motor activity is modulated via different neuronal circuits in rats with chronic liver failure than in normal rats.
    The European journal of neuroscience, 2007, Volume: 25, Issue:7

    Topics: Animals; Behavior, Animal; Brain; Chronic Disease; Dopamine; Excitatory Amino Acid Agonists; Excitat

2007
[Effects of acute maximal electroshock and chronic transauricular kindled seizures on learning abilities in Sprague-Dawley rats].
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2007, Volume: 36, Issue:2

    Topics: Animals; Chronic Disease; Electric Stimulation; Electrodes; Electroshock; gamma-Aminobutyric Acid; H

2007
Chronic orchialgia: consider gabapentin or nortriptyline before considering surgery.
    International journal of urology : official journal of the Japanese Urological Association, 2007, Volume: 14, Issue:7

    Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Amines; Calcium Channel Blockers; Chronic Disease; Cycloh

2007
[The 10-minute-consultation: chronic singultus].
    MMW Fortschritte der Medizin, 2007, Mar-22, Volume: 149, Issue:12

    Topics: Aged; Amines; Anti-Ulcer Agents; Anticonvulsants; Chronic Disease; Cyclohexanecarboxylic Acids; Diag

2007
Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia.
    Pain research & management, 2007,Autumn, Volume: 12, Issue:3

    Topics: Amitriptyline; Analgesics; Anti-Ulcer Agents; Anticoagulants; Antidepressive Agents; Anxiety; Cardio

2007
Pregabalin-induced generalized myoclonic status epilepticus in patients with chronic pain.
    Epilepsy & behavior : E&B, 2007, Volume: 11, Issue:3

    Topics: Aged, 80 and over; Analgesics; Chronic Disease; Electroencephalography; Epilepsies, Myoclonic; Femal

2007
Efficacy of pregabalin in the treatment of trigeminal neuralgia.
    Cephalalgia : an international journal of headache, 2008, Volume: 28, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Analgesics; Chronic Disease; Dose-Response Relationship, Drug; Facia

2008
Pregabalin in the treatment of chronic pruritus.
    Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:2 Suppl

    Topics: Anticonvulsants; Chronic Disease; gamma-Aminobutyric Acid; Humans; Pregabalin; Pruritus

2008
Pharmacologic investigation of the mechanism underlying cold allodynia using a new cold plate procedure in rats with chronic constriction injuries.
    Behavioural pharmacology, 2008, Volume: 19, Issue:1

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Calcium Channel Blockers; Chronic Disease; Cold Tempe

2008
Experimental autoimmune prostatitis induces chronic pelvic pain.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 294, Issue:4

    Topics: Amines; Analgesics; Anesthetics, Local; Animals; Autoimmune Diseases; Chronic Disease; Cyclohexaneca

2008
Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice.
    European journal of pain (London, England), 2008, Volume: 12, Issue:8

    Topics: Amines; Amitriptyline; Animals; Anticonvulsants; Antidepressive Agents, Tricyclic; Brain; Chronic Di

2008
Pharmacological treatment of neuropathic pain in older persons.
    Clinical interventions in aging, 2008, Volume: 3, Issue:1

    Topics: Aged; Amines; Analgesics, Opioid; Anticonvulsants; Antidepressive Agents, Tricyclic; Chronic Disease

2008
Side effects in preventive maintenance therapy with neuroleptics with special emphasis on tardive dyskinesia.
    Bibliotheca psychiatrica, 1981, Issue:160

    Topics: Antipsychotic Agents; Chronic Disease; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; Pa

1981
Neurotransmitters and CNS disease. Schizophrenia.
    Lancet (London, England), 1982, Oct-30, Volume: 2, Issue:8305

    Topics: Antipsychotic Agents; Atrophy; Brain; Cerebral Ventricles; Chronic Disease; Dopamine; Endorphins; GA

1982
Effects of a GABA-mimetic drug (sodium valproate) on visually evoked potentials in chronic schizophrenics.
    Neuropsychobiology, 1984, Volume: 11, Issue:1

    Topics: Adult; Brain; Brief Psychiatric Rating Scale; Chronic Disease; Clozapine; Dibenzazepines; Drug Thera

1984
[Sleep in chronic chorea patients after therapy with sodium valproate].
    Bollettino della Societa italiana di biologia sperimentale, 1984, May-30, Volume: 60, Issue:5

    Topics: Adult; Chorea; Chronic Disease; Female; gamma-Aminobutyric Acid; Humans; Huntington Disease; Male; M

1984
Increased GABA binding in mouse brain following acute swim stress.
    Brain research, 1981, Jun-29, Volume: 215, Issue:1-2

    Topics: Acute Disease; Analgesia; Animals; Brain; Chronic Disease; Female; gamma-Aminobutyric Acid; Kinetics

1981
[Effect of gamma-aminobutyric acid preparations on cerebral circulation in chronic cerebrovascular insufficiency].
    Klinicheskaia meditsina, 1982, Volume: 60, Issue:10

    Topics: Blood Pressure; Brachial Artery; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Dis

1982
gamma-Aminobutyric acid concentration in cerebrospinal fluid in schizophrenia.
    Journal of neurochemistry, 1981, Volume: 36, Issue:4

    Topics: Acute Disease; Adult; Chronic Disease; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; R

1981
[Possibility of using gamma-aminobutyric acid for treating chronic xanthate poisoning].
    Gigiena truda i professional'nye zabolevaniia, 1980, Issue:5

    Topics: Animals; Carbonates; Chronic Disease; Drug Evaluation, Preclinical; Environmental Exposure; gamma-Am

1980
L-glutamate and gamma-aminobutyric acid uptake in synaptosomes from the cerebral cortex of dogs with congenital chronic hepatic encephalopathy.
    Metabolic brain disease, 1995, Volume: 10, Issue:2

    Topics: Ammonia; Animals; Cerebral Cortex; Chronic Disease; Dogs; gamma-Aminobutyric Acid; Glutamic Acid; He

1995
Area-dependent changes in GABAergic function after acute and chronic cold stress.
    Neuroscience letters, 1993, May-14, Volume: 154, Issue:1-2

    Topics: Acute Disease; Animals; Cerebral Cortex; Chronic Disease; Cold Temperature; gamma-Aminobutyric Acid;

1993
Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.
    BMJ (Clinical research ed.), 1996, Nov-09, Volume: 313, Issue:7066

    Topics: Chronic Disease; Clinical Trials as Topic; Epilepsy; Follow-Up Studies; gamma-Aminobutyric Acid; Hum

1996
The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain.
    European journal of pharmacology, 1997, Apr-18, Volume: 324, Issue:2-3

    Topics: Acetates; Acute Disease; Amines; Analgesics; Animals; Anticonvulsants; Chronic Disease; Cyclohexanec

1997
Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions.
    BMJ (Clinical research ed.), 1997, Jun-07, Volume: 314, Issue:7095

    Topics: Adult; Anticonvulsants; Chronic Disease; Epilepsy; gamma-Aminobutyric Acid; Humans; Male; Vigabatrin

1997
Modulation of excitatory amino acids pathway: a possible therapeutic approach to chronic daily headache associated with analgesic drugs abuse.
    International journal of clinical pharmacology research, 1997, Volume: 17, Issue:2-3

    Topics: Acetates; Adult; Amines; Chronic Disease; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagon

1997
[Prophylactic treatment with gabapentin in chronic daily headache resistant to other drugs].
    Revista de neurologia, 1998, Volume: 26, Issue:153

    Topics: Acetates; Adult; Aged; Amines; Analgesics; Chronic Disease; Cyclohexanecarboxylic Acids; Drug Resist

1998
Physiological analysis of Rasmussen's encephalitis: patch clamp recordings of altered inhibitory neurotransmitter function in resected frontal cortical tissue.
    Epilepsy research, 1998, Volume: 31, Issue:1

    Topics: Cell Size; Cells, Cultured; Cerebral Cortex; Child; Chronic Disease; Clonazepam; Dose-Response Relat

1998
Characteristics of neurons with high-frequency discharge in the central nervous system and their relationship to chronic pain. Experimental and clinical investigations.
    Stereotactic and functional neurosurgery, 1997, Volume: 68, Issue:1-4 Pt 1

    Topics: Animals; Calcium Channel Blockers; Chronic Disease; Denervation; Disease Models, Animal; Electric St

1997
[ETICS Study: Empirical therapy of idiopathic chronic singultus].
    Zeitschrift fur Gastroenterologie, 1998, Volume: 36, Issue:7

    Topics: Acetates; Aged; Aged, 80 and over; Amines; Baclofen; Chronic Disease; Cisapride; Cyclohexanecarboxyl

1998
GABA synapses enter the molecular big time.
    Nature medicine, 1998, Volume: 4, Issue:10

    Topics: Chronic Disease; Epilepsy; gamma-Aminobutyric Acid; Humans; Neural Inhibition; Neuronal Plasticity;

1998
Long-term treatment with vigabatrin - 10 years of clinical experience.
    Seizure, 1999, Volume: 8, Issue:3

    Topics: Anticonvulsants; Chronic Disease; Cohort Studies; Epilepsy; Female; Follow-Up Studies; gamma-Aminobu

1999
Seizure-induced hippocampal damage and chronic epilepsy: a hebbian theory of epileptogenesis.
    Advances in neurology, 1999, Volume: 79

    Topics: Animals; Chronic Disease; Dentate Gyrus; Epilepsy; gamma-Aminobutyric Acid; Hippocampus; Interneuron

1999
Amino acid efflux and cell volume regulation in cerebrocortical minislices prepared from chronically hyponatraemic and hypernatraemic rats.
    Neurochemistry international, 1999, Volume: 35, Issue:6

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amino Acids; Animals; Aspartic Acid; Biological Tr

1999
The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy.
    Epilepsia, 1999, Volume: 40, Issue:10

    Topics: Acetates; Ambulatory Care; Amines; Anticonvulsants; Chronic Disease; Clinical Trials as Topic; Cyclo

1999
Gabapentin therapy for vulvodynia.
    Anesthesia and analgesia, 1999, Volume: 89, Issue:6

    Topics: Acetates; Adult; Aged; Aged, 80 and over; Amines; Analgesics; Chronic Disease; Cyclohexanecarboxylic

1999
Gabapentin "add-on therapy" for idiopathic chronic hiccup (ICH).
    Journal of clinical gastroenterology, 2000, Volume: 30, Issue:3

    Topics: Acetates; Aged; Amines; Baclofen; Chronic Disease; Cisapride; Cyclohexanecarboxylic Acids; Drug Admi

2000
Gabapentin for chronic pain in spinal cord injury: a case report.
    Archives of physical medicine and rehabilitation, 2000, Volume: 81, Issue:10

    Topics: Acetates; Adult; Amines; Analgesics; Chronic Disease; Cyclohexanecarboxylic Acids; Female; Gabapenti

2000
Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study.
    Pain, 2000, Dec-15, Volume: 89, Issue:1

    Topics: Adult; Anxiety; Aspartic Acid; Back Pain; Brain Chemistry; Choline; Chronic Disease; Creatine; Femal

2000
Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
    Epilepsia, 2000, Volume: 41, Issue:12

    Topics: Acetates; Adolescent; Adult; Age of Onset; Aged; Amines; Anticonvulsants; Chronic Disease; Cyclohexa

2000
Collapse of extracellular glutamate regulation during epileptogenesis: down-regulation and functional failure of glutamate transporter function in rats with chronic seizures induced by kainic acid.
    Journal of neurochemistry, 2001, Volume: 76, Issue:3

    Topics: Amino Acid Transport System X-AG; Animals; ATP-Binding Cassette Transporters; Carrier Proteins; Chro

2001
Rodent model of chronic central pain after spinal cord contusion injury and effects of gabapentin.
    Journal of neurotrauma, 2000, Volume: 17, Issue:12

    Topics: Acetates; Amines; Analgesics; Animals; Behavior, Animal; Chronic Disease; Contusions; Cyclohexanecar

2000
The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex.
    Neurosurgery, 2001, Volume: 48, Issue:2

    Topics: Acute Disease; Amino Acids; Animals; Blood Glucose; Brain Ischemia; Cerebral Cortex; Chronic Disease

2001
gamma-Aminobutyric acid (GABA)--A function and binding in the paraventricular nucleus of the hypothalamus in chronic renal-wrap hypertension.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:2 Pt 2

    Topics: Animals; Bicuculline; Binding Sites; Blood Pressure; Chronic Disease; GABA Antagonists; GABA-A Recep

2001
Changes in exploratory behavior as a measure of chronic central pain following spinal cord injury.
    Journal of neurotrauma, 2001, Volume: 18, Issue:10

    Topics: Acetates; Amines; Analgesics; Animals; Chronic Disease; Cyclohexanecarboxylic Acids; Exploratory Beh

2001
Diminished allopregnanolone enhancement of GABA(A) receptor currents in a rat model of chronic temporal lobe epilepsy.
    The Journal of physiology, 2001, Dec-01, Volume: 537, Issue:Pt 2

    Topics: Animals; Anticonvulsants; Chronic Disease; Diazepam; Electric Conductivity; Epilepsy, Temporal Lobe;

2001
Increased [(3)H]tiagabine binding to GAT-1 in the cingulate cortex in schizophrenia.
    Neuropsychobiology, 2002, Volume: 45, Issue:1

    Topics: Aged; Aged, 80 and over; Brain; Carrier Proteins; Case-Control Studies; Caudate Nucleus; Chronic Dis

2002
[Gabapentin in the treatment of chronic intractable pain].
    Schmerz (Berlin, Germany), 2002, Volume: 16, Issue:1

    Topics: Acetates; Amines; Amitriptyline; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non

2002
Spontaneous recurrent seizures and neuropathology in the chronic phase of the pilocarpine and picrotoxin model epilepsy.
    Neurological research, 2002, Volume: 24, Issue:2

    Topics: Acetylcholine; Action Potentials; Aggression; Animals; Behavior, Animal; Brain; Chronic Disease; Dis

2002
Gabapentin for neuropathic pain following spinal cord injury.
    Spinal cord, 2002, Volume: 40, Issue:6

    Topics: Acetates; Acute Disease; Adolescent; Adult; Aged; Amines; Chronic Disease; Cyclohexanecarboxylic Aci

2002
Experimental conditions for the continuous subcutaneous infusion of four central analgesics in rats.
    Pharmacology, biochemistry, and behavior, 2002, Volume: 72, Issue:4

    Topics: Acetates; Amines; Analgesics; Anesthetics, Dissociative; Animals; Anticonvulsants; Antidepressive Ag

2002
Stimulation of prolactin and growth hormone secretion by muscimol, a gamma-aminobutyric acid agonist.
    The Journal of clinical endocrinology and metabolism, 1978, Volume: 47, Issue:6

    Topics: Adult; Aged; Chronic Disease; Female; gamma-Aminobutyric Acid; Growth Hormone; Humans; Huntington Di

1978
[Treatment of chronic diffuse arachnoiditis with aminalon].
    Vrachebnoe delo, 1978, Issue:1

    Topics: Adult; Aminobutyrates; Arachnoiditis; Chronic Disease; Drug Evaluation; Female; gamma-Aminobutyric A

1978
Meeting report: Biochemical aspects of schizophrenia. Alabama, April 1975.
    Psychoneuroendocrinology, 1975, Volume: 1, Issue:2

    Topics: Acute Disease; Blood Platelets; Chronic Disease; Dopamine; Folic Acid; gamma-Aminobutyric Acid; Hall

1975
The gamma-aminobutyric acid (GABA) system in brain during acute and chronic ethanol intoxication.
    Journal of neurochemistry, 1975, Volume: 25, Issue:1

    Topics: 1-Propanol; 4-Aminobutyrate Transaminase; Acute Disease; Alcoholic Intoxication; Aminobutyrates; Ani

1975
Chronic encephalopathies induced by mercury or lead: aspects of underlying cellular and molecular mechanisms.
    British journal of industrial medicine, 1992, Volume: 49, Issue:4

    Topics: Astrocytes; Brain Diseases; Cells, Cultured; Chronic Disease; gamma-Aminobutyric Acid; Glutamates; L

1992
[The gamma-aminobutyric acid content of the blood plasma in patients with Itsenko-Cushing disease and its dependence on clinical and hormonal indices].
    Terapevticheskii arkhiv, 1991, Volume: 63, Issue:10

    Topics: 11-Hydroxycorticosteroids; 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenalectomy; Adrenocorticot

1991
Paradoxical role of GABA in a chronic model of petit mal (absence)-like epilepsy in the rat.
    European journal of pharmacology, 1990, Jan-25, Volume: 176, Issue:1

    Topics: Animals; Anticonvulsants; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug;

1990
[Immunological and metabolic disorders and the means for their correction in patients with chronic bronchitis].
    Terapevticheskii arkhiv, 1991, Volume: 63, Issue:12

    Topics: Adolescent; Adult; Antibody Formation; Antioxidants; Bronchitis; Chronic Disease; Drug Evaluation; F

1991
Reversal of chronic hepatic encephalopathy by colonic exclusion: poor correlation with blood GABA levels.
    The American journal of gastroenterology, 1990, Volume: 85, Issue:12

    Topics: Ammonia; Chronic Disease; Electroencephalography; Female; gamma-Aminobutyric Acid; Hepatic Encephalo

1990
Changes in GABA-immunoreactive cell density during motor focal epilepsy induced by cobalt in the rat.
    Experimental brain research, 1989, Volume: 76, Issue:2

    Topics: Animals; Cell Count; Chronic Disease; Cobalt; Epilepsies, Partial; gamma-Aminobutyric Acid; Male; Mo

1989
Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease.
    Hepato-gastroenterology, 1989, Volume: 36, Issue:6

    Topics: Acute Disease; Adult; Chronic Disease; Delta Rhythm; Female; gamma-Aminobutyric Acid; Hepatic Enceph

1989
Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients.
    Psychiatry research, 1987, Volume: 22, Issue:4

    Topics: Adult; Aged; Amino Acids; Amygdala; Brain Chemistry; Chronic Disease; Female; gamma-Aminobutyric Aci

1987
Failure of the GABAergic drug, sodium valproate, to reduce basal plasma prolactin secretion in chronic schizophrenia.
    Psychoneuroendocrinology, 1985, Volume: 10, Issue:4

    Topics: Adult; Chronic Disease; Female; gamma-Aminobutyric Acid; Humans; Hypothalamo-Hypophyseal System; Mid

1985
Effects of chronic intracerebroventricular GABAergic treatment on basal and chronic or acute stress-induced adrenocortical activities in the thalamic pigeon.
    Neuroendocrinology, 1986, Volume: 44, Issue:4

    Topics: Acute Disease; Adrenal Cortex; Animals; Chronic Disease; Columbidae; Corticosterone; Decerebrate Sta

1986
Serum gamma-aminobutyric acid (GABA) levels in patients with hepatic encephalopathy.
    Hepato-gastroenterology, 1985, Volume: 32, Issue:4

    Topics: Ammonia; Chronic Disease; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Humans; Kidney Failure, C

1985
Proceedings: Ammonia and amino acids in the brain of the rat with chronic hepatic failure.
    Archives internationales de physiologie et de biochimie, 1974, Volume: 82, Issue:4

    Topics: Amino Acids; Ammonia; Animals; Aspartic Acid; Brain; Carbon Tetrachloride Poisoning; Chronic Disease

1974